id	sid	tid	token	lemma	pos
gsrj-6	1	1	determinants	determinant	NOUN
gsrj-6	1	2	of	of	ADP
gsrj-6	1	3	hepatocellular	hepatocellular	ADJ
gsrj-6	1	4	carcinoma	carcinoma	NOUN
gsrj-6	1	5	in	in	ADP
gsrj-6	1	6	the	the	DET
gsrj-6	1	7	united	united	PROPN
gsrj-6	1	8	states	states	PROPN
gsrj-6	1	9	:	:	PUNCT
gsrj-6	1	10	differences	difference	NOUN
gsrj-6	1	11	in	in	ADP
gsrj-6	1	12	risk	risk	NOUN
gsrj-6	1	13	factor	factor	NOUN
gsrj-6	1	14	and	and	CCONJ
gsrj-6	1	15	genetic	genetic	ADJ
gsrj-6	1	16	susceptibility	susceptibility	NOUN
gsrj-6	1	17	by	by	ADP
gsrj-6	1	18	race/	race/	NUM
gsrj-6	1	19	ethnicity	ethnicity	NOUN
gsrj-6	1	20	mehwish	mehwish	PROPN
gsrj-6	1	21	rafique	rafique	PROPN
gsrj-6	1	22	,	,	PUNCT
gsrj-6	1	23	dana	dana	PROPN
gsrj-6	1	24	kristjansson	kristjansson	PROPN
gsrj-6	1	25	,	,	PUNCT
gsrj-6	1	26	phd	phd	PROPN
gsrj-6	2	1	.	.	PUNCT
gsrj-6	2	2	volume	volume	NOUN
gsrj-6	2	3	one	one	NUM
gsrj-6	2	4	edition	edition	NOUN
gsrj-6	2	5	one	one	NUM
gsrj-6	2	6	february	february	PROPN
gsrj-6	2	7	2021	2021	NUM
gsrj-6	2	8	georgetown	georgetown	PROPN
gsrj-6	2	9	scientific	scientific	PROPN
gsrj-6	2	10	research	research	PROPN
gsrj-6	2	11	journal	journal	PROPN
gsrj-6	2	12	18	18	NUM
gsrj-6	2	13	georgetown	georgetown	PROPN
gsrj-6	2	14	scientific	scientific	PROPN
gsrj-6	2	15	research	research	PROPN
gsrj-6	2	16	journal	journal	PROPN
gsrj-6	2	17	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	2	18	determinants	determinant	NOUN
gsrj-6	2	19	of	of	ADP
gsrj-6	2	20	hepatocellular	hepatocellular	ADJ
gsrj-6	2	21	carcinoma	carcinoma	NOUN
gsrj-6	2	22	in	in	ADP
gsrj-6	2	23	the	the	DET
gsrj-6	2	24	united	united	PROPN
gsrj-6	2	25	states	states	PROPN
gsrj-6	2	26	:	:	PUNCT
gsrj-6	2	27	differences	difference	NOUN
gsrj-6	2	28	in	in	ADP
gsrj-6	2	29	risk	risk	NOUN
gsrj-6	2	30	factor	factor	NOUN
gsrj-6	2	31	and	and	CCONJ
gsrj-6	2	32	genetic	genetic	ADJ
gsrj-6	2	33	susceptibility	susceptibility	NOUN
gsrj-6	2	34	by	by	ADP
gsrj-6	2	35	race	race	NOUN
gsrj-6	2	36	/	/	SYM
gsrj-6	2	37	ethnicity	ethnicity	NOUN
gsrj-6	2	38	mehwish	mehwish	NOUN
gsrj-6	2	39	rafique1	rafique1	ADV
gsrj-6	2	40	and	and	CCONJ
gsrj-6	2	41	dana	dana	PROPN
gsrj-6	2	42	kristjansson2	kristjansson2	PROPN
gsrj-6	3	1	1	1	NUM
gsrj-6	3	2	department	department	PROPN
gsrj-6	3	3	of	of	ADP
gsrj-6	3	4	systems	system	NOUN
gsrj-6	3	5	medicine	medicine	NOUN
gsrj-6	3	6	,	,	PUNCT
gsrj-6	3	7	georgetown	georgetown	PROPN
gsrj-6	3	8	university	university	PROPN
gsrj-6	3	9	school	school	NOUN
gsrj-6	3	10	of	of	ADP
gsrj-6	3	11	medicine	medicine	NOUN
gsrj-6	3	12	,	,	PUNCT
gsrj-6	3	13	washington	washington	PROPN
gsrj-6	3	14	dc	dc	PROPN
gsrj-6	3	15	2	2	NUM
gsrj-6	3	16	department	department	NOUN
gsrj-6	3	17	of	of	ADP
gsrj-6	3	18	genetics	genetic	NOUN
gsrj-6	3	19	and	and	CCONJ
gsrj-6	3	20	bioinformatics	bioinformatic	NOUN
gsrj-6	3	21	,	,	PUNCT
gsrj-6	3	22	norwegian	norwegian	PROPN
gsrj-6	3	23	institute	institute	NOUN
gsrj-6	3	24	of	of	ADP
gsrj-6	3	25	public	public	PROPN
gsrj-6	3	26	health	health	PROPN
gsrj-6	3	27	,	,	PUNCT
gsrj-6	3	28	oslo	oslo	PROPN
gsrj-6	3	29	,	,	PUNCT
gsrj-6	3	30	norway	norway	PROPN
gsrj-6	3	31	e	e	NOUN
gsrj-6	3	32	-	-	NOUN
gsrj-6	3	33	mail	mail	NOUN
gsrj-6	3	34	:	:	PUNCT
gsrj-6	3	35	mr1502@georgetown.edu	mr1502@georgetown.edu	PROPN
gsrj-6	3	36	abstract	abstract	ADJ
gsrj-6	3	37	background	background	NOUN
gsrj-6	3	38	:	:	PUNCT
gsrj-6	3	39	hepatocellular	hepatocellular	ADJ
gsrj-6	3	40	carcinoma	carcinoma	NOUN
gsrj-6	3	41	(	(	PUNCT
gsrj-6	3	42	hcc	hcc	PROPN
gsrj-6	3	43	)	)	PUNCT
gsrj-6	3	44	is	be	AUX
gsrj-6	3	45	one	one	NUM
gsrj-6	3	46	of	of	ADP
gsrj-6	3	47	the	the	DET
gsrj-6	3	48	few	few	ADJ
gsrj-6	3	49	cancers	cancer	NOUN
gsrj-6	3	50	with	with	ADP
gsrj-6	3	51	an	an	DET
gsrj-6	3	52	increasing	increase	VERB
gsrj-6	3	53	incidence	incidence	NOUN
gsrj-6	3	54	and	and	CCONJ
gsrj-6	3	55	mortality	mortality	NOUN
gsrj-6	3	56	worldwide	worldwide	ADV
gsrj-6	3	57	.	.	PUNCT
gsrj-6	4	1	this	this	DET
gsrj-6	4	2	study	study	NOUN
gsrj-6	4	3	aims	aim	VERB
gsrj-6	4	4	to	to	PART
gsrj-6	4	5	determine	determine	VERB
gsrj-6	4	6	the	the	DET
gsrj-6	4	7	contribution	contribution	NOUN
gsrj-6	4	8	of	of	ADP
gsrj-6	4	9	known	know	VERB
gsrj-6	4	10	risk	risk	NOUN
gsrj-6	4	11	factors	factor	NOUN
gsrj-6	4	12	for	for	ADP
gsrj-6	4	13	hcc	hcc	PROPN
gsrj-6	4	14	by	by	ADP
gsrj-6	4	15	race	race	NOUN
gsrj-6	4	16	and	and	CCONJ
gsrj-6	4	17	ethnicity	ethnicity	NOUN
gsrj-6	4	18	.	.	PUNCT
gsrj-6	5	1	methods	method	NOUN
gsrj-6	5	2	:	:	PUNCT
gsrj-6	5	3	data	datum	NOUN
gsrj-6	5	4	on	on	ADP
gsrj-6	5	5	race	race	NOUN
gsrj-6	5	6	,	,	PUNCT
gsrj-6	5	7	ethnicity	ethnicity	NOUN
gsrj-6	5	8	,	,	PUNCT
gsrj-6	5	9	age	age	NOUN
gsrj-6	5	10	,	,	PUNCT
gsrj-6	5	11	and	and	CCONJ
gsrj-6	5	12	gender	gender	NOUN
gsrj-6	5	13	were	be	AUX
gsrj-6	5	14	obtained	obtain	VERB
gsrj-6	5	15	from	from	ADP
gsrj-6	5	16	national	national	ADJ
gsrj-6	5	17	health	health	PROPN
gsrj-6	5	18	and	and	CCONJ
gsrj-6	5	19	nutrition	nutrition	NOUN
gsrj-6	5	20	examination	examination	NOUN
gsrj-6	5	21	survey	survey	NOUN
gsrj-6	5	22	(	(	PUNCT
gsrj-6	5	23	nhanes	nhane	NOUN
gsrj-6	5	24	)	)	PUNCT
gsrj-6	5	25	.	.	PUNCT
gsrj-6	6	1	population	population	NOUN
gsrj-6	6	2	attributable	attributable	ADJ
gsrj-6	6	3	fractions	fraction	NOUN
gsrj-6	6	4	(	(	PUNCT
gsrj-6	6	5	pafs	pafs	NOUN
gsrj-6	6	6	)	)	PUNCT
gsrj-6	6	7	of	of	ADP
gsrj-6	6	8	risk	risk	NOUN
gsrj-6	6	9	factors	factor	NOUN
gsrj-6	6	10	were	be	AUX
gsrj-6	6	11	estimated	estimate	VERB
gsrj-6	6	12	using	use	VERB
gsrj-6	6	13	non	non	ADJ
gsrj-6	6	14	-	-	ADJ
gsrj-6	6	15	invasive	invasive	ADJ
gsrj-6	6	16	scoring	scoring	NOUN
gsrj-6	6	17	measures	measure	NOUN
gsrj-6	6	18	of	of	ADP
gsrj-6	6	19	hepatitis	hepatitis	PROPN
gsrj-6	6	20	b	b	PROPN
gsrj-6	6	21	and	and	CCONJ
gsrj-6	6	22	c	c	PROPN
gsrj-6	6	23	virus	virus	NOUN
gsrj-6	6	24	infection	infection	NOUN
gsrj-6	6	25	,	,	PUNCT
gsrj-6	6	26	excessive	excessive	ADJ
gsrj-6	6	27	alcohol	alcohol	NOUN
gsrj-6	6	28	use	use	NOUN
gsrj-6	6	29	,	,	PUNCT
gsrj-6	6	30	smoking	smoking	NOUN
gsrj-6	6	31	,	,	PUNCT
gsrj-6	6	32	diabetes	diabetes	NOUN
gsrj-6	6	33	and	and	CCONJ
gsrj-6	6	34	emerging	emerge	VERB
gsrj-6	6	35	metabolic	metabolic	NOUN
gsrj-6	6	36	risk	risk	NOUN
gsrj-6	6	37	factors	factor	NOUN
gsrj-6	6	38	[	[	X
gsrj-6	6	39	non	non	ADJ
gsrj-6	6	40	-	-	ADJ
gsrj-6	6	41	alcoholic	alcoholic	ADJ
gsrj-6	6	42	steatohepatitis	steatohepatitis	NOUN
gsrj-6	6	43	advanced	advanced	ADJ
gsrj-6	6	44	cirrhosis	cirrhosis	NOUN
gsrj-6	6	45	(	(	PUNCT
gsrj-6	6	46	nash	nash	NOUN
gsrj-6	6	47	)	)	PUNCT
gsrj-6	6	48	and	and	CCONJ
gsrj-6	6	49	non	non	ADJ
gsrj-6	6	50	-	-	ADJ
gsrj-6	6	51	alcoholic	alcoholic	ADJ
gsrj-6	6	52	fatty	fatty	NOUN
gsrj-6	6	53	liver	liver	NOUN
gsrj-6	6	54	disease	disease	NOUN
gsrj-6	6	55	-	-	PUNCT
gsrj-6	6	56	advanced	advance	VERB
gsrj-6	6	57	fibrosis	fibrosis	NOUN
gsrj-6	6	58	(	(	PUNCT
gsrj-6	6	59	nafld	nafld	ADV
gsrj-6	6	60	-	-	PUNCT
gsrj-6	6	61	fib	fib	NOUN
gsrj-6	6	62	)	)	PUNCT
gsrj-6	6	63	]	]	PUNCT
gsrj-6	6	64	over	over	ADP
gsrj-6	6	65	a	a	DET
gsrj-6	6	66	10	10	NUM
gsrj-6	6	67	-	-	PUNCT
gsrj-6	6	68	year	year	NOUN
gsrj-6	6	69	period	period	NOUN
gsrj-6	6	70	,	,	PUNCT
gsrj-6	6	71	1999	1999	NUM
gsrj-6	6	72	-	-	SYM
gsrj-6	6	73	2002	2002	NUM
gsrj-6	6	74	and	and	CCONJ
gsrj-6	6	75	2009	2009	NUM
gsrj-6	6	76	-	-	SYM
gsrj-6	6	77	2012	2012	NUM
gsrj-6	6	78	.	.	PUNCT
gsrj-6	7	1	genetic	genetic	ADJ
gsrj-6	7	2	analysis	analysis	NOUN
gsrj-6	7	3	was	be	AUX
gsrj-6	7	4	performed	perform	VERB
gsrj-6	7	5	using	use	VERB
gsrj-6	7	6	disgenet	disgenet	NOUN
gsrj-6	7	7	platform	platform	NOUN
gsrj-6	7	8	by	by	ADP
gsrj-6	7	9	attaining	attain	VERB
gsrj-6	7	10	the	the	DET
gsrj-6	7	11	top	top	ADJ
gsrj-6	7	12	enriched	enrich	VERB
gsrj-6	7	13	genes	gene	NOUN
gsrj-6	7	14	strongly	strongly	ADV
gsrj-6	7	15	related	relate	VERB
gsrj-6	7	16	to	to	ADP
gsrj-6	7	17	hcc	hcc	PROPN
gsrj-6	7	18	.	.	PUNCT
gsrj-6	8	1	furthermore	furthermore	ADV
gsrj-6	8	2	,	,	PUNCT
gsrj-6	8	3	cytoscape	cytoscape	NOUN
gsrj-6	8	4	network	network	NOUN
gsrj-6	8	5	was	be	AUX
gsrj-6	8	6	used	use	VERB
gsrj-6	8	7	to	to	PART
gsrj-6	8	8	form	form	VERB
gsrj-6	8	9	a	a	DET
gsrj-6	8	10	gene	gene	NOUN
gsrj-6	8	11	-	-	PUNCT
gsrj-6	8	12	disease	disease	NOUN
gsrj-6	8	13	network	network	NOUN
gsrj-6	8	14	association	association	PROPN
gsrj-6	8	15	.	.	PUNCT
gsrj-6	9	1	results	result	NOUN
gsrj-6	9	2	:	:	PUNCT
gsrj-6	9	3	nash	nash	NOUN
gsrj-6	9	4	-	-	PUNCT
gsrj-6	9	5	cirrhosis	cirrhosis	NOUN
gsrj-6	9	6	increased	increase	VERB
gsrj-6	9	7	in	in	ADP
gsrj-6	9	8	the	the	DET
gsrj-6	9	9	overall	overall	ADJ
gsrj-6	9	10	population	population	NOUN
gsrj-6	9	11	and	and	CCONJ
gsrj-6	9	12	among	among	ADP
gsrj-6	9	13	all	all	DET
gsrj-6	9	14	race	race	NOUN
gsrj-6	9	15	and	and	CCONJ
gsrj-6	9	16	ethnic	ethnic	ADJ
gsrj-6	9	17	groups	group	NOUN
gsrj-6	9	18	.	.	PUNCT
gsrj-6	10	1	both	both	PRON
gsrj-6	10	2	liver	liver	VERB
gsrj-6	10	3	fat	fat	ADJ
gsrj-6	10	4	accumulation	accumulation	NOUN
gsrj-6	10	5	and	and	CCONJ
gsrj-6	10	6	alt	alt	PROPN
gsrj-6	10	7	levels	level	NOUN
gsrj-6	10	8	vary	vary	VERB
gsrj-6	10	9	among	among	ADP
gsrj-6	10	10	different	different	ADJ
gsrj-6	10	11	populations	population	NOUN
gsrj-6	10	12	;	;	PUNCT
gsrj-6	10	13	however	however	ADV
gsrj-6	10	14	,	,	PUNCT
gsrj-6	10	15	hispanics	hispanic	NOUN
gsrj-6	10	16	have	have	VERB
gsrj-6	10	17	the	the	DET
gsrj-6	10	18	highest	high	ADJ
gsrj-6	10	19	prevalence	prevalence	NOUN
gsrj-6	10	20	of	of	ADP
gsrj-6	10	21	nafld	nafld	ADJ
gsrj-6	10	22	and	and	CCONJ
gsrj-6	10	23	elevated	elevated	ADJ
gsrj-6	10	24	alt	alt	PROPN
gsrj-6	10	25	levels	level	NOUN
gsrj-6	10	26	.	.	PUNCT
gsrj-6	11	1	non	non	ADJ
gsrj-6	11	2	-	-	ADJ
gsrj-6	11	3	hispanic	hispanic	ADJ
gsrj-6	11	4	(	(	PUNCT
gsrj-6	11	5	nh	nh	NOUN
gsrj-6	11	6	)	)	PUNCT
gsrj-6	11	7	blacks	black	NOUN
gsrj-6	11	8	and	and	CCONJ
gsrj-6	11	9	hispanics	hispanic	NOUN
gsrj-6	11	10	had	have	VERB
gsrj-6	11	11	a	a	DET
gsrj-6	11	12	3	3	NUM
gsrj-6	11	13	to	to	PART
gsrj-6	11	14	4	4	NUM
gsrj-6	11	15	times	time	NOUN
gsrj-6	11	16	higher	high	ADJ
gsrj-6	11	17	paf	paf	PROPN
gsrj-6	11	18	for	for	ADP
gsrj-6	11	19	hcc	hcc	PROPN
gsrj-6	11	20	than	than	ADP
gsrj-6	11	21	whites	white	NOUN
gsrj-6	11	22	attributed	attribute	VERB
gsrj-6	11	23	due	due	ADP
gsrj-6	11	24	to	to	ADP
gsrj-6	11	25	chronic	chronic	ADJ
gsrj-6	11	26	liver	liver	NOUN
gsrj-6	11	27	diseases	disease	NOUN
gsrj-6	11	28	,	,	PUNCT
gsrj-6	11	29	including	include	VERB
gsrj-6	11	30	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	11	31	and	and	CCONJ
gsrj-6	11	32	nafld	nafld	ADV
gsrj-6	11	33	-	-	PUNCT
gsrj-6	11	34	fib	fib	NOUN
gsrj-6	11	35	.	.	PUNCT
gsrj-6	12	1	our	our	PRON
gsrj-6	12	2	genetic	genetic	ADJ
gsrj-6	12	3	analysis	analysis	NOUN
gsrj-6	12	4	demonstrated	demonstrate	VERB
gsrj-6	12	5	that	that	SCONJ
gsrj-6	12	6	pnpla3	pnpla3	NOUN
gsrj-6	12	7	polymorphism	polymorphism	NOUN
gsrj-6	12	8	is	be	AUX
gsrj-6	12	9	strongly	strongly	ADV
gsrj-6	12	10	associated	associate	VERB
gsrj-6	12	11	with	with	ADP
gsrj-6	12	12	nafld	nafld	ADV
gsrj-6	12	13	-	-	PUNCT
gsrj-6	12	14	fib	fib	NOUN
gsrj-6	12	15	,	,	PUNCT
gsrj-6	12	16	which	which	PRON
gsrj-6	12	17	appears	appear	VERB
gsrj-6	12	18	to	to	PART
gsrj-6	12	19	represent	represent	VERB
gsrj-6	12	20	susceptibility	susceptibility	NOUN
gsrj-6	12	21	to	to	PART
gsrj-6	12	22	liver	liver	NOUN
gsrj-6	12	23	disease	disease	NOUN
gsrj-6	12	24	among	among	ADP
gsrj-6	12	25	the	the	DET
gsrj-6	12	26	hispanic	hispanic	ADJ
gsrj-6	12	27	community	community	NOUN
gsrj-6	12	28	.	.	PUNCT
gsrj-6	13	1	conclusion	conclusion	NOUN
gsrj-6	13	2	:	:	PUNCT
gsrj-6	13	3	hispanics	hispanic	NOUN
gsrj-6	13	4	and	and	CCONJ
gsrj-6	13	5	nh	nh	PROPN
gsrj-6	13	6	blacks	black	NOUN
gsrj-6	13	7	are	be	AUX
gsrj-6	13	8	at	at	ADP
gsrj-6	13	9	a	a	DET
gsrj-6	13	10	disproportionately	disproportionately	ADV
gsrj-6	13	11	higher	high	ADJ
gsrj-6	13	12	risk	risk	NOUN
gsrj-6	13	13	for	for	ADP
gsrj-6	13	14	hcc	hcc	PROPN
gsrj-6	13	15	in	in	ADP
gsrj-6	13	16	part	part	NOUN
gsrj-6	13	17	due	due	ADP
gsrj-6	13	18	to	to	ADP
gsrj-6	13	19	the	the	DET
gsrj-6	13	20	higher	high	ADJ
gsrj-6	13	21	prevalence	prevalence	NOUN
gsrj-6	13	22	of	of	ADP
gsrj-6	13	23	liver	liver	NOUN
gsrj-6	13	24	disease	disease	NOUN
gsrj-6	13	25	comorbidities	comorbiditie	NOUN
gsrj-6	13	26	,	,	PUNCT
gsrj-6	13	27	including	include	VERB
gsrj-6	13	28	nash	nash	NOUN
gsrj-6	13	29	-	-	PUNCT
gsrj-6	13	30	cirrhosis	cirrhosis	NOUN
gsrj-6	13	31	and	and	CCONJ
gsrj-6	13	32	nafld	nafld	ADV
gsrj-6	13	33	-	-	PUNCT
gsrj-6	13	34	fib	fib	NOUN
gsrj-6	13	35	.	.	PUNCT
gsrj-6	14	1	compared	compare	VERB
gsrj-6	14	2	19	19	NUM
gsrj-6	14	3	georgetown	georgetown	PROPN
gsrj-6	14	4	scientific	scientific	PROPN
gsrj-6	14	5	research	research	PROPN
gsrj-6	14	6	journal	journal	PROPN
gsrj-6	14	7	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	14	8	to	to	ADP
gsrj-6	14	9	nh	nh	PROPN
gsrj-6	14	10	whites	white	NOUN
gsrj-6	14	11	,	,	PUNCT
gsrj-6	14	12	hispanics	hispanics	PROPN
gsrj-6	14	13	and	and	CCONJ
gsrj-6	14	14	nh	nh	PROPN
gsrj-6	14	15	blacks	black	NOUN
gsrj-6	14	16	have	have	VERB
gsrj-6	14	17	a	a	DET
gsrj-6	14	18	higher	high	ADJ
gsrj-6	14	19	baseline	baseline	NOUN
gsrj-6	14	20	risk	risk	NOUN
gsrj-6	14	21	for	for	ADP
gsrj-6	14	22	liver	liver	NOUN
gsrj-6	14	23	cancer	cancer	NOUN
gsrj-6	14	24	due	due	ADP
gsrj-6	14	25	to	to	ADP
gsrj-6	14	26	non	non	ADJ
gsrj-6	14	27	-	-	ADJ
gsrj-6	14	28	metabolic	metabolic	ADJ
gsrj-6	14	29	factors	factor	NOUN
gsrj-6	14	30	,	,	PUNCT
gsrj-6	14	31	which	which	PRON
gsrj-6	14	32	may	may	AUX
gsrj-6	14	33	include	include	VERB
gsrj-6	14	34	a	a	DET
gsrj-6	14	35	genetic	genetic	ADJ
gsrj-6	14	36	susceptibility	susceptibility	NOUN
gsrj-6	14	37	.	.	PUNCT
gsrj-6	15	1	metabolic	metabolic	NOUN
gsrj-6	15	2	risk	risk	NOUN
gsrj-6	15	3	factors	factor	NOUN
gsrj-6	15	4	have	have	AUX
gsrj-6	15	5	increased	increase	VERB
gsrj-6	15	6	and	and	CCONJ
gsrj-6	15	7	are	be	AUX
gsrj-6	15	8	now	now	ADV
gsrj-6	15	9	contributing	contribute	VERB
gsrj-6	15	10	to	to	ADP
gsrj-6	15	11	nearly	nearly	ADV
gsrj-6	15	12	half	half	NOUN
gsrj-6	15	13	of	of	ADP
gsrj-6	15	14	hcc	hcc	PROPN
gsrj-6	15	15	cases	case	NOUN
gsrj-6	15	16	in	in	ADP
gsrj-6	15	17	the	the	DET
gsrj-6	15	18	us	us	PROPN
gsrj-6	15	19	.	.	PUNCT
gsrj-6	16	1	keywords	keyword	NOUN
gsrj-6	16	2	:	:	PUNCT
gsrj-6	16	3	non	non	ADJ
gsrj-6	16	4	-	-	ADJ
gsrj-6	16	5	alcoholic	alcoholic	ADJ
gsrj-6	16	6	fatty	fatty	NOUN
gsrj-6	16	7	liver	liver	NOUN
gsrj-6	16	8	disease	disease	NOUN
gsrj-6	16	9	advanced	advance	VERB
gsrj-6	16	10	fibrosis	fibrosis	NOUN
gsrj-6	16	11	;	;	PUNCT
gsrj-6	16	12	hepatocellular	hepatocellular	ADJ
gsrj-6	16	13	carcinoma	carcinoma	NOUN
gsrj-6	16	14	;	;	PUNCT
gsrj-6	16	15	non	non	ADJ
gsrj-6	16	16	-	-	ADJ
gsrj-6	16	17	alcoholic	alcoholic	ADJ
gsrj-6	16	18	steatohepatitis	steatohepatitis	NOUN
gsrj-6	16	19	;	;	PUNCT
gsrj-6	16	20	metabolic	metabolic	ADJ
gsrj-6	16	21	risk	risk	NOUN
gsrj-6	16	22	factors	factor	NOUN
gsrj-6	16	23	;	;	PUNCT
gsrj-6	16	24	non	non	ADJ
gsrj-6	16	25	-	-	ADJ
gsrj-6	16	26	metabolic	metabolic	ADJ
gsrj-6	16	27	risk	risk	NOUN
gsrj-6	16	28	factors	factor	NOUN
gsrj-6	16	29	;	;	PUNCT
gsrj-6	16	30	population	population	NOUN
gsrj-6	16	31	attributable	attributable	ADJ
gsrj-6	16	32	fraction	fraction	NOUN
gsrj-6	16	33	1	1	NUM
gsrj-6	16	34	.	.	PUNCT
gsrj-6	16	35	introduction	introduction	NOUN
gsrj-6	16	36	hepatocellular	hepatocellular	ADJ
gsrj-6	16	37	carcinoma	carcinoma	NOUN
gsrj-6	16	38	(	(	PUNCT
gsrj-6	16	39	hcc	hcc	PROPN
gsrj-6	16	40	)	)	PUNCT
gsrj-6	16	41	is	be	AUX
gsrj-6	16	42	the	the	DET
gsrj-6	16	43	third	third	ADJ
gsrj-6	16	44	most	most	ADV
gsrj-6	16	45	common	common	ADJ
gsrj-6	16	46	cause	cause	NOUN
gsrj-6	16	47	of	of	ADP
gsrj-6	16	48	cancer	cancer	NOUN
gsrj-6	16	49	related	relate	VERB
gsrj-6	16	50	deaths	death	NOUN
gsrj-6	16	51	worldwide.1	worldwide.1	ADP
gsrj-6	16	52	in	in	ADP
gsrj-6	16	53	the	the	DET
gsrj-6	16	54	us	us	PROPN
gsrj-6	16	55	,	,	PUNCT
gsrj-6	16	56	hcc	hcc	PROPN
gsrj-6	16	57	incidence	incidence	NOUN
gsrj-6	16	58	and	and	CCONJ
gsrj-6	16	59	mortality	mortality	NOUN
gsrj-6	16	60	rates	rate	NOUN
gsrj-6	16	61	are	be	AUX
gsrj-6	16	62	increasing	increase	VERB
gsrj-6	16	63	at	at	ADP
gsrj-6	16	64	a	a	DET
gsrj-6	16	65	rate	rate	NOUN
gsrj-6	16	66	of	of	ADP
gsrj-6	16	67	3	3	NUM
gsrj-6	16	68	%	%	NOUN
gsrj-6	16	69	per	per	ADP
gsrj-6	16	70	year	year	NOUN
gsrj-6	16	71	and	and	CCONJ
gsrj-6	16	72	are	be	AUX
gsrj-6	16	73	distributed	distribute	VERB
gsrj-6	16	74	disproportionally	disproportionally	ADV
gsrj-6	16	75	among	among	ADP
gsrj-6	16	76	certain	certain	ADJ
gsrj-6	16	77	racial	racial	ADJ
gsrj-6	16	78	/	/	SYM
gsrj-6	16	79	ethnic	ethnic	ADJ
gsrj-6	16	80	groups	group	NOUN
gsrj-6	16	81	.	.	PUNCT
gsrj-6	17	1	2	2	NUM
gsrj-6	17	2	hcc	hcc	NOUN
gsrj-6	17	3	most	most	ADV
gsrj-6	17	4	often	often	ADV
gsrj-6	17	5	occurs	occur	VERB
gsrj-6	17	6	among	among	ADP
gsrj-6	17	7	individuals	individual	NOUN
gsrj-6	17	8	who	who	PRON
gsrj-6	17	9	have	have	VERB
gsrj-6	17	10	chronic	chronic	ADJ
gsrj-6	17	11	liver	liver	NOUN
gsrj-6	17	12	diseases	disease	NOUN
gsrj-6	17	13	.	.	PUNCT
gsrj-6	18	1	nonalcoholic	nonalcoholic	ADJ
gsrj-6	18	2	fatty	fatty	NOUN
gsrj-6	18	3	liver	liver	NOUN
gsrj-6	18	4	disease	disease	NOUN
gsrj-6	18	5	(	(	PUNCT
gsrj-6	18	6	nafld	nafld	ADV
gsrj-6	18	7	)	)	PUNCT
gsrj-6	18	8	and	and	CCONJ
gsrj-6	18	9	non	non	ADJ
gsrj-6	18	10	-	-	ADJ
gsrj-6	18	11	alcoholic	alcoholic	ADJ
gsrj-6	18	12	steatohepatitis	steatohepatitis	NOUN
gsrj-6	18	13	(	(	PUNCT
gsrj-6	18	14	nash	nash	PROPN
gsrj-6	18	15	)	)	PUNCT
gsrj-6	18	16	are	be	AUX
gsrj-6	18	17	growing	grow	VERB
gsrj-6	18	18	and	and	CCONJ
gsrj-6	18	19	becoming	become	VERB
gsrj-6	18	20	the	the	DET
gsrj-6	18	21	leading	lead	VERB
gsrj-6	18	22	risk	risk	NOUN
gsrj-6	18	23	factors	factor	NOUN
gsrj-6	18	24	for	for	ADP
gsrj-6	18	25	hcc	hcc	PROPN
gsrj-6	18	26	.	.	PUNCT
gsrj-6	19	1	nafld	nafld	ADJ
gsrj-6	19	2	-	-	PUNCT
gsrj-6	19	3	fib	fib	NOUN
gsrj-6	19	4	and	and	CCONJ
gsrj-6	19	5	its	its	PRON
gsrj-6	19	6	subtype	subtype	NOUN
gsrj-6	19	7	nash	nash	NOUN
gsrj-6	19	8	-	-	PUNCT
gsrj-6	19	9	cirrhosis	cirrhosis	NOUN
gsrj-6	19	10	affect	affect	VERB
gsrj-6	19	11	approximately	approximately	ADV
gsrj-6	19	12	30	30	NUM
gsrj-6	19	13	%	%	NOUN
gsrj-6	19	14	and	and	CCONJ
gsrj-6	19	15	5	5	NUM
gsrj-6	19	16	%	%	NOUN
gsrj-6	19	17	,	,	PUNCT
gsrj-6	19	18	respectively	respectively	ADV
gsrj-6	19	19	,	,	PUNCT
gsrj-6	19	20	of	of	ADP
gsrj-6	19	21	the	the	DET
gsrj-6	19	22	us	us	PROPN
gsrj-6	19	23	population.3	population.3	PROPN
gsrj-6	19	24	the	the	DET
gsrj-6	19	25	major	major	ADJ
gsrj-6	19	26	risk	risk	NOUN
gsrj-6	19	27	factors	factor	NOUN
gsrj-6	19	28	are	be	AUX
gsrj-6	19	29	hepatitis	hepatitis	PROPN
gsrj-6	19	30	c	c	PROPN
gsrj-6	19	31	virus	virus	NOUN
gsrj-6	19	32	(	(	PUNCT
gsrj-6	19	33	hcv	hcv	NOUN
gsrj-6	19	34	)	)	PUNCT
gsrj-6	19	35	infection	infection	NOUN
gsrj-6	19	36	,	,	PUNCT
gsrj-6	19	37	hepatitis	hepatitis	PROPN
gsrj-6	19	38	b	b	PROPN
gsrj-6	19	39	virus	virus	NOUN
gsrj-6	19	40	(	(	PUNCT
gsrj-6	19	41	hbv	hbv	NOUN
gsrj-6	19	42	)	)	PUNCT
gsrj-6	19	43	infection	infection	NOUN
gsrj-6	19	44	,	,	PUNCT
gsrj-6	19	45	cigarette	cigarette	NOUN
gsrj-6	19	46	smoking	smoking	NOUN
gsrj-6	19	47	,	,	PUNCT
gsrj-6	19	48	excessive	excessive	ADJ
gsrj-6	19	49	alcohol	alcohol	NOUN
gsrj-6	19	50	consumption	consumption	NOUN
gsrj-6	19	51	,	,	PUNCT
gsrj-6	19	52	hereditary	hereditary	ADJ
gsrj-6	19	53	genetic	genetic	ADJ
gsrj-6	19	54	diseases	disease	NOUN
gsrj-6	19	55	,	,	PUNCT
gsrj-6	19	56	and	and	CCONJ
gsrj-6	19	57	metabolic	metabolic	NOUN
gsrj-6	19	58	disorders	disorder	NOUN
gsrj-6	19	59	(	(	PUNCT
gsrj-6	19	60	diabetes	diabetes	NOUN
gsrj-6	19	61	,	,	PUNCT
gsrj-6	19	62	obesity	obesity	NOUN
gsrj-6	19	63	,	,	PUNCT
gsrj-6	19	64	impaired	impaired	ADJ
gsrj-6	19	65	glucose	glucose	NOUN
gsrj-6	19	66	tolerance	tolerance	NOUN
gsrj-6	19	67	,	,	PUNCT
gsrj-6	19	68	metabolic	metabolic	NOUN
gsrj-6	19	69	syndrome	syndrome	NOUN
gsrj-6	19	70	,	,	PUNCT
gsrj-6	19	71	and	and	CCONJ
gsrj-6	19	72	non	non	ADJ
gsrj-6	19	73	-	-	ADJ
gsrj-6	19	74	alcoholic	alcoholic	ADJ
gsrj-6	19	75	fatty	fatty	NOUN
gsrj-6	19	76	liver	liver	NOUN
gsrj-6	19	77	disease).4	disease).4	NOUN
gsrj-6	19	78	some	some	DET
gsrj-6	19	79	risk	risk	NOUN
gsrj-6	19	80	factors	factor	NOUN
gsrj-6	19	81	of	of	ADP
gsrj-6	19	82	metabolic	metabolic	NOUN
gsrj-6	19	83	diseases	disease	NOUN
gsrj-6	19	84	have	have	AUX
gsrj-6	19	85	been	be	AUX
gsrj-6	19	86	shown	show	VERB
gsrj-6	19	87	to	to	PART
gsrj-6	19	88	be	be	AUX
gsrj-6	19	89	more	more	ADV
gsrj-6	19	90	prominent	prominent	ADJ
gsrj-6	19	91	in	in	ADP
gsrj-6	19	92	certain	certain	ADJ
gsrj-6	19	93	ethnic	ethnic	ADJ
gsrj-6	19	94	groups	group	NOUN
gsrj-6	19	95	.	.	PUNCT
gsrj-6	20	1	data	datum	NOUN
gsrj-6	20	2	from	from	ADP
gsrj-6	20	3	the	the	DET
gsrj-6	20	4	united	united	PROPN
gsrj-6	20	5	states	states	PROPN
gsrj-6	20	6	national	national	PROPN
gsrj-6	20	7	center	center	PROPN
gsrj-6	20	8	for	for	ADP
gsrj-6	20	9	health	health	NOUN
gsrj-6	20	10	statistics	statistic	NOUN
gsrj-6	20	11	(	(	PUNCT
gsrj-6	20	12	2000	2000	NUM
gsrj-6	20	13	-	-	SYM
gsrj-6	20	14	2006	2006	NUM
gsrj-6	20	15	)	)	PUNCT
gsrj-6	20	16	identified	identify	VERB
gsrj-6	20	17	chronic	chronic	ADJ
gsrj-6	20	18	liver	liver	NOUN
gsrj-6	20	19	diseases	disease	NOUN
gsrj-6	20	20	as	as	ADP
gsrj-6	20	21	the	the	DET
gsrj-6	20	22	sixth	sixth	ADJ
gsrj-6	20	23	most	most	ADV
gsrj-6	20	24	common	common	ADJ
gsrj-6	20	25	cause	cause	NOUN
gsrj-6	20	26	of	of	ADP
gsrj-6	20	27	death	death	NOUN
gsrj-6	20	28	in	in	ADP
gsrj-6	20	29	the	the	DET
gsrj-6	20	30	hispanic	hispanic	ADJ
gsrj-6	20	31	population.5	population.5	NOUN
gsrj-6	20	32	obesity	obesity	NOUN
gsrj-6	20	33	and	and	CCONJ
gsrj-6	20	34	diabetes	diabetes	NOUN
gsrj-6	20	35	are	be	AUX
gsrj-6	20	36	highly	highly	ADV
gsrj-6	20	37	prevalent	prevalent	ADJ
gsrj-6	20	38	among	among	ADP
gsrj-6	20	39	both	both	CCONJ
gsrj-6	20	40	hispanic	hispanic	ADJ
gsrj-6	20	41	and	and	CCONJ
gsrj-6	20	42	non	non	ADJ
gsrj-6	20	43	-	-	ADJ
gsrj-6	20	44	hispanic	hispanic	ADJ
gsrj-6	20	45	(	(	PUNCT
gsrj-6	20	46	nh	nh	NOUN
gsrj-6	20	47	)	)	PUNCT
gsrj-6	20	48	blacks	black	NOUN
gsrj-6	20	49	due	due	ADJ
gsrj-6	20	50	to	to	ADP
gsrj-6	20	51	lifestyle	lifestyle	NOUN
gsrj-6	20	52	choices	choice	NOUN
gsrj-6	20	53	,	,	PUNCT
gsrj-6	20	54	diet	diet	NOUN
gsrj-6	20	55	,	,	PUNCT
gsrj-6	20	56	or	or	CCONJ
gsrj-6	20	57	genetic	genetic	ADJ
gsrj-6	20	58	polymorphism	polymorphism	NOUN
gsrj-6	20	59	,	,	PUNCT
gsrj-6	20	60	which	which	PRON
gsrj-6	20	61	causes	cause	VERB
gsrj-6	20	62	all	all	PRON
gsrj-6	20	63	racerelated	racerelate	VERB
gsrj-6	20	64	genetic	genetic	ADJ
gsrj-6	20	65	differences	difference	NOUN
gsrj-6	20	66	between	between	ADP
gsrj-6	20	67	different	different	ADJ
gsrj-6	20	68	groups	group	NOUN
gsrj-6	20	69	.	.	PUNCT
gsrj-6	21	1	the	the	DET
gsrj-6	21	2	proportion	proportion	NOUN
gsrj-6	21	3	of	of	ADP
gsrj-6	21	4	incident	incident	NOUN
gsrj-6	21	5	cases	case	NOUN
gsrj-6	21	6	of	of	ADP
gsrj-6	21	7	heavy	heavy	ADJ
gsrj-6	21	8	drinkers	drinker	NOUN
gsrj-6	21	9	in	in	ADP
gsrj-6	21	10	the	the	DET
gsrj-6	21	11	united	united	PROPN
gsrj-6	21	12	states	states	PROPN
gsrj-6	21	13	between	between	ADP
gsrj-6	21	14	1984	1984	NUM
gsrj-6	21	15	and	and	CCONJ
gsrj-6	21	16	1992	1992	NUM
gsrj-6	21	17	was	be	AUX
gsrj-6	21	18	highest	high	ADJ
gsrj-6	21	19	among	among	ADP
gsrj-6	21	20	nh	nh	PROPN
gsrj-6	21	21	blacks	black	NOUN
gsrj-6	21	22	(	(	PUNCT
gsrj-6	21	23	51	51	NUM
gsrj-6	21	24	%	%	NOUN
gsrj-6	21	25	)	)	PUNCT
gsrj-6	21	26	,	,	PUNCT
gsrj-6	21	27	followed	follow	VERB
gsrj-6	21	28	by	by	ADP
gsrj-6	21	29	hispanics	hispanic	NOUN
gsrj-6	21	30	(	(	PUNCT
gsrj-6	21	31	43	43	NUM
gsrj-6	21	32	%	%	NOUN
gsrj-6	21	33	)	)	PUNCT
gsrj-6	21	34	and	and	CCONJ
gsrj-6	21	35	whites	white	NOUN
gsrj-6	21	36	(	(	PUNCT
gsrj-6	21	37	32	32	NUM
gsrj-6	21	38	%	%	NOUN
gsrj-6	21	39	)	)	PUNCT
gsrj-6	21	40	.	.	PUNCT
gsrj-6	22	1	there	there	PRON
gsrj-6	22	2	are	be	VERB
gsrj-6	22	3	several	several	ADJ
gsrj-6	22	4	lines	line	NOUN
gsrj-6	22	5	of	of	ADP
gsrj-6	22	6	evidence	evidence	NOUN
gsrj-6	22	7	suggesting	suggest	VERB
gsrj-6	22	8	that	that	SCONJ
gsrj-6	22	9	nh	nh	PROPN
gsrj-6	22	10	blacks	black	NOUN
gsrj-6	22	11	who	who	PRON
gsrj-6	22	12	consume	consume	VERB
gsrj-6	22	13	alcohol	alcohol	NOUN
gsrj-6	22	14	have	have	VERB
gsrj-6	22	15	greater	great	ADJ
gsrj-6	22	16	liver	liver	NOUN
gsrj-6	22	17	enzyme	enzyme	NOUN
gsrj-6	22	18	elevation	elevation	NOUN
gsrj-6	22	19	than	than	ADP
gsrj-6	22	20	whites	white	NOUN
gsrj-6	22	21	,	,	PUNCT
gsrj-6	22	22	which	which	PRON
gsrj-6	22	23	further	far	ADV
gsrj-6	22	24	leads	lead	VERB
gsrj-6	22	25	to	to	ADP
gsrj-6	22	26	liver	liver	NOUN
gsrj-6	22	27	disease	disease	NOUN
gsrj-6	22	28	.6,7	.6,7	PROPN
gsrj-6	23	1	the	the	DET
gsrj-6	23	2	prevalence	prevalence	NOUN
gsrj-6	23	3	of	of	ADP
gsrj-6	23	4	nafld	nafld	ADV
gsrj-6	23	5	-	-	PUNCT
gsrj-6	23	6	fib	fib	NOUN
gsrj-6	23	7	and	and	CCONJ
gsrj-6	23	8	risk	risk	NOUN
gsrj-6	23	9	of	of	ADP
gsrj-6	23	10	progression	progression	NOUN
gsrj-6	23	11	is	be	AUX
gsrj-6	23	12	higher	high	ADJ
gsrj-6	23	13	among	among	ADP
gsrj-6	23	14	hispanics	hispanic	NOUN
gsrj-6	23	15	than	than	ADP
gsrj-6	23	16	other	other	ADJ
gsrj-6	23	17	racial	racial	ADJ
gsrj-6	23	18	and	and	CCONJ
gsrj-6	23	19	ethnic	ethnic	ADJ
gsrj-6	23	20	groups.8	groups.8	PROPN
gsrj-6	23	21	the	the	DET
gsrj-6	23	22	higher	high	ADJ
gsrj-6	23	23	incidence	incidence	NOUN
gsrj-6	23	24	of	of	ADP
gsrj-6	23	25	hcc	hcc	PROPN
gsrj-6	23	26	among	among	ADP
gsrj-6	23	27	hispanics	hispanic	NOUN
gsrj-6	23	28	is	be	AUX
gsrj-6	23	29	driven	drive	VERB
gsrj-6	23	30	by	by	ADP
gsrj-6	23	31	higher	high	ADJ
gsrj-6	23	32	levels	level	NOUN
gsrj-6	23	33	of	of	ADP
gsrj-6	23	34	sugar	sugar	NOUN
gsrj-6	23	35	,	,	PUNCT
gsrj-6	23	36	carbohydrates	carbohydrate	NOUN
gsrj-6	23	37	and	and	CCONJ
gsrj-6	23	38	intake	intake	NOUN
gsrj-6	23	39	of	of	ADP
gsrj-6	23	40	saturated	saturate	VERB
gsrj-6	23	41	fat	fat	NOUN
gsrj-6	23	42	as	as	SCONJ
gsrj-6	23	43	compared	compare	VERB
gsrj-6	23	44	to	to	ADP
gsrj-6	23	45	whites	white	NOUN
gsrj-6	23	46	.	.	PUNCT
gsrj-6	24	1	obesity	obesity	NOUN
gsrj-6	24	2	and	and	CCONJ
gsrj-6	24	3	insulin	insulin	NOUN
gsrj-6	24	4	resistance	resistance	NOUN
gsrj-6	24	5	,	,	PUNCT
gsrj-6	24	6	two	two	NUM
gsrj-6	24	7	important	important	ADJ
gsrj-6	24	8	risk	risk	NOUN
gsrj-6	24	9	factors	factor	NOUN
gsrj-6	24	10	for	for	ADP
gsrj-6	24	11	the	the	DET
gsrj-6	24	12	metabolic	metabolic	NOUN
gsrj-6	24	13	syndrome	syndrome	NOUN
gsrj-6	24	14	,	,	PUNCT
gsrj-6	24	15	have	have	AUX
gsrj-6	24	16	been	be	AUX
gsrj-6	24	17	found	find	VERB
gsrj-6	24	18	to	to	PART
gsrj-6	24	19	have	have	VERB
gsrj-6	24	20	a	a	DET
gsrj-6	24	21	positive	positive	ADJ
gsrj-6	24	22	correlation	correlation	NOUN
gsrj-6	24	23	with	with	ADP
gsrj-6	24	24	nash	nash	NOUN
gsrj-6	24	25	-	-	PUNCT
gsrj-6	24	26	cirrhosis	cirrhosis	NOUN
gsrj-6	24	27	in	in	ADP
gsrj-6	24	28	hispanic	hispanic	ADJ
gsrj-6	24	29	persons	person	NOUN
gsrj-6	24	30	only.5	only.5	NOUN
gsrj-6	24	31	hispanics	hispanics	PROPN
gsrj-6	24	32	and	and	CCONJ
gsrj-6	24	33	nh	nh	PROPN
gsrj-6	24	34	blacks	black	NOUN
gsrj-6	24	35	have	have	AUX
gsrj-6	24	36	also	also	ADV
gsrj-6	24	37	been	be	AUX
gsrj-6	24	38	shown	show	VERB
gsrj-6	24	39	to	to	PART
gsrj-6	24	40	have	have	VERB
gsrj-6	24	41	higher	high	ADJ
gsrj-6	24	42	hcc	hcc	NOUN
gsrj-6	24	43	rates	rate	NOUN
gsrj-6	24	44	than	than	ADP
gsrj-6	24	45	whites	white	NOUN
gsrj-6	24	46	.	.	PUNCT
gsrj-6	25	1	cirrhosis	cirrhosis	NOUN
gsrj-6	25	2	rates	rate	NOUN
gsrj-6	25	3	are	be	AUX
gsrj-6	25	4	higher	high	ADJ
gsrj-6	25	5	for	for	ADP
gsrj-6	25	6	nh	nh	PROPN
gsrj-6	25	7	blacks	black	NOUN
gsrj-6	25	8	than	than	ADP
gsrj-6	25	9	for	for	ADP
gsrj-6	25	10	whites	white	NOUN
gsrj-6	25	11	,	,	PUNCT
gsrj-6	25	12	and	and	CCONJ
gsrj-6	25	13	the	the	DET
gsrj-6	25	14	highest	high	ADJ
gsrj-6	25	15	cirrhosis	cirrhosis	NOUN
gsrj-6	25	16	mortality	mortality	NOUN
gsrj-6	25	17	rates	rate	NOUN
gsrj-6	25	18	are	be	AUX
gsrj-6	25	19	observed	observe	VERB
gsrj-6	25	20	among	among	ADP
gsrj-6	25	21	hispanics.7	hispanics.7	VERB
gsrj-6	25	22	mortality	mortality	NOUN
gsrj-6	25	23	from	from	ADP
gsrj-6	25	24	chronic	chronic	ADJ
gsrj-6	25	25	liver	liver	NOUN
gsrj-6	25	26	disease	disease	NOUN
gsrj-6	25	27	in	in	ADP
gsrj-6	25	28	hispanic	hispanic	ADJ
gsrj-6	25	29	people	people	NOUN
gsrj-6	25	30	in	in	ADP
gsrj-6	25	31	the	the	DET
gsrj-6	25	32	united	united	PROPN
gsrj-6	25	33	states	states	PROPN
gsrj-6	25	34	is	be	AUX
gsrj-6	25	35	nearly	nearly	ADV
gsrj-6	25	36	50	50	NUM
gsrj-6	25	37	%	%	NOUN
gsrj-6	25	38	higher	high	ADJ
gsrj-6	25	39	than	than	ADP
gsrj-6	25	40	in	in	ADP
gsrj-6	25	41	nh	nh	PROPN
gsrj-6	25	42	white	white	ADJ
gsrj-6	25	43	persons	person	NOUN
gsrj-6	25	44	(	(	PUNCT
gsrj-6	25	45	13.7	13.7	NUM
gsrj-6	25	46	per	per	ADP
gsrj-6	25	47	100,000	100,000	NUM
gsrj-6	25	48	in	in	ADP
gsrj-6	25	49	hispanic	hispanic	ADJ
gsrj-6	25	50	persons	person	NOUN
gsrj-6	25	51	vs	vs	ADP
gsrj-6	25	52	9.2	9.2	NUM
gsrj-6	25	53	in	in	ADP
gsrj-6	25	54	nh	nh	PROPN
gsrj-6	25	55	whites	white	NOUN
gsrj-6	25	56	and	and	CCONJ
gsrj-6	25	57	7.5	7.5	NUM
gsrj-6	25	58	in	in	ADP
gsrj-6	25	59	african	african	ADJ
gsrj-6	25	60	american	american	PROPN
gsrj-6	25	61	persons).5	persons).5	PROPN
gsrj-6	25	62	in	in	ADP
gsrj-6	25	63	addition	addition	NOUN
gsrj-6	25	64	to	to	ADP
gsrj-6	25	65	known	know	VERB
gsrj-6	25	66	hcc	hcc	PROPN
gsrj-6	25	67	risk	risk	NOUN
gsrj-6	25	68	factors	factor	NOUN
gsrj-6	25	69	,	,	PUNCT
gsrj-6	25	70	it	it	PRON
gsrj-6	25	71	is	be	AUX
gsrj-6	25	72	likely	likely	ADJ
gsrj-6	25	73	that	that	SCONJ
gsrj-6	25	74	access	access	NOUN
gsrj-6	25	75	to	to	ADP
gsrj-6	25	76	preventive	preventive	ADJ
gsrj-6	25	77	health	health	NOUN
gsrj-6	25	78	education	education	NOUN
gsrj-6	25	79	and	and	CCONJ
gsrj-6	25	80	early	early	ADJ
gsrj-6	25	81	treatment	treatment	NOUN
gsrj-6	25	82	may	may	AUX
gsrj-6	25	83	be	be	AUX
gsrj-6	25	84	a	a	DET
gsrj-6	25	85	barrier	barrier	NOUN
gsrj-6	25	86	to	to	ADP
gsrj-6	25	87	some	some	DET
gsrj-6	25	88	racial	racial	ADJ
gsrj-6	25	89	and	and	CCONJ
gsrj-6	25	90	ethnic	ethnic	ADJ
gsrj-6	25	91	groups	group	NOUN
gsrj-6	25	92	.	.	PUNCT
gsrj-6	26	1	the	the	DET
gsrj-6	26	2	incidence	incidence	NOUN
gsrj-6	26	3	of	of	ADP
gsrj-6	26	4	hcc	hcc	PROPN
gsrj-6	26	5	varies	varie	NOUN
gsrj-6	26	6	by	by	ADP
gsrj-6	26	7	race	race	NOUN
gsrj-6	26	8	and	and	CCONJ
gsrj-6	26	9	ethnicity	ethnicity	NOUN
gsrj-6	26	10	primarily	primarily	ADV
gsrj-6	26	11	as	as	ADP
gsrj-6	26	12	a	a	DET
gsrj-6	26	13	result	result	NOUN
gsrj-6	26	14	of	of	ADP
gsrj-6	26	15	differences	difference	NOUN
gsrj-6	26	16	in	in	ADP
gsrj-6	26	17	the	the	DET
gsrj-6	26	18	prevalence	prevalence	NOUN
gsrj-6	26	19	of	of	ADP
gsrj-6	26	20	major	major	ADJ
gsrj-6	26	21	risk	risk	NOUN
gsrj-6	26	22	factors	factor	NOUN
gsrj-6	26	23	and	and	CCONJ
gsrj-6	26	24	also	also	ADV
gsrj-6	26	25	disparities	disparity	NOUN
gsrj-6	26	26	in	in	ADP
gsrj-6	26	27	access	access	NOUN
gsrj-6	26	28	to	to	ADP
gsrj-6	26	29	high	high	ADJ
gsrj-6	26	30	-	-	PUNCT
gsrj-6	26	31	quality	quality	NOUN
gsrj-6	26	32	healthcare.9	healthcare.9	NOUN
gsrj-6	26	33	socioeconomic	socioeconomic	ADJ
gsrj-6	26	34	disadvantage	disadvantage	NOUN
gsrj-6	26	35	,	,	PUNCT
gsrj-6	26	36	lack	lack	NOUN
gsrj-6	26	37	of	of	ADP
gsrj-6	26	38	health	health	NOUN
gsrj-6	26	39	insurance	insurance	NOUN
gsrj-6	26	40	,	,	PUNCT
gsrj-6	26	41	and	and	CCONJ
gsrj-6	26	42	language	language	NOUN
gsrj-6	26	43	barriers	barrier	NOUN
gsrj-6	26	44	limit	limit	VERB
gsrj-6	26	45	access	access	NOUN
gsrj-6	26	46	to	to	ADP
gsrj-6	26	47	cancer	cancer	NOUN
gsrj-6	26	48	screening	screening	NOUN
gsrj-6	26	49	and	and	CCONJ
gsrj-6	26	50	treatment	treatment	NOUN
gsrj-6	26	51	among	among	ADP
gsrj-6	26	52	nh	nh	PROPN
gsrj-6	26	53	blacks	black	NOUN
gsrj-6	26	54	and	and	CCONJ
gsrj-6	26	55	hispanics.10	hispanics.10	NOUN
gsrj-6	26	56	it	it	PRON
gsrj-6	26	57	has	have	AUX
gsrj-6	26	58	also	also	ADV
gsrj-6	26	59	been	be	AUX
gsrj-6	26	60	found	find	VERB
gsrj-6	26	61	that	that	SCONJ
gsrj-6	26	62	20	20	NUM
gsrj-6	26	63	georgetown	georgetown	PROPN
gsrj-6	26	64	scientific	scientific	PROPN
gsrj-6	26	65	research	research	PROPN
gsrj-6	26	66	journal	journal	PROPN
gsrj-6	26	67	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	26	68	hispanics	hispanics	PROPN
gsrj-6	26	69	and	and	CCONJ
gsrj-6	26	70	nh	nh	PROPN
gsrj-6	26	71	blacks	black	NOUN
gsrj-6	26	72	were	be	AUX
gsrj-6	26	73	less	less	ADV
gsrj-6	26	74	likely	likely	ADJ
gsrj-6	26	75	to	to	PART
gsrj-6	26	76	be	be	AUX
gsrj-6	26	77	diagnosed	diagnose	VERB
gsrj-6	26	78	with	with	ADP
gsrj-6	26	79	early	early	ADJ
gsrj-6	26	80	-	-	PUNCT
gsrj-6	26	81	stage	stage	NOUN
gsrj-6	26	82	hcc	hcc	PROPN
gsrj-6	26	83	compared	compare	VERB
gsrj-6	26	84	with	with	ADP
gsrj-6	26	85	whites.10	whites.10	NOUN
gsrj-6	26	86	there	there	PRON
gsrj-6	26	87	is	be	VERB
gsrj-6	26	88	a	a	DET
gsrj-6	26	89	need	need	NOUN
gsrj-6	26	90	to	to	PART
gsrj-6	26	91	understand	understand	VERB
gsrj-6	26	92	how	how	SCONJ
gsrj-6	26	93	hcc	hcc	PROPN
gsrj-6	26	94	risk	risk	NOUN
gsrj-6	26	95	factors	factor	NOUN
gsrj-6	26	96	contribute	contribute	VERB
gsrj-6	26	97	to	to	ADP
gsrj-6	26	98	hcc	hcc	PROPN
gsrj-6	26	99	prevalence	prevalence	NOUN
gsrj-6	26	100	rates	rate	NOUN
gsrj-6	26	101	within	within	ADP
gsrj-6	26	102	racial	racial	ADJ
gsrj-6	26	103	and	and	CCONJ
gsrj-6	26	104	ethnic	ethnic	ADJ
gsrj-6	26	105	groups	group	NOUN
gsrj-6	26	106	,	,	PUNCT
gsrj-6	26	107	to	to	PART
gsrj-6	26	108	reduce	reduce	VERB
gsrj-6	26	109	health	health	NOUN
gsrj-6	26	110	-	-	PUNCT
gsrj-6	26	111	care	care	NOUN
gsrj-6	26	112	disparities	disparity	NOUN
gsrj-6	26	113	.	.	PUNCT
gsrj-6	27	1	the	the	DET
gsrj-6	27	2	aim	aim	NOUN
gsrj-6	27	3	of	of	ADP
gsrj-6	27	4	this	this	DET
gsrj-6	27	5	study	study	NOUN
gsrj-6	27	6	was	be	AUX
gsrj-6	27	7	to	to	PART
gsrj-6	27	8	determine	determine	VERB
gsrj-6	27	9	contribution	contribution	NOUN
gsrj-6	27	10	of	of	ADP
gsrj-6	27	11	specific	specific	ADJ
gsrj-6	27	12	known	know	VERB
gsrj-6	27	13	risk	risk	NOUN
gsrj-6	27	14	factors	factor	NOUN
gsrj-6	27	15	for	for	ADP
gsrj-6	27	16	hcc	hcc	PROPN
gsrj-6	27	17	by	by	ADP
gsrj-6	27	18	race	race	NOUN
gsrj-6	27	19	and	and	CCONJ
gsrj-6	27	20	ethnicity	ethnicity	NOUN
gsrj-6	27	21	,	,	PUNCT
gsrj-6	27	22	using	use	VERB
gsrj-6	27	23	a	a	DET
gsrj-6	27	24	nationally	nationally	ADV
gsrj-6	27	25	representative	representative	ADJ
gsrj-6	27	26	us	us	PROPN
gsrj-6	27	27	population	population	NOUN
gsrj-6	27	28	.	.	PUNCT
gsrj-6	28	1	a	a	DET
gsrj-6	28	2	further	further	ADJ
gsrj-6	28	3	network	network	NOUN
gsrj-6	28	4	study	study	NOUN
gsrj-6	28	5	of	of	ADP
gsrj-6	28	6	gene	gene	NOUN
gsrj-6	28	7	specificity	specificity	NOUN
gsrj-6	28	8	and	and	CCONJ
gsrj-6	28	9	hcc	hcc	PROPN
gsrj-6	28	10	was	be	AUX
gsrj-6	28	11	conducted	conduct	VERB
gsrj-6	28	12	.	.	PUNCT
gsrj-6	29	1	1	1	X
gsrj-6	29	2	.	.	X
gsrj-6	29	3	methods	method	NOUN
gsrj-6	29	4	1.1	1.1	NUM
gsrj-6	29	5	study	study	NOUN
gsrj-6	29	6	population	population	NOUN
gsrj-6	29	7	the	the	DET
gsrj-6	29	8	national	national	ADJ
gsrj-6	29	9	health	health	PROPN
gsrj-6	29	10	and	and	CCONJ
gsrj-6	29	11	nutrition	nutrition	NOUN
gsrj-6	29	12	examination	examination	NOUN
gsrj-6	29	13	survey	survey	NOUN
gsrj-6	29	14	(	(	PUNCT
gsrj-6	29	15	nhanes	nhane	NOUN
gsrj-6	29	16	)	)	PUNCT
gsrj-6	29	17	is	be	AUX
gsrj-6	29	18	a	a	DET
gsrj-6	29	19	biennial	biennial	ADJ
gsrj-6	29	20	cross	cross	ADJ
gsrj-6	29	21	-	-	ADJ
gsrj-6	29	22	sectional	sectional	ADJ
gsrj-6	29	23	survey	survey	NOUN
gsrj-6	29	24	representative	representative	NOUN
gsrj-6	29	25	of	of	ADP
gsrj-6	29	26	the	the	DET
gsrj-6	29	27	us	us	PROPN
gsrj-6	29	28	civilian	civilian	NOUN
gsrj-6	29	29	,	,	PUNCT
gsrj-6	29	30	non	non	ADJ
gsrj-6	29	31	-	-	ADJ
gsrj-6	29	32	institutionalized	institutionalized	ADJ
gsrj-6	29	33	population	population	NOUN
gsrj-6	29	34	.	.	PUNCT
gsrj-6	30	1	details	detail	NOUN
gsrj-6	30	2	of	of	ADP
gsrj-6	30	3	the	the	DET
gsrj-6	30	4	nhanes	nhane	NOUN
gsrj-6	30	5	methods	method	NOUN
gsrj-6	30	6	and	and	CCONJ
gsrj-6	30	7	sampling	sample	VERB
gsrj-6	30	8	strategy	strategy	NOUN
gsrj-6	30	9	have	have	AUX
gsrj-6	30	10	been	be	AUX
gsrj-6	30	11	described	describe	VERB
gsrj-6	30	12	by	by	ADP
gsrj-6	30	13	the	the	DET
gsrj-6	30	14	national	national	ADJ
gsrj-6	30	15	center	center	NOUN
gsrj-6	30	16	for	for	ADP
gsrj-6	30	17	health	health	NOUN
gsrj-6	30	18	statistics	statistic	NOUN
gsrj-6	30	19	(	(	PUNCT
gsrj-6	30	20	nchs	nch	NOUN
gsrj-6	30	21	)	)	PUNCT
gsrj-6	30	22	of	of	ADP
gsrj-6	30	23	the	the	DET
gsrj-6	30	24	centers	center	NOUN
gsrj-6	30	25	for	for	ADP
gsrj-6	30	26	disease	disease	NOUN
gsrj-6	30	27	control	control	NOUN
gsrj-6	30	28	and	and	CCONJ
gsrj-6	30	29	prevention	prevention	NOUN
gsrj-6	30	30	(	(	PUNCT
gsrj-6	30	31	cdc).11	cdc).11	ADV
gsrj-6	30	32	briefly	briefly	ADV
gsrj-6	30	33	,	,	PUNCT
gsrj-6	30	34	subjects	subject	NOUN
gsrj-6	30	35	were	be	AUX
gsrj-6	30	36	recruited	recruit	VERB
gsrj-6	30	37	though	though	SCONJ
gsrj-6	30	38	a	a	DET
gsrj-6	30	39	multistage	multistage	NOUN
gsrj-6	30	40	probability	probability	NOUN
gsrj-6	30	41	sampling	sample	VERB
gsrj-6	30	42	design	design	NOUN
gsrj-6	30	43	,	,	PUNCT
gsrj-6	30	44	which	which	PRON
gsrj-6	30	45	was	be	AUX
gsrj-6	30	46	used	use	VERB
gsrj-6	30	47	to	to	PART
gsrj-6	30	48	select	select	VERB
gsrj-6	30	49	participants	participant	NOUN
gsrj-6	30	50	representative	representative	NOUN
gsrj-6	30	51	of	of	ADP
gsrj-6	30	52	the	the	DET
gsrj-6	30	53	civilian	civilian	ADJ
gsrj-6	30	54	,	,	PUNCT
gsrj-6	30	55	non	non	ADJ
gsrj-6	30	56	-	-	ADJ
gsrj-6	30	57	institutionalized	institutionalize	VERB
gsrj-6	30	58	us	us	PROPN
gsrj-6	30	59	population	population	NOUN
gsrj-6	30	60	,	,	PUNCT
gsrj-6	30	61	with	with	ADP
gsrj-6	30	62	a	a	DET
gsrj-6	30	63	sample	sample	NOUN
gsrj-6	30	64	weight	weight	NOUN
gsrj-6	30	65	assigned	assign	VERB
gsrj-6	30	66	to	to	ADP
gsrj-6	30	67	each	each	DET
gsrj-6	30	68	person.12	person.12	NOUN
gsrj-6	30	69	next	next	ADV
gsrj-6	30	70	,	,	PUNCT
gsrj-6	30	71	each	each	DET
gsrj-6	30	72	subject	subject	NOUN
gsrj-6	30	73	was	be	AUX
gsrj-6	30	74	interviewed	interview	VERB
gsrj-6	30	75	and	and	CCONJ
gsrj-6	30	76	underwent	undergo	VERB
gsrj-6	30	77	a	a	DET
gsrj-6	30	78	physical	physical	ADJ
gsrj-6	30	79	examination	examination	NOUN
gsrj-6	30	80	,	,	PUNCT
gsrj-6	30	81	including	include	VERB
gsrj-6	30	82	a	a	DET
gsrj-6	30	83	blood	blood	NOUN
gsrj-6	30	84	draw	draw	NOUN
gsrj-6	30	85	.	.	PUNCT
gsrj-6	31	1	general	general	ADJ
gsrj-6	31	2	demographic	demographic	ADJ
gsrj-6	31	3	characteristics	characteristic	NOUN
gsrj-6	31	4	,	,	PUNCT
gsrj-6	31	5	including	include	VERB
gsrj-6	31	6	age	age	NOUN
gsrj-6	31	7	,	,	PUNCT
gsrj-6	31	8	sex	sex	NOUN
gsrj-6	31	9	,	,	PUNCT
gsrj-6	31	10	race	race	NOUN
gsrj-6	31	11	/	/	SYM
gsrj-6	31	12	ethnicity	ethnicity	NOUN
gsrj-6	31	13	(	(	PUNCT
gsrj-6	31	14	non	non	ADJ
gsrj-6	31	15	-	-	ADJ
gsrj-6	31	16	hispanic	hispanic	ADJ
gsrj-6	31	17	white	white	ADJ
gsrj-6	31	18	,	,	PUNCT
gsrj-6	31	19	nonhispanic	nonhispanic	ADJ
gsrj-6	31	20	black	black	ADJ
gsrj-6	31	21	,	,	PUNCT
gsrj-6	31	22	mexican	mexican	PROPN
gsrj-6	31	23	american	american	PROPN
gsrj-6	31	24	,	,	PUNCT
gsrj-6	31	25	other	other	ADJ
gsrj-6	31	26	hispanic	hispanic	NOUN
gsrj-6	31	27	,	,	PUNCT
gsrj-6	31	28	other	other	ADJ
gsrj-6	31	29	race	race	NOUN
gsrj-6	31	30	including	include	VERB
gsrj-6	31	31	asian	asian	ADJ
gsrj-6	31	32	descent	descent	NOUN
gsrj-6	31	33	and	and	CCONJ
gsrj-6	31	34	multiracial	multiracial	ADJ
gsrj-6	31	35	(	(	PUNCT
gsrj-6	31	36	other	other	ADJ
gsrj-6	31	37	/	/	SYM
gsrj-6	31	38	mixed	mixed	ADJ
gsrj-6	31	39	)	)	PUNCT
gsrj-6	31	40	)	)	PUNCT
gsrj-6	31	41	,	,	PUNCT
gsrj-6	31	42	and	and	CCONJ
gsrj-6	31	43	smoking	smoking	NOUN
gsrj-6	31	44	behavior	behavior	NOUN
gsrj-6	31	45	were	be	AUX
gsrj-6	31	46	collected	collect	VERB
gsrj-6	31	47	during	during	ADP
gsrj-6	31	48	the	the	DET
gsrj-6	31	49	mobile	mobile	ADJ
gsrj-6	31	50	examination	examination	NOUN
gsrj-6	31	51	center	center	NOUN
gsrj-6	31	52	interview	interview	NOUN
gsrj-6	31	53	stage	stage	NOUN
gsrj-6	31	54	.	.	PUNCT
gsrj-6	32	1	during	during	ADP
gsrj-6	32	2	the	the	DET
gsrj-6	32	3	examination	examination	NOUN
gsrj-6	32	4	,	,	PUNCT
gsrj-6	32	5	body	body	NOUN
gsrj-6	32	6	measurements	measurement	NOUN
gsrj-6	32	7	,	,	PUNCT
gsrj-6	32	8	including	include	VERB
gsrj-6	32	9	height	height	NOUN
gsrj-6	32	10	,	,	PUNCT
gsrj-6	32	11	weight	weight	NOUN
gsrj-6	32	12	,	,	PUNCT
gsrj-6	32	13	and	and	CCONJ
gsrj-6	32	14	waist	waist	NOUN
gsrj-6	32	15	circumference	circumference	NOUN
gsrj-6	32	16	(	(	PUNCT
gsrj-6	32	17	cm	cm	NOUN
gsrj-6	32	18	)	)	PUNCT
gsrj-6	32	19	were	be	AUX
gsrj-6	32	20	also	also	ADV
gsrj-6	32	21	collected	collect	VERB
gsrj-6	32	22	.	.	PUNCT
gsrj-6	33	1	serum	serum	NOUN
gsrj-6	33	2	samples	sample	NOUN
gsrj-6	33	3	were	be	AUX
gsrj-6	33	4	obtained	obtain	VERB
gsrj-6	33	5	and	and	CCONJ
gsrj-6	33	6	analyzed	analyze	VERB
gsrj-6	33	7	for	for	ADP
gsrj-6	33	8	albumin	albumin	NOUN
gsrj-6	33	9	(	(	PUNCT
gsrj-6	33	10	g	g	PROPN
gsrj-6	33	11	/	/	SYM
gsrj-6	33	12	dl	dl	NOUN
gsrj-6	33	13	)	)	PUNCT
gsrj-6	33	14	,	,	PUNCT
gsrj-6	33	15	alanine	alanine	NOUN
gsrj-6	33	16	aminotransferase	aminotransferase	PROPN
gsrj-6	33	17	(	(	PUNCT
gsrj-6	33	18	alt	alt	ADJ
gsrj-6	33	19	,	,	PUNCT
gsrj-6	33	20	u	u	NOUN
gsrj-6	33	21	/	/	SYM
gsrj-6	33	22	l	l	NOUN
gsrj-6	33	23	)	)	PUNCT
gsrj-6	33	24	,	,	PUNCT
gsrj-6	33	25	aspartate	aspartate	NOUN
gsrj-6	33	26	(	(	PUNCT
gsrj-6	33	27	aminotransferase	aminotransferase	PROPN
gsrj-6	33	28	(	(	PUNCT
gsrj-6	33	29	ast	ast	PROPN
gsrj-6	33	30	,	,	PUNCT
gsrj-6	33	31	u	u	NOUN
gsrj-6	33	32	/	/	SYM
gsrj-6	33	33	l	l	NOUN
gsrj-6	33	34	)	)	PUNCT
gsrj-6	33	35	,	,	PUNCT
gsrj-6	33	36	alkaline	alkaline	NOUN
gsrj-6	33	37	phosphatase	phosphatase	NOUN
gsrj-6	33	38	(	(	PUNCT
gsrj-6	33	39	u	u	NOUN
gsrj-6	33	40	/	/	SYM
gsrj-6	33	41	l	l	NOUN
gsrj-6	33	42	)	)	PUNCT
gsrj-6	33	43	,	,	PUNCT
gsrj-6	33	44	fasting	fast	VERB
gsrj-6	33	45	glucose	glucose	NOUN
gsrj-6	33	46	(	(	PUNCT
gsrj-6	33	47	mg	mg	PROPN
gsrj-6	33	48	/	/	SYM
gsrj-6	33	49	dl	dl	PROPN
gsrj-6	33	50	)	)	PUNCT
gsrj-6	33	51	,	,	PUNCT
gsrj-6	33	52	fasting	fast	VERB
gsrj-6	33	53	insulin	insulin	NOUN
gsrj-6	33	54	(	(	PUNCT
gsrj-6	33	55	uu	uu	ADJ
gsrj-6	33	56	/	/	SYM
gsrj-6	33	57	ml	ml	NOUN
gsrj-6	33	58	)	)	PUNCT
gsrj-6	33	59	,	,	PUNCT
gsrj-6	33	60	gammaglutamyl	gammaglutamyl	NOUN
gsrj-6	33	61	transpeptidase	transpeptidase	NOUN
gsrj-6	33	62	(	(	PUNCT
gsrj-6	33	63	ggt	ggt	NOUN
gsrj-6	33	64	,	,	PUNCT
gsrj-6	33	65	u	u	NOUN
gsrj-6	33	66	/	/	SYM
gsrj-6	33	67	l	l	NOUN
gsrj-6	33	68	)	)	PUNCT
gsrj-6	33	69	,	,	PUNCT
gsrj-6	33	70	platelet	platelet	NOUN
gsrj-6	33	71	count	count	NOUN
gsrj-6	33	72	(	(	PUNCT
gsrj-6	33	73	1000	1000	NUM
gsrj-6	33	74	cells/µl	cells/µl	NOUN
gsrj-6	33	75	)	)	PUNCT
gsrj-6	33	76	,	,	PUNCT
gsrj-6	33	77	total	total	ADJ
gsrj-6	33	78	bilirubin	bilirubin	NOUN
gsrj-6	33	79	(	(	PUNCT
gsrj-6	33	80	mg	mg	PROPN
gsrj-6	33	81	/	/	SYM
gsrj-6	33	82	dl	dl	PROPN
gsrj-6	33	83	)	)	PUNCT
gsrj-6	33	84	,	,	PUNCT
gsrj-6	33	85	hemoglobin	hemoglobin	NOUN
gsrj-6	33	86	a1c	a1c	PROPN
gsrj-6	33	87	(	(	PUNCT
gsrj-6	33	88	%	%	INTJ
gsrj-6	33	89	)	)	PUNCT
gsrj-6	33	90	,	,	PUNCT
gsrj-6	33	91	total	total	ADJ
gsrj-6	33	92	cholesterol	cholesterol	NOUN
gsrj-6	33	93	(	(	PUNCT
gsrj-6	33	94	mg	mg	PROPN
gsrj-6	33	95	/	/	SYM
gsrj-6	33	96	dl	dl	PROPN
gsrj-6	33	97	)	)	PUNCT
gsrj-6	33	98	,	,	PUNCT
gsrj-6	33	99	high	high	ADJ
gsrj-6	33	100	density	density	NOUN
gsrj-6	33	101	lipoprotein	lipoprotein	ADJ
gsrj-6	33	102	(	(	PUNCT
gsrj-6	33	103	hdl	hdl	NOUN
gsrj-6	33	104	)	)	PUNCT
gsrj-6	33	105	,	,	PUNCT
gsrj-6	33	106	low	low	ADJ
gsrj-6	33	107	density	density	NOUN
gsrj-6	33	108	lipoprotein	lipoprotein	ADJ
gsrj-6	33	109	(	(	PUNCT
gsrj-6	33	110	ldl	ldl	NOUN
gsrj-6	33	111	)	)	PUNCT
gsrj-6	33	112	cholesterol	cholesterol	NOUN
gsrj-6	33	113	(	(	PUNCT
gsrj-6	33	114	mg	mg	PROPN
gsrj-6	33	115	/	/	SYM
gsrj-6	33	116	dl	dl	PROPN
gsrj-6	33	117	)	)	PUNCT
gsrj-6	33	118	,	,	PUNCT
gsrj-6	33	119	and	and	CCONJ
gsrj-6	33	120	triglycerides	triglyceride	NOUN
gsrj-6	33	121	(	(	PUNCT
gsrj-6	33	122	mg	mg	PROPN
gsrj-6	33	123	/	/	SYM
gsrj-6	33	124	dl	dl	NOUN
gsrj-6	33	125	)	)	PUNCT
gsrj-6	33	126	.	.	PUNCT
gsrj-6	34	1	all	all	DET
gsrj-6	34	2	participants	participant	NOUN
gsrj-6	34	3	provided	provide	VERB
gsrj-6	34	4	informed	informed	ADJ
gsrj-6	34	5	consent	consent	NOUN
gsrj-6	34	6	.	.	PUNCT
gsrj-6	35	1	nhanes	nhane	NOUN
gsrj-6	35	2	is	be	AUX
gsrj-6	35	3	approved	approve	VERB
gsrj-6	35	4	by	by	ADP
gsrj-6	35	5	the	the	DET
gsrj-6	35	6	institutional	institutional	ADJ
gsrj-6	35	7	review	review	PROPN
gsrj-6	35	8	board	board	NOUN
gsrj-6	35	9	of	of	ADP
gsrj-6	35	10	the	the	DET
gsrj-6	35	11	cdc	cdc	PROPN
gsrj-6	35	12	.	.	PUNCT
gsrj-6	36	1	subjects	subject	NOUN
gsrj-6	36	2	who	who	PRON
gsrj-6	36	3	were	be	AUX
gsrj-6	36	4	less	less	ADJ
gsrj-6	36	5	than	than	ADP
gsrj-6	36	6	18	18	NUM
gsrj-6	36	7	years	year	NOUN
gsrj-6	36	8	old	old	ADJ
gsrj-6	36	9	or	or	CCONJ
gsrj-6	36	10	pregnant	pregnant	ADJ
gsrj-6	36	11	were	be	AUX
gsrj-6	36	12	excluded	exclude	VERB
gsrj-6	36	13	from	from	ADP
gsrj-6	36	14	this	this	DET
gsrj-6	36	15	analysis	analysis	NOUN
gsrj-6	36	16	(	(	PUNCT
gsrj-6	36	17	figure	figure	NOUN
gsrj-6	36	18	1	1	NUM
gsrj-6	36	19	)	)	PUNCT
gsrj-6	36	20	.	.	PUNCT
gsrj-6	37	1	figure	figure	NOUN
gsrj-6	37	2	1	1	NUM
gsrj-6	37	3	.	.	PUNCT
gsrj-6	37	4	exclusion	exclusion	NOUN
gsrj-6	37	5	criteria	criterion	NOUN
gsrj-6	37	6	the	the	DET
gsrj-6	37	7	prevalence	prevalence	NOUN
gsrj-6	37	8	of	of	ADP
gsrj-6	37	9	hcc	hcc	PROPN
gsrj-6	37	10	risk	risk	NOUN
gsrj-6	37	11	factors	factor	NOUN
gsrj-6	37	12	was	be	AUX
gsrj-6	37	13	determined	determine	VERB
gsrj-6	37	14	using	use	VERB
gsrj-6	37	15	interview	interview	NOUN
gsrj-6	37	16	,	,	PUNCT
gsrj-6	37	17	physical	physical	ADJ
gsrj-6	37	18	exam	exam	NOUN
gsrj-6	37	19	,	,	PUNCT
gsrj-6	37	20	and/or	and/or	CCONJ
gsrj-6	37	21	laboratory	laboratory	NOUN
gsrj-6	37	22	nhanes	nhane	NOUN
gsrj-6	37	23	data	data	PROPN
gsrj-6	37	24	.	.	PUNCT
gsrj-6	38	1	hepatitis	hepatitis	PROPN
gsrj-6	38	2	c	c	PROPN
gsrj-6	38	3	virus	virus	NOUN
gsrj-6	38	4	was	be	AUX
gsrj-6	38	5	defined	define	VERB
gsrj-6	38	6	as	as	ADP
gsrj-6	38	7	having	have	VERB
gsrj-6	38	8	a	a	DET
gsrj-6	38	9	positive	positive	ADJ
gsrj-6	38	10	hepatitis	hepatitis	NOUN
gsrj-6	38	11	c	c	PROPN
gsrj-6	38	12	virus	virus	NOUN
gsrj-6	38	13	antibody	antibody	NOUN
gsrj-6	38	14	(	(	PUNCT
gsrj-6	38	15	anti	anti	ADJ
gsrj-6	38	16	-	-	ADJ
gsrj-6	38	17	hcv	hcv	ADJ
gsrj-6	38	18	)	)	PUNCT
gsrj-6	38	19	in	in	ADP
gsrj-6	38	20	laboratory	laboratory	NOUN
gsrj-6	38	21	testing	testing	NOUN
gsrj-6	38	22	.	.	PUNCT
gsrj-6	39	1	hepatitis	hepatitis	PROPN
gsrj-6	39	2	b	b	ADP
gsrj-6	39	3	viral	viral	ADJ
gsrj-6	39	4	infection	infection	NOUN
gsrj-6	39	5	was	be	AUX
gsrj-6	39	6	defined	define	VERB
gsrj-6	39	7	as	as	ADP
gsrj-6	39	8	having	have	VERB
gsrj-6	39	9	a	a	DET
gsrj-6	39	10	positive	positive	ADJ
gsrj-6	39	11	surface	surface	NOUN
gsrj-6	39	12	antigen	antigen	NOUN
gsrj-6	39	13	(	(	PUNCT
gsrj-6	39	14	hbsag	hbsag	NOUN
gsrj-6	39	15	)	)	PUNCT
gsrj-6	39	16	on	on	ADP
gsrj-6	39	17	laboratory	laboratory	NOUN
gsrj-6	39	18	testing	testing	NOUN
gsrj-6	39	19	.	.	PUNCT
gsrj-6	40	1	persons	person	NOUN
gsrj-6	40	2	were	be	AUX
gsrj-6	40	3	identified	identify	VERB
gsrj-6	40	4	as	as	ADP
gsrj-6	40	5	smokers	smoker	NOUN
gsrj-6	40	6	when	when	SCONJ
gsrj-6	40	7	they	they	PRON
gsrj-6	40	8	reported	report	VERB
gsrj-6	40	9	current	current	ADJ
gsrj-6	40	10	smoking	smoking	NOUN
gsrj-6	40	11	on	on	ADP
gsrj-6	40	12	the	the	DET
gsrj-6	40	13	nhanes	nhane	NOUN
gsrj-6	40	14	questionnaire	questionnaire	NOUN
gsrj-6	40	15	.	.	PUNCT
gsrj-6	41	1	men	man	NOUN
gsrj-6	41	2	who	who	PRON
gsrj-6	41	3	reported	report	VERB
gsrj-6	41	4	consuming	consume	VERB
gsrj-6	41	5	more	more	ADJ
gsrj-6	41	6	than	than	ADP
gsrj-6	41	7	14	14	NUM
gsrj-6	41	8	drinks	drink	NOUN
gsrj-6	41	9	per	per	ADP
gsrj-6	41	10	week	week	NOUN
gsrj-6	41	11	and	and	CCONJ
gsrj-6	41	12	women	woman	NOUN
gsrj-6	41	13	who	who	PRON
gsrj-6	41	14	reported	report	VERB
gsrj-6	41	15	more	more	ADJ
gsrj-6	41	16	than	than	ADP
gsrj-6	41	17	7	7	NUM
gsrj-6	41	18	drinks	drink	NOUN
gsrj-6	41	19	per	per	ADP
gsrj-6	41	20	week	week	NOUN
gsrj-6	41	21	were	be	AUX
gsrj-6	41	22	defined	define	VERB
gsrj-6	41	23	as	as	ADP
gsrj-6	41	24	excessive	excessive	ADJ
gsrj-6	41	25	drinkers.13	drinkers.13	NOUN
gsrj-6	41	26	of	of	ADP
gsrj-6	41	27	the	the	DET
gsrj-6	41	28	metabolic	metabolic	NOUN
gsrj-6	41	29	risk	risk	NOUN
gsrj-6	41	30	factors	factor	NOUN
gsrj-6	41	31	,	,	PUNCT
gsrj-6	41	32	obesity	obesity	NOUN
gsrj-6	41	33	was	be	AUX
gsrj-6	41	34	defined	define	VERB
gsrj-6	41	35	by	by	ADP
gsrj-6	41	36	bmi	bmi	NOUN
gsrj-6	41	37	greater	great	ADJ
gsrj-6	41	38	than	than	ADP
gsrj-6	41	39	or	or	CCONJ
gsrj-6	41	40	equal	equal	ADJ
gsrj-6	41	41	to	to	ADP
gsrj-6	41	42	30	30	NUM
gsrj-6	41	43	from	from	ADP
gsrj-6	41	44	body	body	NOUN
gsrj-6	41	45	measurements	measurement	NOUN
gsrj-6	41	46	taken	take	VERB
gsrj-6	41	47	on	on	ADP
gsrj-6	41	48	physical	physical	ADJ
gsrj-6	41	49	exam	exam	NOUN
gsrj-6	41	50	.	.	PUNCT
gsrj-6	42	1	metabolic	metabolic	NOUN
gsrj-6	42	2	syndrome	syndrome	PROPN
gsrj-6	42	3	was	be	AUX
gsrj-6	42	4	defined	define	VERB
gsrj-6	42	5	using	use	VERB
gsrj-6	42	6	the	the	DET
gsrj-6	42	7	21	21	NUM
gsrj-6	42	8	georgetown	georgetown	PROPN
gsrj-6	42	9	scientific	scientific	ADJ
gsrj-6	42	10	research	research	PROPN
gsrj-6	42	11	journal	journal	PROPN
gsrj-6	42	12	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	42	13	international	international	ADJ
gsrj-6	42	14	diabetes	diabetes	PROPN
gsrj-6	42	15	federation	federation	PROPN
gsrj-6	42	16	definition.14	definition.14	PROPN
gsrj-6	42	17	persons	person	NOUN
gsrj-6	42	18	with	with	ADP
gsrj-6	42	19	any	any	DET
gsrj-6	42	20	three	three	NUM
gsrj-6	42	21	of	of	ADP
gsrj-6	42	22	the	the	DET
gsrj-6	42	23	following	follow	VERB
gsrj-6	42	24	five	five	NUM
gsrj-6	42	25	criteria	criterion	NOUN
gsrj-6	42	26	were	be	AUX
gsrj-6	42	27	defined	define	VERB
gsrj-6	42	28	as	as	ADP
gsrj-6	42	29	having	have	VERB
gsrj-6	42	30	metabolic	metabolic	NOUN
gsrj-6	42	31	syndrome	syndrome	NOUN
gsrj-6	42	32	:	:	PUNCT
gsrj-6	42	33	1	1	X
gsrj-6	42	34	)	)	PUNCT
gsrj-6	42	35	elevated	elevated	ADJ
gsrj-6	42	36	waist	waist	NOUN
gsrj-6	42	37	circumference	circumference	NOUN
gsrj-6	42	38	(	(	PUNCT
gsrj-6	42	39	men	man	NOUN
gsrj-6	42	40	>	>	PUNCT
gsrj-6	42	41	102	102	NUM
gsrj-6	42	42	cm	cm	NOUN
gsrj-6	42	43	,	,	PUNCT
gsrj-6	42	44	women	woman	NOUN
gsrj-6	42	45	>	>	X
gsrj-6	42	46	88	88	NUM
gsrj-6	42	47	cm	cm	NOUN
gsrj-6	42	48	)	)	PUNCT
gsrj-6	42	49	which	which	PRON
gsrj-6	42	50	was	be	AUX
gsrj-6	42	51	measured	measure	VERB
gsrj-6	42	52	during	during	ADP
gsrj-6	42	53	physical	physical	ADJ
gsrj-6	42	54	exam	exam	NOUN
gsrj-6	42	55	;	;	PUNCT
gsrj-6	42	56	2	2	X
gsrj-6	42	57	)	)	PUNCT
gsrj-6	42	58	elevated	elevated	ADJ
gsrj-6	42	59	triglycerides	triglyceride	NOUN
gsrj-6	42	60	(	(	PUNCT
gsrj-6	42	61	>	>	SYM
gsrj-6	42	62	=	=	SYM
gsrj-6	42	63	150	150	NUM
gsrj-6	42	64	mg	mg	PROPN
gsrj-6	42	65	/	/	SYM
gsrj-6	42	66	dl	dl	PROPN
gsrj-6	42	67	or	or	CCONJ
gsrj-6	42	68	currently	currently	ADV
gsrj-6	42	69	taking	take	VERB
gsrj-6	42	70	prescription	prescription	NOUN
gsrj-6	42	71	to	to	ADP
gsrj-6	42	72	lower	low	ADJ
gsrj-6	42	73	lipids	lipid	NOUN
gsrj-6	42	74	)	)	PUNCT
gsrj-6	42	75	;	;	PUNCT
gsrj-6	42	76	3	3	X
gsrj-6	42	77	)	)	PUNCT
gsrj-6	42	78	reduced	reduce	VERB
gsrj-6	42	79	high	high	ADJ
gsrj-6	42	80	-	-	PUNCT
gsrj-6	42	81	density	density	NOUN
gsrj-6	42	82	lipoprotein	lipoprotein	NOUN
gsrj-6	42	83	(	(	PUNCT
gsrj-6	42	84	<	<	X
gsrj-6	42	85	40mg	40mg	X
gsrj-6	42	86	/	/	SYM
gsrj-6	42	87	dl	dl	PROPN
gsrj-6	42	88	for	for	ADP
gsrj-6	42	89	males	male	NOUN
gsrj-6	42	90	or	or	CCONJ
gsrj-6	42	91	<	<	X
gsrj-6	42	92	50mg	50mg	ADJ
gsrj-6	42	93	/	/	SYM
gsrj-6	42	94	dl	dl	PROPN
gsrj-6	42	95	for	for	ADP
gsrj-6	42	96	females	female	NOUN
gsrj-6	42	97	)	)	PUNCT
gsrj-6	42	98	;	;	PUNCT
gsrj-6	42	99	4	4	X
gsrj-6	42	100	)	)	PUNCT
gsrj-6	42	101	hypertension	hypertension	NOUN
gsrj-6	42	102	(	(	PUNCT
gsrj-6	42	103	blood	blood	NOUN
gsrj-6	42	104	pressure	pressure	NOUN
gsrj-6	42	105	measurements	measurement	NOUN
gsrj-6	42	106	greater	great	ADJ
gsrj-6	42	107	than	than	ADP
gsrj-6	42	108	140mg	140mg	PROPN
gsrj-6	42	109	/	/	SYM
gsrj-6	42	110	dl	dl	PROPN
gsrj-6	42	111	for	for	ADP
gsrj-6	42	112	systolic	systolic	ADJ
gsrj-6	42	113	blood	blood	NOUN
gsrj-6	42	114	pressure	pressure	NOUN
gsrj-6	42	115	or	or	CCONJ
gsrj-6	42	116	greater	great	ADJ
gsrj-6	42	117	than	than	ADP
gsrj-6	42	118	90	90	NUM
gsrj-6	42	119	for	for	ADP
gsrj-6	42	120	diastolic	diastolic	NOUN
gsrj-6	42	121	)	)	PUNCT
gsrj-6	42	122	;	;	PUNCT
gsrj-6	42	123	or	or	CCONJ
gsrj-6	42	124	5	5	X
gsrj-6	42	125	)	)	PUNCT
gsrj-6	42	126	elevated	elevated	ADJ
gsrj-6	42	127	fasting	fasting	NOUN
gsrj-6	42	128	glucose	glucose	NOUN
gsrj-6	42	129	(	(	PUNCT
gsrj-6	42	130	!	!	PUNCT
gsrj-6	42	131	100mg	100mg	PROPN
gsrj-6	42	132	/	/	SYM
gsrj-6	42	133	dl	dl	PROPN
gsrj-6	42	134	)	)	PUNCT
gsrj-6	42	135	.	.	PUNCT
gsrj-6	43	1	diabetes	diabetes	NOUN
gsrj-6	43	2	was	be	AUX
gsrj-6	43	3	defined	define	VERB
gsrj-6	43	4	as	as	ADP
gsrj-6	43	5	having	having	AUX
gsrj-6	43	6	answered	answer	VERB
gsrj-6	43	7	yes	yes	INTJ
gsrj-6	43	8	to	to	ADP
gsrj-6	43	9	the	the	DET
gsrj-6	43	10	questionnaire	questionnaire	NOUN
gsrj-6	43	11	question	question	NOUN
gsrj-6	43	12	of	of	ADP
gsrj-6	43	13	“	"	PUNCT
gsrj-6	43	14	have	have	AUX
gsrj-6	43	15	you	you	PRON
gsrj-6	43	16	ever	ever	ADV
gsrj-6	43	17	been	be	AUX
gsrj-6	43	18	diagnosed	diagnose	VERB
gsrj-6	43	19	by	by	ADP
gsrj-6	43	20	a	a	DET
gsrj-6	43	21	physician	physician	NOUN
gsrj-6	43	22	as	as	ADP
gsrj-6	43	23	having	have	VERB
gsrj-6	43	24	diabetes	diabetes	NOUN
gsrj-6	43	25	?	?	PUNCT
gsrj-6	43	26	”	"	PUNCT
gsrj-6	43	27	or	or	CCONJ
gsrj-6	43	28	“	"	PUNCT
gsrj-6	43	29	are	be	AUX
gsrj-6	43	30	you	you	PRON
gsrj-6	43	31	currently	currently	ADV
gsrj-6	43	32	taking	take	VERB
gsrj-6	43	33	a	a	DET
gsrj-6	43	34	blood	blood	NOUN
gsrj-6	43	35	glucose	glucose	NOUN
gsrj-6	43	36	lowering	lower	VERB
gsrj-6	43	37	medication	medication	NOUN
gsrj-6	43	38	?	?	PUNCT
gsrj-6	43	39	”	"	PUNCT
gsrj-6	43	40	,	,	PUNCT
gsrj-6	43	41	and/or	and/or	CCONJ
gsrj-6	43	42	having	have	VERB
gsrj-6	43	43	a	a	DET
gsrj-6	43	44	fasting	fasting	NOUN
gsrj-6	43	45	glucose	glucose	NOUN
gsrj-6	43	46	level	level	NOUN
gsrj-6	43	47	greater	great	ADJ
gsrj-6	43	48	than	than	ADP
gsrj-6	43	49	126	126	NUM
gsrj-6	43	50	mg	mg	PROPN
gsrj-6	43	51	/	/	SYM
gsrj-6	43	52	dl	dl	PROPN
gsrj-6	43	53	,	,	PUNCT
gsrj-6	43	54	or	or	CCONJ
gsrj-6	43	55	having	have	VERB
gsrj-6	43	56	a	a	DET
gsrj-6	43	57	hemoglobin	hemoglobin	NOUN
gsrj-6	43	58	a1c	a1c	NOUN
gsrj-6	43	59	level	level	VERB
gsrj-6	43	60	greater	great	ADJ
gsrj-6	43	61	than	than	ADP
gsrj-6	43	62	6.5	6.5	NUM
gsrj-6	43	63	%	%	NOUN
gsrj-6	43	64	.	.	PUNCT
gsrj-6	44	1	cirrhosis	cirrhosis	NOUN
gsrj-6	44	2	was	be	AUX
gsrj-6	44	3	defined	define	VERB
gsrj-6	44	4	as	as	ADP
gsrj-6	44	5	having	have	VERB
gsrj-6	44	6	an	an	DET
gsrj-6	44	7	ast	ast	ADJ
gsrj-6	44	8	-	-	PUNCT
gsrj-6	44	9	toplatelet	toplatelet	NOUN
gsrj-6	44	10	ratio	ratio	NOUN
gsrj-6	44	11	index	index	NOUN
gsrj-6	44	12	(	(	PUNCT
gsrj-6	44	13	apri	apri	PROPN
gsrj-6	44	14	)	)	PUNCT
gsrj-6	44	15	>	>	SYM
gsrj-6	44	16	2	2	NUM
gsrj-6	44	17	and	and	CCONJ
gsrj-6	44	18	any	any	DET
gsrj-6	44	19	one	one	NUM
gsrj-6	44	20	of	of	ADP
gsrj-6	44	21	the	the	DET
gsrj-6	44	22	following	follow	VERB
gsrj-6	44	23	abnormal	abnormal	ADJ
gsrj-6	44	24	liver	liver	NOUN
gsrj-6	44	25	function	function	NOUN
gsrj-6	44	26	tests	test	NOUN
gsrj-6	44	27	:	:	PUNCT
gsrj-6	44	28	1	1	X
gsrj-6	44	29	)	)	PUNCT
gsrj-6	44	30	elevated	elevated	ADJ
gsrj-6	44	31	alt	alt	ADJ
gsrj-6	44	32	levels	level	NOUN
gsrj-6	44	33	(	(	PUNCT
gsrj-6	44	34	>	>	SYM
gsrj-6	44	35	40	40	NUM
gsrj-6	44	36	u	u	NOUN
gsrj-6	44	37	/	/	SYM
gsrj-6	44	38	l	l	NOUN
gsrj-6	44	39	for	for	ADP
gsrj-6	44	40	men	man	NOUN
gsrj-6	44	41	or	or	CCONJ
gsrj-6	44	42	>	>	SYM
gsrj-6	44	43	30	30	NUM
gsrj-6	44	44	u	u	NOUN
gsrj-6	44	45	/	/	SYM
gsrj-6	44	46	l	l	NOUN
gsrj-6	44	47	for	for	ADP
gsrj-6	44	48	women	woman	NOUN
gsrj-6	44	49	)	)	PUNCT
gsrj-6	44	50	;	;	PUNCT
gsrj-6	44	51	2	2	X
gsrj-6	44	52	)	)	PUNCT
gsrj-6	44	53	elevated	elevated	ADJ
gsrj-6	44	54	alkaline	alkaline	NOUN
gsrj-6	44	55	phosphatase	phosphatase	NOUN
gsrj-6	44	56	(	(	PUNCT
gsrj-6	44	57	>	>	X
gsrj-6	44	58	113	113	NUM
gsrj-6	44	59	u	u	NOUN
gsrj-6	44	60	/	/	SYM
gsrj-6	44	61	l	l	NOUN
gsrj-6	44	62	)	)	PUNCT
gsrj-6	44	63	;	;	PUNCT
gsrj-6	44	64	or	or	CCONJ
gsrj-6	44	65	3	3	X
gsrj-6	44	66	)	)	PUNCT
gsrj-6	44	67	elevated	elevated	ADJ
gsrj-6	44	68	total	total	ADJ
gsrj-6	44	69	bilirubin	bilirubin	NOUN
gsrj-6	44	70	(	(	PUNCT
gsrj-6	44	71	>	>	SYM
gsrj-6	44	72	1.3	1.3	NUM
gsrj-6	44	73	mg	mg	PROPN
gsrj-6	44	74	/	/	SYM
gsrj-6	44	75	dl	dl	NOUN
gsrj-6	44	76	)	)	PUNCT
gsrj-6	44	77	.	.	PUNCT
gsrj-6	45	1	nafld	nafld	ADV
gsrj-6	45	2	-	-	PUNCT
gsrj-6	45	3	advanced	advance	VERB
gsrj-6	45	4	fibrosis	fibrosis	NOUN
gsrj-6	45	5	(	(	PUNCT
gsrj-6	45	6	nafld	nafld	ADV
gsrj-6	45	7	-	-	PUNCT
gsrj-6	45	8	fib	fib	NOUN
gsrj-6	45	9	)	)	PUNCT
gsrj-6	45	10	was	be	AUX
gsrj-6	45	11	defined	define	VERB
gsrj-6	45	12	using	use	VERB
gsrj-6	45	13	three	three	NUM
gsrj-6	45	14	different	different	ADJ
gsrj-6	45	15	noninvasive	noninvasive	ADJ
gsrj-6	45	16	formulas	formula	NOUN
gsrj-6	45	17	:	:	PUNCT
gsrj-6	45	18	hepatic	hepatic	ADJ
gsrj-6	45	19	steatosis	steatosis	NOUN
gsrj-6	45	20	index	index	NOUN
gsrj-6	45	21	(	(	PUNCT
gsrj-6	45	22	hsi	hsi	PROPN
gsrj-6	45	23	)	)	PUNCT
gsrj-6	45	24	,	,	PUNCT
gsrj-6	45	25	the	the	DET
gsrj-6	45	26	fib-4	fib-4	ADJ
gsrj-6	45	27	index	index	NOUN
gsrj-6	45	28	(	(	PUNCT
gsrj-6	45	29	fib4	fib4	NOUN
gsrj-6	45	30	)	)	PUNCT
gsrj-6	45	31	,	,	PUNCT
gsrj-6	45	32	and	and	CCONJ
gsrj-6	45	33	the	the	DET
gsrj-6	45	34	nafld	nafld	ADJ
gsrj-6	45	35	fibrosis	fibrosis	NOUN
gsrj-6	45	36	score	score	NOUN
gsrj-6	45	37	(	(	PUNCT
gsrj-6	45	38	nfs).15,16	nfs).15,16	NOUN
gsrj-6	45	39	persons	person	NOUN
gsrj-6	45	40	who	who	PRON
gsrj-6	45	41	had	have	VERB
gsrj-6	45	42	fatty	fatty	NOUN
gsrj-6	45	43	liver	liver	NOUN
gsrj-6	45	44	based	base	VERB
gsrj-6	45	45	on	on	ADP
gsrj-6	45	46	the	the	DET
gsrj-6	45	47	hsi	hsi	PROPN
gsrj-6	45	48	and	and	CCONJ
gsrj-6	45	49	had	have	VERB
gsrj-6	45	50	fibrosis	fibrosis	NOUN
gsrj-6	45	51	based	base	VERB
gsrj-6	45	52	on	on	ADP
gsrj-6	45	53	the	the	DET
gsrj-6	45	54	fib4	fib4	NOUN
gsrj-6	45	55	and/or	and/or	CCONJ
gsrj-6	45	56	the	the	DET
gsrj-6	45	57	nfs	nfs	NOUN
gsrj-6	45	58	were	be	AUX
gsrj-6	45	59	defined	define	VERB
gsrj-6	45	60	as	as	ADP
gsrj-6	45	61	having	have	VERB
gsrj-6	45	62	nafld	nafld	ADV
gsrj-6	45	63	-	-	PUNCT
gsrj-6	45	64	advanced	advance	VERB
gsrj-6	45	65	fibrosis	fibrosis	NOUN
gsrj-6	45	66	.	.	PUNCT
gsrj-6	46	1	𝑯𝑯𝑯𝑯𝑯𝑯	𝑯𝑯𝑯𝑯𝑯𝑯	NOUN
gsrj-6	46	2	=	=	PUNCT
gsrj-6	46	3	8	8	NUM
gsrj-6	46	4	×	×	NOUN
gsrj-6	46	5	'	'	PUNCT
gsrj-6	46	6	𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴	𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴	ADJ
gsrj-6	46	7	,	,	PUNCT
gsrj-6	46	8	+	+	CCONJ
gsrj-6	46	9	𝐵𝐵𝐵𝐵𝐵𝐵	𝐵𝐵𝐵𝐵𝐵𝐵	PROPN
gsrj-6	47	1	[	[	X
gsrj-6	47	2	+2	+2	ADP
gsrj-6	47	3	𝑖𝑖𝑖𝑖	𝑖𝑖𝑖𝑖	ADV
gsrj-6	47	4	𝐷𝐷𝑖𝑖𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷	𝐷𝐷𝑖𝑖𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷	NOUN
gsrj-6	47	5	,	,	PUNCT
gsrj-6	47	6	+2	+2	DET
gsrj-6	47	7	𝑖𝑖𝑖𝑖	𝑖𝑖𝑖𝑖	PROPN
gsrj-6	47	8	𝐹𝐹𝐷𝐷𝐹𝐹𝐷𝐷𝐹𝐹𝐷𝐷	𝐹𝐹𝐷𝐷𝐹𝐹𝐷𝐷𝐹𝐹𝐷𝐷	PROPN
gsrj-6	47	9	]	]	X
gsrj-6	47	10	𝑭𝑭𝑯𝑯𝑭𝑭𝑭𝑭	𝑭𝑭𝑯𝑯𝑭𝑭𝑭𝑭	NOUN
gsrj-6	47	11	=	=	SYM
gsrj-6	47	12	𝐴𝐴𝐴𝐴𝐷𝐷	𝐴𝐴𝐴𝐴𝐷𝐷	VERB
gsrj-6	47	13	!	!	PUNCT
gsrj-6	48	1	"	"	PUNCT
gsrj-6	48	2	#	#	SYM
gsrj-6	48	3	$	$	SYM
gsrj-6	48	4	%	%	NOUN
gsrj-6	48	5	×	×	NOUN
gsrj-6	48	6	𝐴𝐴𝐴𝐴𝐴𝐴	𝐴𝐴𝐴𝐴𝐴𝐴	NOUN
gsrj-6	48	7	(	(	PUNCT
gsrj-6	48	8	𝑈𝑈𝐴𝐴	𝑈𝑈𝐴𝐴	PROPN
gsrj-6	48	9	)	)	PUNCT
gsrj-6	48	10	𝑃𝑃𝐹𝐹𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷𝐷𝐷	𝑃𝑃𝐹𝐹𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷𝐷𝐷	PROPN
gsrj-6	48	11	𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐷𝐷	𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐷𝐷	PROPN
gsrj-6	48	12	'	'	NUM
gsrj-6	48	13	10	10	NUM
gsrj-6	48	14	&	&	CCONJ
gsrj-6	48	15	𝐴𝐴	𝐴𝐴	PROPN
gsrj-6	48	16	,	,	PUNCT
gsrj-6	48	17	×	×	NOUN
gsrj-6	48	18	o𝐴𝐴𝐴𝐴𝐴𝐴	o𝐴𝐴𝐴𝐴𝐴𝐴	ADV
gsrj-6	48	19	(	(	PUNCT
gsrj-6	48	20	𝑈𝑈𝐴𝐴	𝑈𝑈𝐴𝐴	PROPN
gsrj-6	48	21	)	)	PUNCT
gsrj-6	48	22	𝑵𝑵𝑵𝑵𝑭𝑭𝑵𝑵𝑵𝑵	𝑵𝑵𝑵𝑵𝑭𝑭𝑵𝑵𝑵𝑵	PROPN
gsrj-6	48	23	𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭	𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭𝑭	VERB
gsrj-6	48	24	𝑯𝑯𝑺𝑺𝑭𝑭𝑭𝑭𝑺𝑺	𝑯𝑯𝑺𝑺𝑭𝑭𝑭𝑭𝑺𝑺	PROPN
gsrj-6	48	25	=	=	SYM
gsrj-6	48	26	−1.675	−1.675	PROPN
gsrj-6	49	1	+	+	NUM
gsrj-6	49	2	0.037	0.037	NUM
gsrj-6	49	3	(	(	PUNCT
gsrj-6	49	4	𝐴𝐴𝐴𝐴𝐷𝐷!"#$	𝐴𝐴𝐴𝐴𝐷𝐷!"#$	NOUN
gsrj-6	49	5	)	)	PUNCT
gsrj-6	50	1	+	+	CCONJ
gsrj-6	50	2	0.094	0.094	NUM
gsrj-6	50	3	(	(	PUNCT
gsrj-6	50	4	𝐵𝐵𝐵𝐵𝐵𝐵	𝐵𝐵𝐵𝐵𝐵𝐵	PROPN
gsrj-6	50	5	)	)	PUNCT
gsrj-6	51	1	+	+	CCONJ
gsrj-6	51	2	1.13(𝐹𝐹𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖𝐶𝐶𝐴𝐴	1.13(𝐹𝐹𝐷𝐷𝐷𝐷𝐷𝐷𝑖𝑖𝐶𝐶𝐴𝐴	NUM
gsrj-6	51	3	𝐺𝐺𝐹𝐹𝐶𝐶𝐺𝐺𝐶𝐶𝐷𝐷𝐷𝐷	𝐺𝐺𝐹𝐹𝐶𝐶𝐺𝐺𝐶𝐶𝐷𝐷𝐷𝐷	ADJ
gsrj-6	51	4	)	)	PUNCT
gsrj-6	51	5	(	(	PUNCT
gsrj-6	51	6	𝐷𝐷𝑖𝑖𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷	𝐷𝐷𝑖𝑖𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷𝐷	X
gsrj-6	51	7	(	(	PUNCT
gsrj-6	51	8	𝑦𝑦𝐷𝐷𝐷𝐷	𝑦𝑦𝐷𝐷𝐷𝐷	NOUN
gsrj-6	51	9	=	=	SYM
gsrj-6	51	10	1	1	NUM
gsrj-6	51	11	,	,	PUNCT
gsrj-6	51	12	𝐶𝐶𝐶𝐶	𝐶𝐶𝐶𝐶	NOUN
gsrj-6	51	13	=	=	SYM
gsrj-6	51	14	0	0	NUM
gsrj-6	51	15	)	)	PUNCT
gsrj-6	51	16	)	)	PUNCT
gsrj-6	52	1	+	+	CCONJ
gsrj-6	52	2	0.99	0.99	NUM
gsrj-6	52	3	f𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴g	f𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴g	NOUN
gsrj-6	52	4	−	−	PROPN
gsrj-6	52	5	0.013	0.013	NUM
gsrj-6	52	6	'	'	PUNCT
gsrj-6	52	7	𝑃𝑃𝐹𝐹𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷𝐷𝐷	𝑃𝑃𝐹𝐹𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷𝐷𝐷	PROPN
gsrj-6	52	8	𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐷𝐷(10	𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐷𝐷(10	NOUN
gsrj-6	52	9	&	&	CCONJ
gsrj-6	52	10	𝐴𝐴	𝐴𝐴	PROPN
gsrj-6	52	11	,	,	PUNCT
gsrj-6	52	12	−	−	PROPN
gsrj-6	52	13	0.66(𝐴𝐴𝐹𝐹𝐷𝐷𝐶𝐶𝐹𝐹𝑖𝑖𝐶𝐶	0.66(𝐴𝐴𝐹𝐹𝐷𝐷𝐶𝐶𝐹𝐹𝑖𝑖𝐶𝐶	NUM
gsrj-6	52	14	f𝐴𝐴𝐴𝐴g	f𝐴𝐴𝐴𝐴g	NOUN
gsrj-6	52	15	)	)	PUNCT
gsrj-6	52	16	nhanes	nhane	NOUN
gsrj-6	52	17	does	do	AUX
gsrj-6	52	18	not	not	PART
gsrj-6	52	19	include	include	VERB
gsrj-6	52	20	genetic	genetic	ADJ
gsrj-6	52	21	disorders	disorder	NOUN
gsrj-6	52	22	which	which	PRON
gsrj-6	52	23	are	be	AUX
gsrj-6	52	24	risk	risk	NOUN
gsrj-6	52	25	factors	factor	NOUN
gsrj-6	52	26	for	for	ADP
gsrj-6	52	27	hcc	hcc	PROPN
gsrj-6	52	28	or	or	CCONJ
gsrj-6	52	29	impaired	impaired	ADJ
gsrj-6	52	30	glucose	glucose	NOUN
gsrj-6	52	31	tolerance	tolerance	NOUN
gsrj-6	52	32	.	.	PUNCT
gsrj-6	53	1	thus	thus	ADV
gsrj-6	53	2	,	,	PUNCT
gsrj-6	53	3	these	these	DET
gsrj-6	53	4	risk	risk	NOUN
gsrj-6	53	5	factors	factor	NOUN
gsrj-6	53	6	could	could	AUX
gsrj-6	53	7	not	not	PART
gsrj-6	53	8	be	be	AUX
gsrj-6	53	9	included	include	VERB
gsrj-6	53	10	in	in	ADP
gsrj-6	53	11	our	our	PRON
gsrj-6	53	12	analysis	analysis	NOUN
gsrj-6	53	13	.	.	PUNCT
gsrj-6	54	1	1.2	1.2	NUM
gsrj-6	54	2	statistical	statistical	ADJ
gsrj-6	54	3	analysis	analysis	NOUN
gsrj-6	54	4	.	.	PUNCT
gsrj-6	55	1	this	this	DET
gsrj-6	55	2	analysis	analysis	NOUN
gsrj-6	55	3	used	use	VERB
gsrj-6	55	4	the	the	DET
gsrj-6	55	5	required	require	VERB
gsrj-6	55	6	weighting	weighting	NOUN
gsrj-6	55	7	procedures	procedure	NOUN
gsrj-6	55	8	to	to	PART
gsrj-6	55	9	account	account	VERB
gsrj-6	55	10	for	for	ADP
gsrj-6	55	11	the	the	DET
gsrj-6	55	12	survey	survey	NOUN
gsrj-6	55	13	design	design	NOUN
gsrj-6	55	14	of	of	ADP
gsrj-6	55	15	nhanes	nhane	NOUN
gsrj-6	55	16	.	.	PUNCT
gsrj-6	56	1	descriptive	descriptive	ADJ
gsrj-6	56	2	analyses	analysis	NOUN
gsrj-6	56	3	were	be	AUX
gsrj-6	56	4	done	do	VERB
gsrj-6	56	5	to	to	PART
gsrj-6	56	6	compare	compare	VERB
gsrj-6	56	7	the	the	DET
gsrj-6	56	8	nhanes	nhane	NOUN
gsrj-6	56	9	population	population	NOUN
gsrj-6	56	10	in	in	ADP
gsrj-6	56	11	1999	1999	NUM
gsrj-6	56	12	-	-	SYM
gsrj-6	56	13	2002	2002	NUM
gsrj-6	56	14	to	to	ADP
gsrj-6	56	15	the	the	DET
gsrj-6	56	16	nhanes	nhane	NOUN
gsrj-6	56	17	population	population	NOUN
gsrj-6	56	18	in	in	ADP
gsrj-6	56	19	2009	2009	NUM
gsrj-6	56	20	-	-	SYM
gsrj-6	56	21	2012	2012	NUM
gsrj-6	56	22	.	.	PUNCT
gsrj-6	57	1	categorical	categorical	ADJ
gsrj-6	57	2	variables	variable	NOUN
gsrj-6	57	3	were	be	AUX
gsrj-6	57	4	compared	compare	VERB
gsrj-6	57	5	using	use	VERB
gsrj-6	57	6	χ2	χ2	NOUN
gsrj-6	57	7	tests	test	NOUN
gsrj-6	57	8	.	.	PUNCT
gsrj-6	58	1	continuous	continuous	ADJ
gsrj-6	58	2	variables	variable	NOUN
gsrj-6	58	3	were	be	AUX
gsrj-6	58	4	compared	compare	VERB
gsrj-6	58	5	using	use	VERB
gsrj-6	58	6	the	the	DET
gsrj-6	58	7	students	student	NOUN
gsrj-6	58	8	t	t	NOUN
gsrj-6	58	9	-	-	PUNCT
gsrj-6	58	10	test	test	NOUN
gsrj-6	58	11	after	after	ADP
gsrj-6	58	12	confirming	confirm	VERB
gsrj-6	58	13	all	all	DET
gsrj-6	58	14	data	datum	NOUN
gsrj-6	58	15	were	be	AUX
gsrj-6	58	16	normally	normally	ADV
gsrj-6	58	17	distributed	distribute	VERB
gsrj-6	58	18	.	.	PUNCT
gsrj-6	59	1	age	age	NOUN
gsrj-6	59	2	-	-	PUNCT
gsrj-6	59	3	adjusted	adjust	VERB
gsrj-6	59	4	prevalence	prevalence	NOUN
gsrj-6	59	5	rates	rate	NOUN
gsrj-6	59	6	for	for	ADP
gsrj-6	59	7	hcv	hcv	NOUN
gsrj-6	59	8	infection	infection	NOUN
gsrj-6	59	9	,	,	PUNCT
gsrj-6	59	10	hbv	hbv	NOUN
gsrj-6	59	11	infection	infection	NOUN
gsrj-6	59	12	,	,	PUNCT
gsrj-6	59	13	smoking	smoking	NOUN
gsrj-6	59	14	,	,	PUNCT
gsrj-6	59	15	excessive	excessive	ADJ
gsrj-6	59	16	alcohol	alcohol	NOUN
gsrj-6	59	17	use	use	NOUN
gsrj-6	59	18	,	,	PUNCT
gsrj-6	59	19	obesity	obesity	NOUN
gsrj-6	59	20	,	,	PUNCT
gsrj-6	59	21	diabetes	diabetes	NOUN
gsrj-6	59	22	,	,	PUNCT
gsrj-6	59	23	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	59	24	,	,	PUNCT
gsrj-6	59	25	and	and	CCONJ
gsrj-6	59	26	nafld	nafld	ADV
gsrj-6	59	27	-	-	PUNCT
gsrj-6	59	28	fib	fib	NOUN
gsrj-6	59	29	for	for	SCONJ
gsrj-6	59	30	the	the	DET
gsrj-6	59	31	two	two	NUM
gsrj-6	59	32	four	four	NUM
gsrj-6	59	33	-	-	PUNCT
gsrj-6	59	34	year	year	NOUN
gsrj-6	59	35	time	time	NOUN
gsrj-6	59	36	periods	period	NOUN
gsrj-6	59	37	were	be	AUX
gsrj-6	59	38	calculated	calculate	VERB
gsrj-6	59	39	using	use	VERB
gsrj-6	59	40	the	the	DET
gsrj-6	59	41	projected	project	VERB
gsrj-6	59	42	population	population	NOUN
gsrj-6	59	43	of	of	ADP
gsrj-6	59	44	the	the	DET
gsrj-6	59	45	united	united	PROPN
gsrj-6	59	46	states	states	PROPN
gsrj-6	59	47	for	for	ADP
gsrj-6	59	48	the	the	DET
gsrj-6	59	49	year	year	NOUN
gsrj-6	59	50	2000.17	2000.17	NUM
gsrj-6	59	51	to	to	PART
gsrj-6	59	52	determine	determine	VERB
gsrj-6	59	53	the	the	DET
gsrj-6	59	54	predicted	predict	VERB
gsrj-6	59	55	contribution	contribution	NOUN
gsrj-6	59	56	of	of	ADP
gsrj-6	59	57	each	each	DET
gsrj-6	59	58	risk	risk	NOUN
gsrj-6	59	59	factor	factor	NOUN
gsrj-6	59	60	towards	towards	ADP
gsrj-6	59	61	the	the	DET
gsrj-6	59	62	development	development	NOUN
gsrj-6	59	63	of	of	ADP
gsrj-6	59	64	hcc	hcc	PROPN
gsrj-6	59	65	,	,	PUNCT
gsrj-6	59	66	the	the	DET
gsrj-6	59	67	population	population	NOUN
gsrj-6	59	68	attributable	attributable	ADJ
gsrj-6	59	69	risk	risk	NOUN
gsrj-6	59	70	was	be	AUX
gsrj-6	59	71	calculated	calculate	VERB
gsrj-6	59	72	.	.	PUNCT
gsrj-6	60	1	a	a	DET
gsrj-6	60	2	medical	medical	ADJ
gsrj-6	60	3	literature	literature	NOUN
gsrj-6	60	4	review	review	NOUN
gsrj-6	60	5	was	be	AUX
gsrj-6	60	6	done	do	VERB
gsrj-6	60	7	to	to	PART
gsrj-6	60	8	find	find	VERB
gsrj-6	60	9	the	the	DET
gsrj-6	60	10	relative	relative	ADJ
gsrj-6	60	11	risk	risk	NOUN
gsrj-6	60	12	(	(	PUNCT
gsrj-6	60	13	rr	rr	NOUN
gsrj-6	60	14	)	)	PUNCT
gsrj-6	60	15	of	of	ADP
gsrj-6	60	16	each	each	DET
gsrj-6	60	17	risk	risk	NOUN
gsrj-6	60	18	factor	factor	NOUN
gsrj-6	60	19	(	(	PUNCT
gsrj-6	60	20	hcv	hcv	PROPN
gsrj-6	60	21	,	,	PUNCT
gsrj-6	60	22	hbv	hbv	NOUN
gsrj-6	60	23	,	,	PUNCT
gsrj-6	60	24	etc	etc	X
gsrj-6	60	25	.	.	X
gsrj-6	60	26	)	)	PUNCT
gsrj-6	60	27	towards	towards	ADP
gsrj-6	60	28	the	the	DET
gsrj-6	60	29	development	development	NOUN
gsrj-6	60	30	of	of	ADP
gsrj-6	60	31	hcc	hcc	PROPN
gsrj-6	60	32	.	.	PUNCT
gsrj-6	61	1	the	the	DET
gsrj-6	61	2	literature	literature	PROPN
gsrj-6	61	3	review	review	NOUN
gsrj-6	61	4	was	be	AUX
gsrj-6	61	5	done	do	VERB
gsrj-6	61	6	using	use	VERB
gsrj-6	61	7	pubmed	pubmed	PROPN
gsrj-6	61	8	and	and	CCONJ
gsrj-6	61	9	with	with	ADP
gsrj-6	61	10	the	the	DET
gsrj-6	61	11	term	term	NOUN
gsrj-6	61	12	for	for	ADP
gsrj-6	61	13	each	each	DET
gsrj-6	61	14	risk	risk	NOUN
gsrj-6	61	15	factor	factor	NOUN
gsrj-6	61	16	,	,	PUNCT
gsrj-6	61	17	risk	risk	NOUN
gsrj-6	61	18	,	,	PUNCT
gsrj-6	61	19	and	and	CCONJ
gsrj-6	61	20	hepatocellular	hepatocellular	ADJ
gsrj-6	61	21	carcinoma	carcinoma	NOUN
gsrj-6	61	22	.	.	PUNCT
gsrj-6	62	1	22	22	NUM
gsrj-6	62	2	georgetown	georgetown	PROPN
gsrj-6	62	3	scientific	scientific	PROPN
gsrj-6	62	4	research	research	PROPN
gsrj-6	62	5	journal	journal	PROPN
gsrj-6	62	6	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	62	7	results	result	NOUN
gsrj-6	62	8	were	be	AUX
gsrj-6	62	9	sorted	sort	VERB
gsrj-6	62	10	by	by	ADP
gsrj-6	62	11	year	year	NOUN
gsrj-6	62	12	of	of	ADP
gsrj-6	62	13	publication	publication	NOUN
gsrj-6	62	14	with	with	ADP
gsrj-6	62	15	us	us	PROPN
gsrj-6	62	16	populations	population	NOUN
gsrj-6	62	17	,	,	PUNCT
gsrj-6	62	18	and	and	CCONJ
gsrj-6	62	19	recent	recent	ADJ
gsrj-6	62	20	meta	meta	NOUN
gsrj-6	62	21	or	or	CCONJ
gsrj-6	62	22	pooled	pool	VERB
gsrj-6	62	23	analyses	analysis	NOUN
gsrj-6	62	24	preferred	prefer	VERB
gsrj-6	62	25	.	.	PUNCT
gsrj-6	63	1	the	the	DET
gsrj-6	63	2	population	population	NOUN
gsrj-6	63	3	attributable	attributable	ADJ
gsrj-6	63	4	fraction	fraction	NOUN
gsrj-6	63	5	(	(	PUNCT
gsrj-6	63	6	paf	paf	PROPN
gsrj-6	63	7	)	)	PUNCT
gsrj-6	63	8	for	for	ADP
gsrj-6	63	9	each	each	DET
gsrj-6	63	10	risk	risk	NOUN
gsrj-6	63	11	factor	factor	NOUN
gsrj-6	63	12	was	be	AUX
gsrj-6	63	13	then	then	ADV
gsrj-6	63	14	calculated	calculate	VERB
gsrj-6	63	15	using	use	VERB
gsrj-6	63	16	the	the	DET
gsrj-6	63	17	formula	formula	NOUN
gsrj-6	63	18	developed	develop	VERB
gsrj-6	63	19	by	by	ADP
gsrj-6	63	20	levin	levin	PROPN
gsrj-6	63	21	for	for	ADP
gsrj-6	63	22	each	each	DET
gsrj-6	63	23	sex	sex	NOUN
gsrj-6	63	24	and	and	CCONJ
gsrj-6	63	25	race	race	NOUN
gsrj-6	63	26	group.18	group.18	VERB
gsrj-6	63	27	𝑃𝑃𝐶𝐶	𝑃𝑃𝐶𝐶	NOUN
gsrj-6	63	28	𝐶𝐶𝐹𝐹𝐷𝐷𝐷𝐷𝑖𝑖𝐶𝐶𝐶𝐶	𝐶𝐶𝐹𝐹𝐷𝐷𝐷𝐷𝑖𝑖𝐶𝐶𝐶𝐶	INTJ
gsrj-6	63	29	𝐴𝐴𝐷𝐷𝐷𝐷	𝐴𝐴𝐷𝐷𝐷𝐷	VERB
gsrj-6	63	30	𝑖𝑖𝐷𝐷𝐶𝐶𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷	𝑖𝑖𝐷𝐷𝐶𝐶𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷	NOUN
gsrj-6	63	31	𝐹𝐹	𝐹𝐹	PROPN
gsrj-6	63	32	𝐷𝐷𝐺𝐺𝐷𝐷𝑖𝑖𝐶𝐶𝐶𝐶	𝐷𝐷𝐺𝐺𝐷𝐷𝑖𝑖𝐶𝐶𝐶𝐶	NOUN
gsrj-6	63	33	=	=	NOUN
gsrj-6	63	34	𝑖𝑖𝐷𝐷	𝑖𝑖𝐷𝐷	NOUN
gsrj-6	63	35	𝑃𝑃	𝑃𝑃	NOUN
gsrj-6	63	36	𝐷𝐷	𝐷𝐷	PROPN
gsrj-6	63	37	𝐷𝐷𝐹𝐹𝐷𝐷𝐶𝐶𝐺𝐺𝐷𝐷	𝐷𝐷𝐹𝐹𝐷𝐷𝐶𝐶𝐺𝐺𝐷𝐷	VERB
gsrj-6	63	38	(	(	PUNCT
gsrj-6	63	39	%	%	INTJ
gsrj-6	63	40	$	$	SYM
gsrj-6	63	41	"	"	PUNCT
gsrj-6	63	42	−	−	PROPN
gsrj-6	63	43	1	1	NUM
gsrj-6	63	44	)	)	PUNCT
gsrj-6	63	45	𝑖𝑖𝐷𝐷	𝑖𝑖𝐷𝐷	NOUN
gsrj-6	63	46	𝑃𝑃	𝑃𝑃	NOUN
gsrj-6	63	47	𝐷𝐷	𝐷𝐷	PROPN
gsrj-6	63	48	𝐷𝐷𝐹𝐹𝐷𝐷𝐶𝐶𝐺𝐺𝐷𝐷	𝐷𝐷𝐹𝐹𝐷𝐷𝐶𝐶𝐺𝐺𝐷𝐷	VERB
gsrj-6	63	49	%	%	NOUN
gsrj-6	63	50	$	$	SYM
gsrj-6	63	51	"	"	PUNCT
gsrj-6	63	52	−	−	PROPN
gsrj-6	63	53	1	1	NUM
gsrj-6	63	54	+	+	SYM
gsrj-6	63	55	1	1	NUM
gsrj-6	63	56	in	in	ADP
gsrj-6	63	57	determining	determine	VERB
gsrj-6	63	58	the	the	DET
gsrj-6	63	59	paf	paf	NOUN
gsrj-6	63	60	,	,	PUNCT
gsrj-6	63	61	the	the	DET
gsrj-6	63	62	risk	risk	NOUN
gsrj-6	63	63	factors	factor	NOUN
gsrj-6	63	64	were	be	AUX
gsrj-6	63	65	analyzed	analyze	VERB
gsrj-6	63	66	independently	independently	ADV
gsrj-6	63	67	,	,	PUNCT
gsrj-6	63	68	without	without	ADP
gsrj-6	63	69	accounting	account	VERB
gsrj-6	63	70	for	for	ADP
gsrj-6	63	71	interaction	interaction	NOUN
gsrj-6	63	72	between	between	ADP
gsrj-6	63	73	their	their	PRON
gsrj-6	63	74	effects	effect	NOUN
gsrj-6	63	75	.	.	PUNCT
gsrj-6	64	1	the	the	DET
gsrj-6	64	2	combined	combined	ADJ
gsrj-6	64	3	effect	effect	NOUN
gsrj-6	64	4	of	of	ADP
gsrj-6	64	5	all	all	DET
gsrj-6	64	6	risk	risk	NOUN
gsrj-6	64	7	factors	factor	NOUN
gsrj-6	64	8	and	and	CCONJ
gsrj-6	64	9	risk	risk	NOUN
gsrj-6	64	10	factors	factor	NOUN
gsrj-6	64	11	by	by	ADP
gsrj-6	64	12	type	type	NOUN
gsrj-6	64	13	(	(	PUNCT
gsrj-6	64	14	metabolic	metabolic	NOUN
gsrj-6	64	15	vs.	vs.	ADP
gsrj-6	64	16	non	non	ADJ
gsrj-6	64	17	-	-	ADJ
gsrj-6	64	18	metabolic	metabolic	ADJ
gsrj-6	64	19	)	)	PUNCT
gsrj-6	64	20	were	be	AUX
gsrj-6	64	21	calculated	calculate	VERB
gsrj-6	64	22	using	use	VERB
gsrj-6	64	23	the	the	DET
gsrj-6	64	24	formula	formula	NOUN
gsrj-6	64	25	below	below	ADP
gsrj-6	64	26	:	:	PUNCT
gsrj-6	64	27	𝐴𝐴𝐶𝐶𝐷𝐷𝐷𝐷𝐹𝐹	𝐴𝐴𝐶𝐶𝐷𝐷𝐷𝐷𝐹𝐹	PROPN
gsrj-6	64	28	𝐴𝐴𝐷𝐷𝐷𝐷	𝐴𝐴𝐷𝐷𝐷𝐷	VERB
gsrj-6	64	29	𝑖𝑖𝐷𝐷𝐶𝐶𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷	𝑖𝑖𝐷𝐷𝐶𝐶𝐷𝐷𝐷𝐷𝐷𝐷𝐹𝐹𝐷𝐷	NOUN
gsrj-6	64	30	𝐹𝐹	𝐹𝐹	PROPN
gsrj-6	64	31	𝐷𝐷𝐺𝐺𝐷𝐷𝑖𝑖𝐶𝐶𝐶𝐶	𝐷𝐷𝐺𝐺𝐷𝐷𝑖𝑖𝐶𝐶𝐶𝐶	NOUN
gsrj-6	65	1	=	=	SYM
gsrj-6	65	2	1	1	NUM
gsrj-6	65	3	−	−	NOUN
gsrj-6	65	4	(	(	PUNCT
gsrj-6	65	5	1	1	NUM
gsrj-6	65	6	−	−	NOUN
gsrj-6	65	7	𝑃𝑃𝐴𝐴𝐹𝐹	𝑃𝑃𝐴𝐴𝐹𝐹	NOUN
gsrj-6	65	8	)	)	PUNCT
gsrj-6	65	9	all	all	DET
gsrj-6	65	10	statistical	statistical	ADJ
gsrj-6	65	11	analyses	analysis	NOUN
gsrj-6	65	12	were	be	AUX
gsrj-6	65	13	conducted	conduct	VERB
gsrj-6	65	14	using	use	VERB
gsrj-6	65	15	sas	sas	PROPN
gsrj-6	65	16	9.4	9.4	NUM
gsrj-6	65	17	(	(	PUNCT
gsrj-6	65	18	cary	cary	PROPN
gsrj-6	65	19	,	,	PUNCT
gsrj-6	65	20	nc	nc	PROPN
gsrj-6	65	21	)	)	PUNCT
gsrj-6	65	22	with	with	ADP
gsrj-6	65	23	p	p	NOUN
gsrj-6	65	24	<	<	X
gsrj-6	65	25	0.05	0.05	NUM
gsrj-6	65	26	considered	consider	VERB
gsrj-6	65	27	significant	significant	ADJ
gsrj-6	65	28	.	.	PUNCT
gsrj-6	66	1	figures	figure	NOUN
gsrj-6	66	2	were	be	AUX
gsrj-6	66	3	developed	develop	VERB
gsrj-6	66	4	using	use	VERB
gsrj-6	66	5	graphpad	graphpad	NOUN
gsrj-6	66	6	prism	prism	NOUN
gsrj-6	66	7	version	version	NOUN
gsrj-6	66	8	8.0.0	8.0.0	NUM
gsrj-6	66	9	for	for	ADP
gsrj-6	66	10	windows	window	NOUN
gsrj-6	66	11	,	,	PUNCT
gsrj-6	66	12	graphpad	graphpad	NOUN
gsrj-6	66	13	software	software	NOUN
gsrj-6	66	14	,	,	PUNCT
gsrj-6	66	15	san	san	PROPN
gsrj-6	66	16	diego	diego	PROPN
gsrj-6	66	17	,	,	PUNCT
gsrj-6	66	18	california	california	PROPN
gsrj-6	66	19	usa	usa	PROPN
gsrj-6	66	20	.	.	PUNCT
gsrj-6	67	1	the	the	DET
gsrj-6	67	2	top	top	ADJ
gsrj-6	67	3	enriched	enrich	VERB
gsrj-6	67	4	pathogenic	pathogenic	ADJ
gsrj-6	67	5	genes	gene	NOUN
gsrj-6	67	6	associated	associate	VERB
gsrj-6	67	7	with	with	ADP
gsrj-6	67	8	liver	liver	NOUN
gsrj-6	67	9	diseases	disease	NOUN
gsrj-6	67	10	were	be	AUX
gsrj-6	67	11	analyzed	analyze	VERB
gsrj-6	67	12	using	use	VERB
gsrj-6	67	13	the	the	DET
gsrj-6	67	14	disgenet	disgenet	NOUN
gsrj-6	67	15	platform	platform	NOUN
gsrj-6	67	16	(	(	PUNCT
gsrj-6	67	17	table	table	NOUN
gsrj-6	67	18	1).19	1).19	NOUN
gsrj-6	67	19	the	the	DET
gsrj-6	67	20	disgenet	disgenet	PROPN
gsrj-6	67	21	database	database	NOUN
gsrj-6	67	22	uses	use	VERB
gsrj-6	67	23	information	information	NOUN
gsrj-6	67	24	of	of	ADP
gsrj-6	67	25	human	human	ADJ
gsrj-6	67	26	gene	gene	NOUN
gsrj-6	67	27	-	-	PUNCT
gsrj-6	67	28	disease	disease	NOUN
gsrj-6	67	29	association	association	NOUN
gsrj-6	67	30	(	(	PUNCT
gsrj-6	67	31	gdas	gdas	PROPN
gsrj-6	67	32	)	)	PUNCT
gsrj-6	67	33	and	and	CCONJ
gsrj-6	67	34	variant	variant	NOUN
gsrj-6	67	35	-	-	PUNCT
gsrj-6	67	36	disease	disease	NOUN
gsrj-6	67	37	association	association	NOUN
gsrj-6	67	38	(	(	PUNCT
gsrj-6	67	39	vdas	vdas	PROPN
gsrj-6	67	40	)	)	PUNCT
gsrj-6	67	41	from	from	ADP
gsrj-6	67	42	expert	expert	ADJ
gsrj-6	67	43	curated	curate	VERB
gsrj-6	67	44	repositories	repository	NOUN
gsrj-6	67	45	.	.	PUNCT
gsrj-6	68	1	the	the	DET
gsrj-6	68	2	gda	gda	PROPN
gsrj-6	68	3	score	score	NOUN
gsrj-6	68	4	was	be	AUX
gsrj-6	68	5	calculated	calculate	VERB
gsrj-6	68	6	using	use	VERB
gsrj-6	68	7	the	the	DET
gsrj-6	68	8	formula	formula	NOUN
gsrj-6	68	9	developed	develop	VERB
gsrj-6	68	10	by	by	ADP
gsrj-6	68	11	disgenet	disgenet	NOUN
gsrj-6	68	12	.	.	PUNCT
gsrj-6	69	1	scoring	scoring	NOUN
gsrj-6	69	2	(	(	PUNCT
gsrj-6	69	3	gda	gda	PROPN
gsrj-6	69	4	)	)	PUNCT
gsrj-6	69	5	was	be	AUX
gsrj-6	69	6	used	use	VERB
gsrj-6	69	7	to	to	PART
gsrj-6	69	8	rank	rank	VERB
gsrj-6	69	9	the	the	DET
gsrj-6	69	10	gene	gene	NOUN
gsrj-6	69	11	-	-	PUNCT
gsrj-6	69	12	disease	disease	NOUN
gsrj-6	69	13	according	accord	VERB
gsrj-6	69	14	to	to	ADP
gsrj-6	69	15	their	their	PRON
gsrj-6	69	16	level	level	NOUN
gsrj-6	69	17	of	of	ADP
gsrj-6	69	18	evidence.19	evidence.19	NOUN
gsrj-6	69	19	the	the	DET
gsrj-6	69	20	disgenet	disgenet	NOUN
gsrj-6	69	21	score	score	NOUN
gsrj-6	69	22	(	(	PUNCT
gsrj-6	69	23	s	s	X
gsrj-6	69	24	)	)	PUNCT
gsrj-6	69	25	for	for	ADP
gsrj-6	69	26	gdas	gda	NOUN
gsrj-6	69	27	is	be	AUX
gsrj-6	69	28	computed	compute	VERB
gsrj-6	69	29	according	accord	VERB
gsrj-6	69	30	to	to	ADP
gsrj-6	69	31	:	:	PUNCT
gsrj-6	69	32	where	where	SCONJ
gsrj-6	69	33	:	:	PUNCT
gsrj-6	69	34	nsourcesi	nsourcesi	PROPN
gsrj-6	69	35	is	be	AUX
gsrj-6	69	36	the	the	DET
gsrj-6	69	37	number	number	NOUN
gsrj-6	69	38	of	of	ADP
gsrj-6	69	39	curated	curate	VERB
gsrj-6	69	40	sources	source	NOUN
gsrj-6	69	41	supporting	support	VERB
gsrj-6	69	42	a	a	DET
gsrj-6	69	43	gda	gda	NOUN
gsrj-6	69	44	i	i	PROPN
gsrj-6	69	45	cgi	cgi	PROPN
gsrj-6	69	46	,	,	PUNCT
gsrj-6	69	47	clingen	clingen	PROPN
gsrj-6	69	48	,	,	PUNCT
gsrj-6	69	49	genomics	genomics	PROPN
gsrj-6	69	50	england	england	PROPN
gsrj-6	69	51	,	,	PUNCT
gsrj-6	69	52	ctd	ctd	PROPN
gsrj-6	69	53	,	,	PUNCT
gsrj-6	69	54	psygenet	psygenet	NOUN
gsrj-6	69	55	,	,	PUNCT
gsrj-6	69	56	orphanet	orphanet	NOUN
gsrj-6	69	57	,	,	PUNCT
gsrj-6	69	58	uniprot	uniprot	VERB
gsrj-6	69	59	where	where	SCONJ
gsrj-6	69	60	:	:	PUNCT
gsrj-6	69	61	j	j	PROPN
gsrj-6	69	62	rat	rat	PROPN
gsrj-6	69	63	,	,	PUNCT
gsrj-6	69	64	mouse	mouse	PROPN
gsrj-6	69	65	from	from	ADP
gsrj-6	69	66	rgd	rgd	PROPN
gsrj-6	69	67	,	,	PUNCT
gsrj-6	69	68	mgd	mgd	PROPN
gsrj-6	69	69	,	,	PUNCT
gsrj-6	69	70	and	and	CCONJ
gsrj-6	69	71	ctd	ctd	VERB
gsrj-6	69	72	where	where	SCONJ
gsrj-6	69	73	:	:	PUNCT
gsrj-6	69	74	k	k	PROPN
gsrj-6	69	75	hpo	hpo	PROPN
gsrj-6	69	76	,	,	PUNCT
gsrj-6	69	77	clinvar	clinvar	PROPN
gsrj-6	69	78	,	,	PUNCT
gsrj-6	69	79	gwascat	gwascat	NOUN
gsrj-6	69	80	,	,	PUNCT
gsrj-6	69	81	gwasdb	gwasdb	NOUN
gsrj-6	69	82	where	where	SCONJ
gsrj-6	69	83	:	:	PUNCT
gsrj-6	69	84	npubs	npub	NOUN
gsrj-6	69	85	is	be	AUX
gsrj-6	69	86	the	the	DET
gsrj-6	69	87	number	number	NOUN
gsrj-6	69	88	of	of	ADP
gsrj-6	69	89	publications	publication	NOUN
gsrj-6	69	90	supporting	support	VERB
gsrj-6	69	91	a	a	DET
gsrj-6	69	92	gda	gda	NOUN
gsrj-6	69	93	in	in	ADP
gsrj-6	69	94	the	the	DET
gsrj-6	69	95	sources	source	NOUN
gsrj-6	69	96	lhgdn	lhgdn	VERB
gsrj-6	69	97	and	and	CCONJ
gsrj-6	69	98	befree	befree	PROPN
gsrj-6	69	99	disgenet	disgenet	PROPN
gsrj-6	69	100	uses	use	VERB
gsrj-6	69	101	two	two	NUM
gsrj-6	69	102	other	other	ADJ
gsrj-6	69	103	metrics	metric	NOUN
gsrj-6	69	104	to	to	PART
gsrj-6	69	105	facilitate	facilitate	VERB
gsrj-6	69	106	the	the	DET
gsrj-6	69	107	ranking	ranking	NOUN
gsrj-6	69	108	of	of	ADP
gsrj-6	69	109	the	the	DET
gsrj-6	69	110	genes	gene	NOUN
gsrj-6	69	111	associated	associate	VERB
gsrj-6	69	112	with	with	ADP
gsrj-6	69	113	hepatocellular	hepatocellular	ADJ
gsrj-6	69	114	carcinoma	carcinoma	NOUN
gsrj-6	69	115	.	.	PUNCT
gsrj-6	70	1	the	the	DET
gsrj-6	70	2	disease	disease	NOUN
gsrj-6	70	3	specificity	specificity	NOUN
gsrj-6	70	4	index	index	NOUN
gsrj-6	70	5	(	(	PUNCT
gsrj-6	70	6	dsi	dsi	NOUN
gsrj-6	70	7	)	)	PUNCT
gsrj-6	70	8	was	be	AUX
gsrj-6	70	9	used	use	VERB
gsrj-6	70	10	,	,	PUNCT
gsrj-6	70	11	which	which	PRON
gsrj-6	70	12	is	be	AUX
gsrj-6	70	13	inversely	inversely	ADV
gsrj-6	70	14	proportional	proportional	ADJ
gsrj-6	70	15	to	to	ADP
gsrj-6	70	16	the	the	DET
gsrj-6	70	17	number	number	NOUN
gsrj-6	70	18	of	of	ADP
gsrj-6	70	19	diseases	disease	NOUN
gsrj-6	70	20	associated	associate	VERB
gsrj-6	70	21	to	to	ADP
gsrj-6	70	22	gene	gene	VERB
gsrj-6	70	23	.	.	PUNCT
gsrj-6	71	1	a	a	DET
gsrj-6	71	2	gene	gene	NOUN
gsrj-6	71	3	associated	associate	VERB
gsrj-6	71	4	with	with	ADP
gsrj-6	71	5	multiple	multiple	ADJ
gsrj-6	71	6	diseases	disease	NOUN
gsrj-6	71	7	23	23	NUM
gsrj-6	71	8	georgetown	georgetown	PROPN
gsrj-6	71	9	scientific	scientific	PROPN
gsrj-6	71	10	research	research	PROPN
gsrj-6	71	11	journal	journal	PROPN
gsrj-6	71	12	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	71	13	gets	get	VERB
gsrj-6	71	14	a	a	DET
gsrj-6	71	15	score	score	NOUN
gsrj-6	71	16	close	close	ADV
gsrj-6	71	17	to	to	ADP
gsrj-6	71	18	zero	zero	NUM
gsrj-6	71	19	,	,	PUNCT
gsrj-6	71	20	and	and	CCONJ
gsrj-6	71	21	a	a	DET
gsrj-6	71	22	gene	gene	NOUN
gsrj-6	71	23	associated	associate	VERB
gsrj-6	71	24	with	with	ADP
gsrj-6	71	25	only	only	ADV
gsrj-6	71	26	one	one	NUM
gsrj-6	71	27	disease	disease	NOUN
gsrj-6	71	28	has	have	VERB
gsrj-6	71	29	dsi	dsi	NOUN
gsrj-6	71	30	of	of	ADP
gsrj-6	71	31	1.18	1.18	NUM
gsrj-6	71	32	it	it	PRON
gsrj-6	71	33	is	be	AUX
gsrj-6	71	34	computed	compute	VERB
gsrj-6	71	35	according	accord	VERB
gsrj-6	71	36	to	to	ADP
gsrj-6	71	37	:	:	PUNCT
gsrj-6	71	38	where	where	SCONJ
gsrj-6	71	39	:	:	PUNCT
gsrj-6	72	1	n	n	X
gsrj-6	72	2	d	d	NOUN
gsrj-6	72	3	is	be	AUX
gsrj-6	72	4	the	the	DET
gsrj-6	72	5	number	number	NOUN
gsrj-6	72	6	of	of	ADP
gsrj-6	72	7	diseases	disease	NOUN
gsrj-6	72	8	associated	associate	VERB
gsrj-6	72	9	to	to	ADP
gsrj-6	72	10	the	the	DET
gsrj-6	72	11	gene	gene	NOUN
gsrj-6	72	12	/	/	SYM
gsrj-6	72	13	variant	variant	NOUN
gsrj-6	72	14	n	n	PRON
gsrj-6	72	15	t	t	NOUN
gsrj-6	72	16	is	be	AUX
gsrj-6	72	17	the	the	DET
gsrj-6	72	18	total	total	ADJ
gsrj-6	72	19	number	number	NOUN
gsrj-6	72	20	of	of	ADP
gsrj-6	72	21	diseases	disease	NOUN
gsrj-6	72	22	in	in	ADP
gsrj-6	72	23	disgenet	disgenet	NOUN
gsrj-6	72	24	the	the	DET
gsrj-6	72	25	disease	disease	NOUN
gsrj-6	72	26	pleiotropy	pleiotropy	NOUN
gsrj-6	72	27	index	index	NOUN
gsrj-6	72	28	(	(	PUNCT
gsrj-6	72	29	dpi	dpi	NOUN
gsrj-6	72	30	)	)	PUNCT
gsrj-6	72	31	was	be	AUX
gsrj-6	72	32	the	the	DET
gsrj-6	72	33	second	second	ADJ
gsrj-6	72	34	metric	metric	NOUN
gsrj-6	72	35	used	use	VERB
gsrj-6	72	36	to	to	PART
gsrj-6	72	37	rank	rank	VERB
gsrj-6	72	38	the	the	DET
gsrj-6	72	39	genes	gene	NOUN
gsrj-6	72	40	.	.	PUNCT
gsrj-6	73	1	it	it	PRON
gsrj-6	73	2	ranges	range	VERB
gsrj-6	73	3	from	from	ADP
gsrj-6	73	4	0	0	NUM
gsrj-6	73	5	to	to	ADP
gsrj-6	73	6	1	1	NUM
gsrj-6	73	7	and	and	CCONJ
gsrj-6	73	8	is	be	AUX
gsrj-6	73	9	proportional	proportional	ADJ
gsrj-6	73	10	to	to	ADP
gsrj-6	73	11	the	the	DET
gsrj-6	73	12	number	number	NOUN
gsrj-6	73	13	of	of	ADP
gsrj-6	73	14	different	different	ADJ
gsrj-6	73	15	(	(	PUNCT
gsrj-6	73	16	mesh	mesh	NOUN
gsrj-6	73	17	)	)	PUNCT
gsrj-6	73	18	disease	disease	NOUN
gsrj-6	73	19	classes	class	VERB
gsrj-6	73	20	a	a	DET
gsrj-6	73	21	gene	gene	NOUN
gsrj-6	73	22	is	be	AUX
gsrj-6	73	23	associated	associate	VERB
gsrj-6	73	24	with	with	ADP
gsrj-6	73	25	.	.	PUNCT
gsrj-6	74	1	the	the	DET
gsrj-6	74	2	dpi	dpi	NOUN
gsrj-6	74	3	is	be	AUX
gsrj-6	74	4	computed	compute	VERB
gsrj-6	74	5	according	accord	VERB
gsrj-6	74	6	to	to	ADP
gsrj-6	74	7	:	:	PUNCT
gsrj-6	74	8	where	where	SCONJ
gsrj-6	74	9	:	:	PUNCT
gsrj-6	74	10	n	n	PRON
gsrj-6	74	11	dc	dc	PROPN
gsrj-6	74	12	is	be	AUX
gsrj-6	74	13	the	the	DET
gsrj-6	74	14	number	number	NOUN
gsrj-6	74	15	of	of	ADP
gsrj-6	74	16	the	the	DET
gsrj-6	74	17	different	different	ADJ
gsrj-6	74	18	mesh	mesh	NOUN
gsrj-6	74	19	disease	disease	NOUN
gsrj-6	74	20	classes	class	NOUN
gsrj-6	74	21	of	of	ADP
gsrj-6	74	22	the	the	DET
gsrj-6	74	23	diseases	disease	NOUN
gsrj-6	74	24	associated	associate	VERB
gsrj-6	74	25	to	to	ADP
gsrj-6	74	26	the	the	DET
gsrj-6	74	27	gene	gene	NOUN
gsrj-6	74	28	/	/	SYM
gsrj-6	74	29	variant	variant	NOUN
gsrj-6	74	30	n	n	DET
gsrj-6	74	31	tc	tc	NOUN
gsrj-6	74	32	is	be	AUX
gsrj-6	74	33	the	the	DET
gsrj-6	74	34	total	total	ADJ
gsrj-6	74	35	number	number	NOUN
gsrj-6	74	36	of	of	ADP
gsrj-6	74	37	mesh	mesh	NOUN
gsrj-6	74	38	diseases	disease	NOUN
gsrj-6	74	39	classes	class	NOUN
gsrj-6	74	40	in	in	ADP
gsrj-6	74	41	disgenet	disgenet	NOUN
gsrj-6	74	42	.	.	PUNCT
gsrj-6	75	1	furthermore	furthermore	ADV
gsrj-6	75	2	,	,	PUNCT
gsrj-6	75	3	cytoscape	cytoscape	NOUN
gsrj-6	75	4	network	network	NOUN
gsrj-6	75	5	was	be	AUX
gsrj-6	75	6	used	use	VERB
gsrj-6	75	7	to	to	PART
gsrj-6	75	8	form	form	VERB
gsrj-6	75	9	a	a	DET
gsrj-6	75	10	gene	gene	NOUN
gsrj-6	75	11	-	-	PUNCT
gsrj-6	75	12	disease	disease	NOUN
gsrj-6	75	13	association	association	NOUN
gsrj-6	75	14	to	to	PART
gsrj-6	75	15	visualize	visualize	VERB
gsrj-6	75	16	interaction	interaction	NOUN
gsrj-6	75	17	among	among	ADP
gsrj-6	75	18	different	different	ADJ
gsrj-6	75	19	genes	gene	NOUN
gsrj-6	75	20	(	(	PUNCT
gsrj-6	75	21	figure	figure	NOUN
gsrj-6	75	22	2	2	NUM
gsrj-6	75	23	)	)	PUNCT
gsrj-6	75	24	.	.	PUNCT
gsrj-6	76	1	cytoscape	cytoscape	NOUN
gsrj-6	76	2	is	be	AUX
gsrj-6	76	3	an	an	DET
gsrj-6	76	4	open	open	ADJ
gsrj-6	76	5	-	-	PUNCT
gsrj-6	76	6	source	source	NOUN
gsrj-6	76	7	platform	platform	NOUN
gsrj-6	76	8	for	for	ADP
gsrj-6	76	9	visualizing	visualize	VERB
gsrj-6	76	10	molecular	molecular	ADJ
gsrj-6	76	11	interactions.20	interactions.20	NOUN
gsrj-6	76	12	1	1	NUM
gsrj-6	76	13	.	.	PUNCT
gsrj-6	77	1	results	result	NOUN
gsrj-6	77	2	there	there	PRON
gsrj-6	77	3	were	be	VERB
gsrj-6	77	4	10,945	10,945	NUM
gsrj-6	77	5	individuals	individual	NOUN
gsrj-6	77	6	in	in	ADP
gsrj-6	77	7	the	the	DET
gsrj-6	77	8	19992002	19992002	NUM
gsrj-6	77	9	sample	sample	NOUN
gsrj-6	77	10	and	and	CCONJ
gsrj-6	77	11	12,305	12,305	NUM
gsrj-6	77	12	in	in	ADP
gsrj-6	77	13	the	the	DET
gsrj-6	77	14	2009	2009	NUM
gsrj-6	77	15	-	-	SYM
gsrj-6	77	16	2012	2012	NUM
gsrj-6	77	17	sample	sample	NOUN
gsrj-6	77	18	(	(	PUNCT
gsrj-6	77	19	figure	figure	NOUN
gsrj-6	77	20	1	1	NUM
gsrj-6	77	21	)	)	PUNCT
gsrj-6	77	22	.	.	PUNCT
gsrj-6	78	1	the	the	DET
gsrj-6	78	2	groups	group	NOUN
gsrj-6	78	3	did	do	AUX
gsrj-6	78	4	not	not	PART
gsrj-6	78	5	differ	differ	VERB
gsrj-6	78	6	among	among	ADP
gsrj-6	78	7	the	the	DET
gsrj-6	78	8	distribution	distribution	NOUN
gsrj-6	78	9	of	of	ADP
gsrj-6	78	10	sex	sex	NOUN
gsrj-6	78	11	,	,	PUNCT
gsrj-6	78	12	age	age	NOUN
gsrj-6	78	13	,	,	PUNCT
gsrj-6	78	14	or	or	CCONJ
gsrj-6	78	15	race	race	NOUN
gsrj-6	78	16	/	/	SYM
gsrj-6	78	17	ethnicity	ethnicity	NOUN
gsrj-6	78	18	.	.	PUNCT
gsrj-6	79	1	the	the	DET
gsrj-6	79	2	mean	mean	ADJ
gsrj-6	79	3	age	age	NOUN
gsrj-6	79	4	at	at	ADP
gsrj-6	79	5	screening	screen	VERB
gsrj-6	79	6	was	be	AUX
gsrj-6	79	7	45.4	45.4	NUM
gsrj-6	79	8	(	(	PUNCT
gsrj-6	79	9	1999	1999	NUM
gsrj-6	79	10	-	-	SYM
gsrj-6	79	11	2002	2002	NUM
gsrj-6	79	12	)	)	PUNCT
gsrj-6	79	13	and	and	CCONJ
gsrj-6	79	14	46.4	46.4	NUM
gsrj-6	79	15	(	(	PUNCT
gsrj-6	79	16	2009	2009	NUM
gsrj-6	79	17	-	-	SYM
gsrj-6	79	18	2012	2012	NUM
gsrj-6	79	19	)	)	PUNCT
gsrj-6	79	20	and	and	CCONJ
gsrj-6	79	21	50.7	50.7	NUM
gsrj-6	79	22	%	%	NOUN
gsrj-6	79	23	of	of	ADP
gsrj-6	79	24	the	the	DET
gsrj-6	79	25	participants	participant	NOUN
gsrj-6	79	26	were	be	AUX
gsrj-6	79	27	female	female	ADJ
gsrj-6	79	28	(	(	PUNCT
gsrj-6	79	29	table	table	NOUN
gsrj-6	79	30	2	2	NUM
gsrj-6	79	31	)	)	PUNCT
gsrj-6	79	32	.	.	PUNCT
gsrj-6	80	1	in	in	ADP
gsrj-6	80	2	the	the	DET
gsrj-6	80	3	overall	overall	ADJ
gsrj-6	80	4	nhanes	nhane	NOUN
gsrj-6	80	5	population	population	NOUN
gsrj-6	80	6	,	,	PUNCT
gsrj-6	80	7	obesity	obesity	NOUN
gsrj-6	80	8	,	,	PUNCT
gsrj-6	80	9	excessive	excessive	ADJ
gsrj-6	80	10	alcohol	alcohol	NOUN
gsrj-6	80	11	consumption	consumption	NOUN
gsrj-6	80	12	,	,	PUNCT
gsrj-6	80	13	and	and	CCONJ
gsrj-6	80	14	smoking	smoking	NOUN
gsrj-6	80	15	were	be	AUX
gsrj-6	80	16	the	the	DET
gsrj-6	80	17	most	most	ADV
gsrj-6	80	18	prevalent	prevalent	ADJ
gsrj-6	80	19	hcc	hcc	PROPN
gsrj-6	80	20	risk	risk	NOUN
gsrj-6	80	21	factors	factor	NOUN
gsrj-6	80	22	in	in	ADP
gsrj-6	80	23	both	both	PRON
gsrj-6	80	24	19992002	19992002	NUM
gsrj-6	80	25	and	and	CCONJ
gsrj-6	80	26	2009	2009	NUM
gsrj-6	80	27	-	-	SYM
gsrj-6	80	28	2012	2012	NUM
gsrj-6	80	29	.	.	PUNCT
gsrj-6	81	1	the	the	DET
gsrj-6	81	2	prevalence	prevalence	NOUN
gsrj-6	81	3	of	of	ADP
gsrj-6	81	4	hbv	hbv	NOUN
gsrj-6	81	5	,	,	PUNCT
gsrj-6	81	6	hcv	hcv	PROPN
gsrj-6	81	7	,	,	PUNCT
gsrj-6	81	8	or	or	CCONJ
gsrj-6	81	9	excessive	excessive	ADJ
gsrj-6	81	10	alcohol	alcohol	NOUN
gsrj-6	81	11	consumption	consumption	NOUN
gsrj-6	81	12	did	do	AUX
gsrj-6	81	13	not	not	PART
gsrj-6	81	14	change	change	VERB
gsrj-6	81	15	over	over	ADP
gsrj-6	81	16	the	the	DET
gsrj-6	81	17	ten	ten	NUM
gsrj-6	81	18	-	-	PUNCT
gsrj-6	81	19	year	year	NOUN
gsrj-6	81	20	period	period	NOUN
gsrj-6	81	21	.	.	PUNCT
gsrj-6	82	1	all	all	DET
gsrj-6	82	2	metabolic	metabolic	ADJ
gsrj-6	82	3	risk	risk	NOUN
gsrj-6	82	4	factors	factor	NOUN
gsrj-6	82	5	(	(	PUNCT
gsrj-6	82	6	obesity	obesity	NOUN
gsrj-6	82	7	,	,	PUNCT
gsrj-6	82	8	diabetes	diabetes	NOUN
gsrj-6	82	9	,	,	PUNCT
gsrj-6	82	10	nafld	nafld	ADV
gsrj-6	82	11	-	-	PUNCT
gsrj-6	82	12	fib	fib	ADJ
gsrj-6	82	13	,	,	PUNCT
gsrj-6	82	14	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	82	15	)	)	PUNCT
gsrj-6	82	16	increased	increase	VERB
gsrj-6	82	17	over	over	ADP
gsrj-6	82	18	the	the	DET
gsrj-6	82	19	ten	ten	NUM
gsrj-6	82	20	years	year	NOUN
gsrj-6	82	21	of	of	ADP
gsrj-6	82	22	study	study	NOUN
gsrj-6	82	23	in	in	ADP
gsrj-6	82	24	the	the	DET
gsrj-6	82	25	overall	overall	ADJ
gsrj-6	82	26	population	population	NOUN
gsrj-6	82	27	(	(	PUNCT
gsrj-6	82	28	table	table	NOUN
gsrj-6	82	29	2	2	NUM
gsrj-6	82	30	)	)	PUNCT
gsrj-6	82	31	.	.	PUNCT
gsrj-6	83	1	concurrently	concurrently	ADV
gsrj-6	83	2	,	,	PUNCT
gsrj-6	83	3	bmi	bmi	PROPN
gsrj-6	83	4	,	,	PUNCT
gsrj-6	83	5	waist	waist	NOUN
gsrj-6	83	6	circumference	circumference	NOUN
gsrj-6	83	7	,	,	PUNCT
gsrj-6	83	8	fasting	fast	VERB
gsrj-6	83	9	glucose	glucose	NOUN
gsrj-6	83	10	levels	level	NOUN
gsrj-6	83	11	,	,	PUNCT
gsrj-6	83	12	and	and	CCONJ
gsrj-6	83	13	triglyceride	triglyceride	ADJ
gsrj-6	83	14	levels	level	NOUN
gsrj-6	83	15	all	all	PRON
gsrj-6	83	16	increased	increase	VERB
gsrj-6	83	17	between	between	ADP
gsrj-6	83	18	the	the	DET
gsrj-6	83	19	two	two	NUM
gsrj-6	83	20	time	time	NOUN
gsrj-6	83	21	periods	period	NOUN
gsrj-6	83	22	(	(	PUNCT
gsrj-6	83	23	all	all	PRON
gsrj-6	83	24	p	p	X
gsrj-6	83	25	<	<	X
gsrj-6	83	26	0.001	0.001	NUM
gsrj-6	83	27	,	,	PUNCT
gsrj-6	83	28	supplemental	supplemental	ADJ
gsrj-6	83	29	table	table	NOUN
gsrj-6	83	30	1	1	NUM
gsrj-6	83	31	)	)	PUNCT
gsrj-6	83	32	.	.	PUNCT
gsrj-6	84	1	24	24	NUM
gsrj-6	84	2	both	both	CCONJ
gsrj-6	84	3	nash	nash	NOUN
gsrj-6	84	4	-	-	PUNCT
gsrj-6	84	5	cirrhosis	cirrhosis	NOUN
gsrj-6	84	6	and	and	CCONJ
gsrj-6	84	7	nafld	nafld	ADV
gsrj-6	84	8	-	-	PUNCT
gsrj-6	84	9	fib	fib	NOUN
gsrj-6	84	10	increased	increase	VERB
gsrj-6	84	11	in	in	ADP
gsrj-6	84	12	prevalence	prevalence	NOUN
gsrj-6	84	13	between	between	ADP
gsrj-6	84	14	1999	1999	NUM
gsrj-6	84	15	-	-	SYM
gsrj-6	84	16	2002	2002	NUM
gsrj-6	84	17	and	and	CCONJ
gsrj-6	84	18	�	�	PROPN
gsrj-6	84	19	�	�	PROPN
gsrj-6	84	20	�	�	PROPN
gsrj-6	84	21	�	�	PROPN
gsrj-6	84	22	�	�	PROPN
gsrj-6	84	23	�	�	PROPN
gsrj-6	84	24	�	�	PROPN
gsrj-6	84	25	�	�	PROPN
gsrj-6	84	26	�	�	PROPN
gsrj-6	84	27	�	�	PROPN
gsrj-6	84	28	�	�	PROPN
gsrj-6	84	29	�	�	PROPN
gsrj-6	84	30	5if	5if	ADJ
gsrj-6	84	31	�	�	PROPN
gsrj-6	84	32	qsfwbmfodf	qsfwbmfodf	NOUN
gsrj-6	84	33	�	�	PROPN
gsrj-6	84	34	sbuft	sbuft	PROPN
gsrj-6	84	35	�	�	PROPN
gsrj-6	84	36	pg	pg	NOUN
gsrj-6	84	37	�	�	PROPN
gsrj-6	84	38	/"'-%	/"'-%	PROPN
gsrj-6	84	39	�	�	PROPN
gsrj-6	84	40	gjc	gjc	NOUN
gsrj-6	84	41	increased	increase	VERB
gsrj-6	84	42	from	from	ADP
gsrj-6	84	43	1999	1999	NUM
gsrj-6	84	44	-	-	SYM
gsrj-6	84	45	2002	2002	NUM
gsrj-6	84	46	(	(	PUNCT
gsrj-6	84	47	1.53	1.53	NUM
gsrj-6	84	48	%	%	NOUN
gsrj-6	84	49	)	)	PUNCT
gsrj-6	84	50	to	to	ADP
gsrj-6	84	51	2009	2009	NUM
gsrj-6	84	52	-	-	SYM
gsrj-6	84	53	2012	2012	NUM
gsrj-6	84	54	(	(	PUNCT
gsrj-6	84	55	4.0	4.0	NUM
gsrj-6	84	56	%	%	NOUN
gsrj-6	84	57	)	)	PUNCT
gsrj-6	84	58	(	(	PUNCT
gsrj-6	84	59	p<0.001	p<0.001	PROPN
gsrj-6	84	60	)	)	PUNCT
gsrj-6	84	61	,	,	PUNCT
gsrj-6	84	62	while	while	SCONJ
gsrj-6	84	63	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	84	64	25	25	NUM
gsrj-6	84	65	georgetown	georgetown	PROPN
gsrj-6	84	66	scientific	scientific	PROPN
gsrj-6	84	67	research	research	PROPN
gsrj-6	84	68	journal	journal	PROPN
gsrj-6	84	69	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	84	70	increased	increase	VERB
gsrj-6	84	71	from	from	ADP
gsrj-6	84	72	0.07	0.07	NUM
gsrj-6	84	73	%	%	NOUN
gsrj-6	84	74	to	to	PART
gsrj-6	84	75	0.20	0.20	NUM
gsrj-6	84	76	%	%	NOUN
gsrj-6	84	77	,	,	PUNCT
gsrj-6	84	78	p=0.03	p=0.03	ADJ
gsrj-6	84	79	)	)	PUNCT
gsrj-6	84	80	.	.	PUNCT
gsrj-6	85	1	this	this	PRON
gsrj-6	85	2	represents	represent	VERB
gsrj-6	85	3	a	a	DET
gsrj-6	85	4	164	164	NUM
gsrj-6	85	5	%	%	NOUN
gsrj-6	85	6	increase	increase	NOUN
gsrj-6	85	7	for	for	ADP
gsrj-6	85	8	nafld	nafld	ADV
gsrj-6	85	9	-	-	PUNCT
gsrj-6	85	10	fib	fib	NOUN
gsrj-6	85	11	and	and	CCONJ
gsrj-6	85	12	�	�	PROPN
gsrj-6	85	13	�	�	PROPN
gsrj-6	85	14	�	�	PROPN
gsrj-6	85	15	�	�	PROPN
gsrj-6	85	16	�	�	PROPN
gsrj-6	85	17	jodsfbtf	jodsfbtf	PROPN
gsrj-6	85	18	�	�	PROPN
gsrj-6	85	19	gps	gps	PROPN
gsrj-6	85	20	�	�	PROPN
gsrj-6	85	21	/"4)	/"4)	SYM
gsrj-6	85	22	�	�	PROPN
gsrj-6	85	23	djssiptjt	djssiptjt	PROPN
gsrj-6	85	24	�	�	PROPN
gsrj-6	85	25	pwfsbmm	pwfsbmm	PROPN
gsrj-6	85	26	�	�	PROPN
gsrj-6	85	27	�	�	PROPN
gsrj-6	85	28	5if	5if	ADJ
gsrj-6	85	29	largest	large	ADJ
gsrj-6	85	30	increase	increase	NOUN
gsrj-6	85	31	of	of	ADP
gsrj-6	85	32	nafld	nafld	ADV
gsrj-6	85	33	-	-	PUNCT
gsrj-6	85	34	fib	fib	NOUN
gsrj-6	85	35	occurred	occur	VERB
gsrj-6	85	36	among	among	ADP
gsrj-6	85	37	the	the	DET
gsrj-6	85	38	hispanic	hispanic	ADJ
gsrj-6	85	39	population	population	NOUN
gsrj-6	85	40	(	(	PUNCT
gsrj-6	85	41	a	a	DET
gsrj-6	85	42	296	296	NUM
gsrj-6	85	43	%	%	NOUN
gsrj-6	85	44	increase	increase	NOUN
gsrj-6	85	45	,	,	PUNCT
gsrj-6	85	46	p<0.001	p<0.001	X
gsrj-6	85	47	)	)	PUNCT
gsrj-6	85	48	(	(	PUNCT
gsrj-6	85	49	table	table	NOUN
gsrj-6	85	50	3	3	NUM
gsrj-6	85	51	)	)	PUNCT
gsrj-6	85	52	.	.	PUNCT
gsrj-6	86	1	the	the	DET
gsrj-6	86	2	risk	risk	NOUN
gsrj-6	86	3	factors	factor	VERB
gsrj-6	86	4	to	to	PART
gsrj-6	86	5	decrease	decrease	VERB
gsrj-6	86	6	over	over	ADP
gsrj-6	86	7	the	the	DET
gsrj-6	86	8	ten	ten	NUM
gsrj-6	86	9	-	-	PUNCT
gsrj-6	86	10	year	year	NOUN
gsrj-6	86	11	period	period	NOUN
gsrj-6	86	12	were	be	AUX
gsrj-6	86	13	the	the	DET
gsrj-6	86	14	number	number	NOUN
gsrj-6	86	15	of	of	ADP
gsrj-6	86	16	current	current	ADJ
gsrj-6	86	17	smokers	smoker	NOUN
gsrj-6	86	18	(	(	PUNCT
gsrj-6	86	19	prevalence	prevalence	NOUN
gsrj-6	86	20	24.5	24.5	NUM
gsrj-6	86	21	%	%	NOUN
gsrj-6	86	22	to	to	ADP
gsrj-6	86	23	20.3	20.3	NUM
gsrj-6	86	24	%	%	NOUN
gsrj-6	86	25	,	,	PUNCT
gsrj-6	86	26	p=<0.001	p=<0.001	NOUN
gsrj-6	86	27	)	)	PUNCT
gsrj-6	86	28	and	and	CCONJ
gsrj-6	86	29	access	access	NOUN
gsrj-6	86	30	alcohol	alcohol	NOUN
gsrj-6	86	31	.	.	PUNCT
gsrj-6	87	1	there	there	PRON
gsrj-6	87	2	were	be	VERB
gsrj-6	87	3	no	no	DET
gsrj-6	87	4	temporal	temporal	ADJ
gsrj-6	87	5	changes	change	NOUN
gsrj-6	87	6	in	in	ADP
gsrj-6	87	7	the	the	DET
gsrj-6	87	8	prevalence	prevalence	NOUN
gsrj-6	87	9	of	of	ADP
gsrj-6	87	10	excessive	excessive	ADJ
gsrj-6	87	11	drinking	drinking	NOUN
gsrj-6	87	12	behaviors	behavior	NOUN
gsrj-6	87	13	overall	overall	ADV
gsrj-6	87	14	,	,	PUNCT
gsrj-6	87	15	which	which	PRON
gsrj-6	87	16	remained	remain	VERB
gsrj-6	87	17	between	between	ADP
gsrj-6	87	18	23.8	23.8	NUM
gsrj-6	87	19	%	%	NOUN
gsrj-6	87	20	and	and	CCONJ
gsrj-6	87	21	21.6	21.6	NUM
gsrj-6	87	22	%	%	NOUN
gsrj-6	87	23	(	(	PUNCT
gsrj-6	87	24	p	p	NOUN
gsrj-6	87	25	=	=	NOUN
gsrj-6	87	26	0.83	0.83	NUM
gsrj-6	87	27	,	,	PUNCT
gsrj-6	87	28	table	table	NOUN
gsrj-6	87	29	2	2	NUM
gsrj-6	87	30	)	)	PUNCT
gsrj-6	87	31	.	.	PUNCT
gsrj-6	88	1	1.1	1.1	NUM
gsrj-6	88	2	population	population	NOUN
gsrj-6	88	3	attributable	attributable	ADJ
gsrj-6	88	4	fractions	fraction	NOUN
gsrj-6	88	5	overall	overall	ADV
gsrj-6	88	6	,	,	PUNCT
gsrj-6	88	7	77.9	77.9	NUM
gsrj-6	88	8	%	%	NOUN
gsrj-6	88	9	of	of	ADP
gsrj-6	88	10	hcc	hcc	PROPN
gsrj-6	88	11	cases	case	NOUN
gsrj-6	88	12	from	from	ADP
gsrj-6	88	13	1999	1999	NUM
gsrj-6	88	14	-	-	SYM
gsrj-6	88	15	2002	2002	NUM
gsrj-6	88	16	and	and	CCONJ
gsrj-6	88	17	76.2	76.2	NUM
gsrj-6	88	18	%	%	NOUN
gsrj-6	88	19	of	of	ADP
gsrj-6	88	20	hcc	hcc	PROPN
gsrj-6	88	21	cases	case	NOUN
gsrj-6	88	22	from	from	ADP
gsrj-6	88	23	2009	2009	NUM
gsrj-6	88	24	-	-	SYM
gsrj-6	88	25	2012	2012	NUM
gsrj-6	88	26	could	could	AUX
gsrj-6	88	27	be	be	AUX
gsrj-6	88	28	attributed	attribute	VERB
gsrj-6	88	29	to	to	ADP
gsrj-6	88	30	the	the	DET
gsrj-6	88	31	risk	risk	NOUN
gsrj-6	88	32	factors	factor	NOUN
gsrj-6	88	33	analyzed	analyze	VERB
gsrj-6	88	34	in	in	ADP
gsrj-6	88	35	this	this	DET
gsrj-6	88	36	study	study	NOUN
gsrj-6	88	37	.	.	PUNCT
gsrj-6	89	1	in	in	ADP
gsrj-6	89	2	the	the	DET
gsrj-6	89	3	overall	overall	ADJ
gsrj-6	89	4	population	population	NOUN
gsrj-6	89	5	,	,	PUNCT
gsrj-6	89	6	metabolic	metabolic	NOUN
gsrj-6	89	7	risk	risk	NOUN
gsrj-6	89	8	factors	factor	NOUN
gsrj-6	89	9	(	(	PUNCT
gsrj-6	89	10	diabetes	diabetes	NOUN
gsrj-6	89	11	,	,	PUNCT
gsrj-6	89	12	obesity	obesity	NOUN
gsrj-6	89	13	,	,	PUNCT
gsrj-6	89	14	nafld	nafld	ADV
gsrj-6	89	15	-	-	PUNCT
gsrj-6	89	16	fib	fib	ADJ
gsrj-6	89	17	,	,	PUNCT
gsrj-6	89	18	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	89	19	)	)	PUNCT
gsrj-6	89	20	composed	compose	VERB
gsrj-6	89	21	35	35	NUM
gsrj-6	89	22	%	%	NOUN
gsrj-6	89	23	of	of	ADP
gsrj-6	89	24	hcc	hcc	PROPN
gsrj-6	89	25	cases	case	NOUN
gsrj-6	89	26	in	in	ADP
gsrj-6	89	27	199926	199926	NUM
gsrj-6	89	28	georgetown	georgetown	PROPN
gsrj-6	89	29	scientific	scientific	PROPN
gsrj-6	89	30	research	research	PROPN
gsrj-6	89	31	journal	journal	PROPN
gsrj-6	89	32	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	89	33	2002	2002	NUM
gsrj-6	89	34	and	and	CCONJ
gsrj-6	89	35	increased	increase	VERB
gsrj-6	89	36	to	to	PART
gsrj-6	89	37	accounted	account	VERB
gsrj-6	89	38	for	for	ADP
gsrj-6	89	39	42	42	NUM
gsrj-6	89	40	%	%	NOUN
gsrj-6	89	41	of	of	ADP
gsrj-6	89	42	hcc	hcc	PROPN
gsrj-6	89	43	cases	case	NOUN
gsrj-6	89	44	in	in	ADP
gsrj-6	89	45	2009	2009	NUM
gsrj-6	89	46	-	-	SYM
gsrj-6	89	47	2012	2012	NUM
gsrj-6	89	48	.	.	PUNCT
gsrj-6	90	1	synchronously	synchronously	ADV
gsrj-6	90	2	,	,	PUNCT
gsrj-6	90	3	nonmetabolic	nonmetabolic	ADJ
gsrj-6	90	4	risk	risk	NOUN
gsrj-6	90	5	factors	factor	NOUN
gsrj-6	90	6	(	(	PUNCT
gsrj-6	90	7	hbv	hbv	NOUN
gsrj-6	90	8	,	,	PUNCT
gsrj-6	90	9	hcv	hcv	PROPN
gsrj-6	90	10	,	,	PUNCT
gsrj-6	90	11	excessive	excessive	ADJ
gsrj-6	90	12	alcohol	alcohol	NOUN
gsrj-6	90	13	use	use	NOUN
gsrj-6	90	14	,	,	PUNCT
gsrj-6	90	15	current	current	ADJ
gsrj-6	90	16	smokers	smoker	NOUN
gsrj-6	90	17	)	)	PUNCT
gsrj-6	90	18	decreased	decrease	VERB
gsrj-6	90	19	from	from	ADP
gsrj-6	90	20	a	a	DET
gsrj-6	90	21	paf	paf	NOUN
gsrj-6	90	22	of	of	ADP
gsrj-6	90	23	66	66	NUM
gsrj-6	90	24	%	%	NOUN
gsrj-6	90	25	in	in	ADP
gsrj-6	90	26	1999	1999	NUM
gsrj-6	90	27	-	-	SYM
gsrj-6	90	28	2002	2002	NUM
gsrj-6	90	29	to	to	ADP
gsrj-6	90	30	59	59	NUM
gsrj-6	90	31	%	%	NOUN
gsrj-6	90	32	in	in	ADP
gsrj-6	90	33	2009	2009	NUM
gsrj-6	90	34	-	-	SYM
gsrj-6	90	35	2012	2012	NUM
gsrj-6	90	36	(	(	PUNCT
gsrj-6	90	37	table	table	NOUN
gsrj-6	90	38	4	4	NUM
gsrj-6	90	39	)	)	PUNCT
gsrj-6	90	40	.	.	PUNCT
gsrj-6	91	1	other	other	ADJ
gsrj-6	91	2	/	/	SYM
gsrj-6	91	3	mixed	mixed	ADJ
gsrj-6	91	4	category	category	NOUN
gsrj-6	91	5	was	be	AUX
gsrj-6	91	6	removed	remove	VERB
gsrj-6	91	7	from	from	ADP
gsrj-6	91	8	the	the	DET
gsrj-6	91	9	study	study	NOUN
gsrj-6	91	10	because	because	SCONJ
gsrj-6	91	11	it	it	PRON
gsrj-6	91	12	was	be	AUX
gsrj-6	91	13	not	not	PART
gsrj-6	91	14	statistically	statistically	ADV
gsrj-6	91	15	significant	significant	ADJ
gsrj-6	91	16	enough	enough	ADV
gsrj-6	91	17	to	to	PART
gsrj-6	91	18	make	make	VERB
gsrj-6	91	19	conclusions	conclusion	NOUN
gsrj-6	91	20	about	about	ADP
gsrj-6	91	21	the	the	DET
gsrj-6	91	22	paf	paf	NOUN
gsrj-6	91	23	due	due	ADP
gsrj-6	91	24	to	to	ADP
gsrj-6	91	25	low	low	ADJ
gsrj-6	91	26	sample	sample	NOUN
gsrj-6	91	27	size	size	NOUN
gsrj-6	91	28	.	.	PUNCT
gsrj-6	92	1	among	among	ADP
gsrj-6	92	2	both	both	CCONJ
gsrj-6	92	3	metabolic	metabolic	NOUN
gsrj-6	92	4	and	and	CCONJ
gsrj-6	92	5	non	non	ADJ
gsrj-6	92	6	-	-	ADJ
gsrj-6	92	7	metabolic	metabolic	ADJ
gsrj-6	92	8	risk	risk	NOUN
gsrj-6	92	9	factors	factor	NOUN
gsrj-6	92	10	,	,	PUNCT
gsrj-6	92	11	hcv	hcv	PROPN
gsrj-6	92	12	was	be	AUX
gsrj-6	92	13	the	the	DET
gsrj-6	92	14	single	single	ADJ
gsrj-6	92	15	highest	high	ADJ
gsrj-6	92	16	attributable	attributable	ADJ
gsrj-6	92	17	cause	cause	NOUN
gsrj-6	92	18	of	of	ADP
gsrj-6	92	19	hcc	hcc	PROPN
gsrj-6	92	20	in	in	ADP
gsrj-6	92	21	both	both	DET
gsrj-6	92	22	time	time	NOUN
gsrj-6	92	23	periods	period	NOUN
gsrj-6	92	24	;	;	PUNCT
gsrj-6	92	25	54.1	54.1	NUM
gsrj-6	92	26	%	%	NOUN
gsrj-6	92	27	of	of	ADP
gsrj-6	92	28	hcc	hcc	PROPN
gsrj-6	92	29	cases	case	NOUN
gsrj-6	92	30	were	be	AUX
gsrj-6	92	31	estimated	estimate	VERB
gsrj-6	92	32	to	to	PART
gsrj-6	92	33	be	be	AUX
gsrj-6	92	34	attributable	attributable	ADJ
gsrj-6	92	35	to	to	ADP
gsrj-6	92	36	hcv	hcv	VERB
gsrj-6	92	37	in	in	ADP
gsrj-6	92	38	1999	1999	NUM
gsrj-6	92	39	-	-	SYM
gsrj-6	92	40	2002	2002	NUM
gsrj-6	92	41	and	and	CCONJ
gsrj-6	92	42	48.4	48.4	NUM
gsrj-6	92	43	%	%	NOUN
gsrj-6	92	44	in	in	ADP
gsrj-6	92	45	2009	2009	NUM
gsrj-6	92	46	-	-	SYM
gsrj-6	92	47	2012	2012	NUM
gsrj-6	92	48	.	.	PUNCT
gsrj-6	93	1	differences	difference	NOUN
gsrj-6	93	2	in	in	ADP
gsrj-6	93	3	paf	paf	NOUN
gsrj-6	93	4	magnitudes	magnitude	NOUN
gsrj-6	93	5	were	be	AUX
gsrj-6	93	6	observed	observe	VERB
gsrj-6	93	7	among	among	ADP
gsrj-6	93	8	race	race	NOUN
gsrj-6	93	9	/	/	SYM
gsrj-6	93	10	ethnic	ethnic	ADJ
gsrj-6	93	11	subgroups	subgroup	NOUN
gsrj-6	93	12	.	.	PUNCT
gsrj-6	94	1	the	the	DET
gsrj-6	94	2	highest	high	ADJ
gsrj-6	94	3	hcv	hcv	PROPN
gsrj-6	94	4	paf	paf	PROPN
gsrj-6	94	5	was	be	AUX
gsrj-6	94	6	observed	observe	VERB
gsrj-6	94	7	among	among	ADP
gsrj-6	94	8	non	non	ADJ
gsrj-6	94	9	-	-	ADJ
gsrj-6	94	10	hispanic	hispanic	ADJ
gsrj-6	94	11	blacks	black	NOUN
gsrj-6	94	12	(	(	PUNCT
gsrj-6	94	13	59	59	NUM
gsrj-6	94	14	%	%	NOUN
gsrj-6	94	15	in	in	ADP
gsrj-6	94	16	2009	2009	NUM
gsrj-6	94	17	-	-	SYM
gsrj-6	94	18	2012	2012	NUM
gsrj-6	94	19	)	)	PUNCT
gsrj-6	94	20	,	,	PUNCT
gsrj-6	94	21	while	while	SCONJ
gsrj-6	94	22	the	the	DET
gsrj-6	94	23	lowest	low	ADJ
gsrj-6	94	24	was	be	AUX
gsrj-6	94	25	among	among	ADP
gsrj-6	94	26	other	other	ADJ
gsrj-6	94	27	/	/	SYM
gsrj-6	94	28	mixed	mixed	ADJ
gsrj-6	94	29	(	(	PUNCT
gsrj-6	94	30	34	34	NUM
gsrj-6	94	31	%	%	NOUN
gsrj-6	94	32	in	in	ADP
gsrj-6	94	33	2009	2009	NUM
gsrj-6	94	34	-	-	SYM
gsrj-6	94	35	2012	2012	NUM
gsrj-6	94	36	)	)	PUNCT
gsrj-6	94	37	.	.	PUNCT
gsrj-6	95	1	these	these	DET
gsrj-6	95	2	values	value	NOUN
gsrj-6	95	3	did	do	AUX
gsrj-6	95	4	not	not	PART
gsrj-6	95	5	significantly	significantly	ADV
gsrj-6	95	6	decrease	decrease	VERB
gsrj-6	95	7	over	over	ADP
gsrj-6	95	8	the	the	DET
gsrj-6	95	9	ten	ten	NUM
gsrj-6	95	10	-	-	PUNCT
gsrj-6	95	11	year	year	NOUN
gsrj-6	95	12	period	period	NOUN
gsrj-6	95	13	.	.	PUNCT
gsrj-6	96	1	non	non	ADJ
gsrj-6	96	2	-	-	ADJ
gsrj-6	96	3	hispanic	hispanic	ADJ
gsrj-6	96	4	blacks	black	NOUN
gsrj-6	96	5	had	have	VERB
gsrj-6	96	6	the	the	DET
gsrj-6	96	7	highest	high	ADJ
gsrj-6	96	8	obesity	obesity	NOUN
gsrj-6	96	9	paf	paf	NOUN
gsrj-6	96	10	(	(	PUNCT
gsrj-6	96	11	31	31	NUM
gsrj-6	96	12	%	%	NOUN
gsrj-6	96	13	in	in	ADP
gsrj-6	96	14	2009	2009	NUM
gsrj-6	96	15	-	-	SYM
gsrj-6	96	16	2012	2012	NUM
gsrj-6	96	17	compared	compare	VERB
gsrj-6	96	18	to	to	ADP
gsrj-6	96	19	25	25	NUM
gsrj-6	96	20	%	%	NOUN
gsrj-6	96	21	in	in	ADP
gsrj-6	96	22	the	the	DET
gsrj-6	96	23	overall	overall	ADJ
gsrj-6	96	24	�	�	PROPN
gsrj-6	96	25	qpqvmbujpo	qpqvmbujpo	PROPN
gsrj-6	96	26	�	�	PROPN
gsrj-6	96	27	xijdi	xijdi	PROPN
gsrj-6	96	28	�	�	PROPN
gsrj-6	96	29	efdsfbtfe	efdsfbtfe	PROPN
gsrj-6	96	30	�	�	PROPN
gsrj-6	96	31	gspn	gspn	PROPN
gsrj-6	96	32	�	�	PROPN
gsrj-6	96	33	�	�	PROPN
gsrj-6	96	34	�	�	PROPN
gsrj-6	96	35	�	�	PROPN
gsrj-6	96	36	�	�	PROPN
gsrj-6	96	37	jo	jo	PROPN
gsrj-6	96	38	�	�	PROPN
gsrj-6	96	39	�	�	PROPN
gsrj-6	96	40	�	�	PROPN
gsrj-6	96	41	�	�	PROPN
gsrj-6	96	42	�	�	PROPN
gsrj-6	96	43	�	�	PROPN
gsrj-6	96	44	�	�	PROPN
gsrj-6	96	45	�	�	PROPN
gsrj-6	96	46	�	�	PROPN
gsrj-6	96	47	�	�	PROPN
gsrj-6	96	48	�	�	PROPN
gsrj-6	96	49	�	�	PROPN
gsrj-6	96	50	nash	nash	NOUN
gsrj-6	96	51	-	-	PUNCT
gsrj-6	96	52	cirrhosis	cirrhosis	NOUN
gsrj-6	96	53	or	or	CCONJ
gsrj-6	96	54	nafld	nafld	ADV
gsrj-6	96	55	-	-	PUNCT
gsrj-6	96	56	fib	fib	NOUN
gsrj-6	96	57	could	could	AUX
gsrj-6	96	58	be	be	AUX
gsrj-6	96	59	attributed	attribute	VERB
gsrj-6	96	60	to	to	ADP
gsrj-6	96	61	,	,	PUNCT
gsrj-6	96	62	at	at	ADP
gsrj-6	96	63	most	most	ADJ
gsrj-6	96	64	,	,	PUNCT
gsrj-6	96	65	8	8	NUM
gsrj-6	96	66	%	%	NOUN
gsrj-6	96	67	of	of	ADP
gsrj-6	96	68	hcc	hcc	PROPN
gsrj-6	96	69	cases	case	NOUN
gsrj-6	96	70	;	;	PUNCT
gsrj-6	96	71	these	these	DET
gsrj-6	96	72	liver	liver	NOUN
gsrj-6	96	73	diseases	disease	NOUN
gsrj-6	96	74	had	have	VERB
gsrj-6	96	75	the	the	DET
gsrj-6	96	76	largest	large	ADJ
gsrj-6	96	77	fold	fold	ADJ
gsrj-6	96	78	change	change	NOUN
gsrj-6	96	79	of	of	ADP
gsrj-6	96	80	any	any	DET
gsrj-6	96	81	risk	risk	NOUN
gsrj-6	96	82	factor	factor	NOUN
gsrj-6	96	83	over	over	ADP
gsrj-6	96	84	the	the	DET
gsrj-6	96	85	study	study	NOUN
gsrj-6	96	86	period	period	NOUN
gsrj-6	96	87	.	.	PUNCT
gsrj-6	97	1	specifically	specifically	ADV
gsrj-6	97	2	,	,	PUNCT
gsrj-6	97	3	nafld	nafld	ADV
gsrj-6	97	4	-	-	PUNCT
gsrj-6	97	5	fib	fib	NOUN
gsrj-6	97	6	had	have	VERB
gsrj-6	97	7	the	the	DET
gsrj-6	97	8	greatest	great	ADJ
gsrj-6	97	9	fold	fold	ADJ
gsrj-6	97	10	increase	increase	NOUN
gsrj-6	97	11	of	of	ADP
gsrj-6	97	12	any	any	DET
gsrj-6	97	13	risk	risk	NOUN
gsrj-6	97	14	factor	factor	NOUN
gsrj-6	97	15	studied	study	VERB
gsrj-6	97	16	,	,	PUNCT
gsrj-6	97	17	increasing	increase	VERB
gsrj-6	97	18	2.6	2.6	NUM
gsrj-6	97	19	-	-	NUM
gsrj-6	97	20	fold	fold	ADJ
gsrj-6	97	21	.	.	PUNCT
gsrj-6	98	1	nash	nash	NOUN
gsrj-6	98	2	-	-	PUNCT
gsrj-6	98	3	cirrhosis	cirrhosis	NOUN
gsrj-6	98	4	had	have	VERB
gsrj-6	98	5	the	the	DET
gsrj-6	98	6	second	second	ADJ
gsrj-6	98	7	greatest	great	ADJ
gsrj-6	98	8	paf	paf	NOUN
gsrj-6	98	9	,	,	PUNCT
gsrj-6	98	10	increasing	increase	VERB
gsrj-6	98	11	to	to	ADP
gsrj-6	98	12	a	a	DET
gsrj-6	98	13	similar	similar	ADJ
gsrj-6	98	14	degree	degree	NOUN
gsrj-6	98	15	of	of	ADP
gsrj-6	98	16	2.4	2.4	NUM
gsrj-6	98	17	-	-	NOUN
gsrj-6	98	18	fold	fold	ADJ
gsrj-6	98	19	.	.	PUNCT
gsrj-6	99	1	nash	nash	NOUN
gsrj-6	99	2	-	-	PUNCT
gsrj-6	99	3	cirrhosis	cirrhosis	NOUN
gsrj-6	99	4	27	27	NUM
gsrj-6	99	5	georgetown	georgetown	NOUN
gsrj-6	99	6	scientific	scientific	ADJ
gsrj-6	99	7	research	research	PROPN
gsrj-6	99	8	journal	journal	PROPN
gsrj-6	99	9	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	99	10	increased	increase	VERB
gsrj-6	99	11	from	from	ADP
gsrj-6	99	12	3.8	3.8	NUM
gsrj-6	99	13	%	%	NOUN
gsrj-6	99	14	of	of	ADP
gsrj-6	99	15	cases	case	NOUN
gsrj-6	99	16	to	to	ADP
gsrj-6	99	17	5.8	5.8	NUM
gsrj-6	99	18	%	%	NOUN
gsrj-6	99	19	and	and	CCONJ
gsrj-6	99	20	nafld	nafld	ADV
gsrj-6	99	21	-	-	PUNCT
gsrj-6	99	22	fib	fib	NOUN
gsrj-6	99	23	increased	increase	VERB
gsrj-6	99	24	from	from	ADP
gsrj-6	99	25	1.4	1.4	NUM
gsrj-6	99	26	%	%	NOUN
gsrj-6	99	27	to	to	ADP
gsrj-6	99	28	3.7	3.7	NUM
gsrj-6	99	29	%	%	NOUN
gsrj-6	99	30	(	(	PUNCT
gsrj-6	99	31	p=0.022	p=0.022	NOUN
gsrj-6	99	32	and	and	CCONJ
gsrj-6	99	33	p<0.001	p<0.001	PROPN
gsrj-6	99	34	,	,	PUNCT
gsrj-6	99	35	respectively	respectively	ADV
gsrj-6	99	36	,	,	PUNCT
gsrj-6	99	37	figure	figure	NOUN
gsrj-6	99	38	3	3	NUM
gsrj-6	99	39	)	)	PUNCT
gsrj-6	99	40	.	.	PUNCT
gsrj-6	100	1	figure	figure	VERB
gsrj-6	100	2	3	3	NUM
gsrj-6	100	3	:	:	PUNCT
gsrj-6	100	4	fold	fold	VERB
gsrj-6	100	5	change	change	NOUN
gsrj-6	100	6	in	in	ADP
gsrj-6	100	7	hepatocellular	hepatocellular	ADJ
gsrj-6	100	8	carcinoma	carcinoma	NOUN
gsrj-6	100	9	risk	risk	NOUN
gsrj-6	100	10	factor	factor	NOUN
gsrj-6	100	11	population	population	NOUN
gsrj-6	100	12	attributablr	attributablr	PROPN
gsrj-6	100	13	fractions	fraction	VERB
gsrj-6	100	14	1999	1999	NUM
gsrj-6	100	15	-	-	SYM
gsrj-6	100	16	2002	2002	NUM
gsrj-6	100	17	and	and	CCONJ
gsrj-6	100	18	2009	2009	NUM
gsrj-6	100	19	-	-	SYM
gsrj-6	100	20	2012	2012	NUM
gsrj-6	100	21	stratification	stratification	NOUN
gsrj-6	100	22	by	by	ADP
gsrj-6	100	23	race	race	NOUN
gsrj-6	100	24	/	/	SYM
gsrj-6	100	25	ethnicity	ethnicity	NOUN
gsrj-6	100	26	showed	show	VERB
gsrj-6	100	27	that	that	SCONJ
gsrj-6	100	28	obesity	obesity	NOUN
gsrj-6	100	29	and	and	CCONJ
gsrj-6	100	30	nafld	nafld	ADV
gsrj-6	100	31	-	-	PUNCT
gsrj-6	100	32	fib	fib	NOUN
gsrj-6	100	33	increased	increase	VERB
gsrj-6	100	34	across	across	ADP
gsrj-6	100	35	all	all	DET
gsrj-6	100	36	groups	group	NOUN
gsrj-6	100	37	.	.	PUNCT
gsrj-6	101	1	the	the	DET
gsrj-6	101	2	largest	large	ADJ
gsrj-6	101	3	increase	increase	NOUN
gsrj-6	101	4	was	be	AUX
gsrj-6	101	5	seen	see	VERB
gsrj-6	101	6	among	among	ADP
gsrj-6	101	7	hispanics	hispanic	NOUN
gsrj-6	101	8	with	with	ADP
gsrj-6	101	9	a	a	DET
gsrj-6	101	10	208	208	NUM
gsrj-6	101	11	%	%	NOUN
gsrj-6	101	12	increase	increase	NOUN
gsrj-6	101	13	in	in	ADP
gsrj-6	101	14	nafld	nafld	ADV
gsrj-6	101	15	-	-	PUNCT
gsrj-6	101	16	fib	fib	NOUN
gsrj-6	101	17	.	.	PUNCT
gsrj-6	101	18	nash	nash	NOUN
gsrj-6	101	19	-	-	PUNCT
gsrj-6	101	20	cirrhosis	cirrhosis	NOUN
gsrj-6	101	21	was	be	AUX
gsrj-6	101	22	more	more	ADV
gsrj-6	101	23	common	common	ADJ
gsrj-6	101	24	among	among	ADP
gsrj-6	101	25	men	man	NOUN
gsrj-6	101	26	than	than	ADP
gsrj-6	101	27	women	woman	NOUN
gsrj-6	101	28	in	in	ADP
gsrj-6	101	29	2009	2009	NUM
gsrj-6	101	30	-	-	SYM
gsrj-6	101	31	2012	2012	NUM
gsrj-6	101	32	(	(	PUNCT
gsrj-6	101	33	relative	relative	ADJ
gsrj-6	101	34	risk	risk	NOUN
gsrj-6	101	35	=	=	NOUN
gsrj-6	101	36	6.2	6.2	NUM
gsrj-6	101	37	)	)	PUNCT
gsrj-6	101	38	.	.	PUNCT
gsrj-6	102	1	the	the	DET
gsrj-6	102	2	largest	large	ADJ
gsrj-6	102	3	increase	increase	NOUN
gsrj-6	102	4	in	in	ADP
gsrj-6	102	5	nash	nash	NOUN
gsrj-6	102	6	-	-	PUNCT
gsrj-6	102	7	cirrhosis	cirrhosis	NOUN
gsrj-6	102	8	was	be	AUX
gsrj-6	102	9	among	among	ADP
gsrj-6	102	10	non	non	ADJ
gsrj-6	102	11	-	-	ADJ
gsrj-6	102	12	hispanic	hispanic	ADJ
gsrj-6	102	13	blacks	black	NOUN
gsrj-6	102	14	,	,	PUNCT
gsrj-6	102	15	increasing	increase	VERB
gsrj-6	102	16	from	from	ADP
gsrj-6	102	17	paf	paf	NOUN
gsrj-6	102	18	of	of	ADP
gsrj-6	102	19	0	0	NUM
gsrj-6	102	20	%	%	NOUN
gsrj-6	102	21	in	in	ADP
gsrj-6	102	22	1999	1999	NUM
gsrj-6	102	23	-	-	SYM
gsrj-6	102	24	2001	2001	NUM
gsrj-6	102	25	to	to	ADP
gsrj-6	102	26	8	8	NUM
gsrj-6	102	27	%	%	NOUN
gsrj-6	102	28	in	in	ADP
gsrj-6	102	29	2009	2009	NUM
gsrj-6	102	30	-	-	SYM
gsrj-6	102	31	2012	2012	NUM
gsrj-6	102	32	.	.	PUNCT
gsrj-6	103	1	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	103	2	increased	increase	VERB
gsrj-6	103	3	significantly	significantly	ADV
gsrj-6	103	4	,	,	PUNCT
gsrj-6	103	5	accounting	account	VERB
gsrj-6	103	6	for	for	ADP
gsrj-6	103	7	6.3	6.3	NUM
gsrj-6	103	8	%	%	NOUN
gsrj-6	103	9	of	of	ADP
gsrj-6	103	10	hcc	hcc	PROPN
gsrj-6	103	11	cases	case	NOUN
gsrj-6	103	12	in	in	ADP
gsrj-6	103	13	2009	2009	NUM
gsrj-6	103	14	-	-	SYM
gsrj-6	103	15	2012	2012	NUM
gsrj-6	103	16	(	(	PUNCT
gsrj-6	103	17	table	table	NOUN
gsrj-6	103	18	3	3	NUM
gsrj-6	103	19	,	,	PUNCT
gsrj-6	103	20	figure	figure	NOUN
gsrj-6	103	21	3	3	NUM
gsrj-6	103	22	)	)	PUNCT
gsrj-6	103	23	.	.	PUNCT
gsrj-6	104	1	1.1.1	1.1.1	NUM
gsrj-6	104	2	genetic	genetic	ADJ
gsrj-6	104	3	analysis	analysis	NOUN
gsrj-6	104	4	.	.	PUNCT
gsrj-6	104	5	  	  	SPACE
gsrj-6	105	1	there	there	PRON
gsrj-6	105	2	are	be	VERB
gsrj-6	105	3	differences	difference	NOUN
gsrj-6	105	4	in	in	ADP
gsrj-6	105	5	hcc	hcc	PROPN
gsrj-6	105	6	outcomes	outcome	NOUN
gsrj-6	105	7	between	between	ADP
gsrj-6	105	8	different	different	ADJ
gsrj-6	105	9	ethnic	ethnic	ADJ
gsrj-6	105	10	groups	group	NOUN
gsrj-6	105	11	.	.	PUNCT
gsrj-6	106	1	the	the	DET
gsrj-6	106	2	gene	gene	NOUN
gsrj-6	106	3	pnpla3	pnpla3	NOUN
gsrj-6	106	4	was	be	AUX
gsrj-6	106	5	shown	show	VERB
gsrj-6	106	6	to	to	PART
gsrj-6	106	7	play	play	VERB
gsrj-6	106	8	a	a	DET
gsrj-6	106	9	major	major	ADJ
gsrj-6	106	10	role	role	NOUN
gsrj-6	106	11	in	in	ADP
gsrj-6	106	12	the	the	DET
gsrj-6	106	13	development	development	NOUN
gsrj-6	106	14	of	of	ADP
gsrj-6	106	15	liver	liver	NOUN
gsrj-6	106	16	disease	disease	NOUN
gsrj-6	106	17	such	such	ADJ
gsrj-6	106	18	as	as	ADP
gsrj-6	106	19	nafld	nafld	ADV
gsrj-6	106	20	-	-	PUNCT
gsrj-6	106	21	fib	fib	ADJ
gsrj-6	106	22	and	and	CCONJ
gsrj-6	106	23	nash	nash	NOUN
gsrj-6	106	24	-	-	PUNCT
gsrj-6	106	25	cirrhosis	cirrhosis	NOUN
gsrj-6	106	26	.	.	PUNCT
gsrj-6	107	1	pnpla3	pnpla3	NOUN
gsrj-6	107	2	represents	represent	VERB
gsrj-6	107	3	a	a	DET
gsrj-6	107	4	gda	gda	NOUN
gsrj-6	107	5	score	score	NOUN
gsrj-6	107	6	of	of	ADP
gsrj-6	107	7	5.00(figure	5.00(figure	NUM
gsrj-6	107	8	2	2	NUM
gsrj-6	107	9	)	)	PUNCT
gsrj-6	107	10	.	.	PUNCT
gsrj-6	108	1	the	the	DET
gsrj-6	108	2	specificity	specificity	NOUN
gsrj-6	108	3	for	for	ADP
gsrj-6	108	4	hcc	hcc	PROPN
gsrj-6	108	5	was	be	AUX
gsrj-6	108	6	0.556	0.556	NUM
gsrj-6	108	7	,	,	PUNCT
gsrj-6	108	8	and	and	CCONJ
gsrj-6	108	9	the	the	DET
gsrj-6	108	10	association	association	NOUN
gsrj-6	108	11	of	of	ADP
gsrj-6	108	12	the	the	DET
gsrj-6	108	13	pnpla3	pnpla3	NOUN
gsrj-6	108	14	with	with	ADP
gsrj-6	108	15	hcc	hcc	PROPN
gsrj-6	108	16	specifically	specifically	ADV
gsrj-6	108	17	is	be	AUX
gsrj-6	108	18	0.692	0.692	NUM
gsrj-6	108	19	.	.	PUNCT
gsrj-6	109	1	this	this	PRON
gsrj-6	109	2	is	be	AUX
gsrj-6	109	3	based	base	VERB
gsrj-6	109	4	on	on	ADP
gsrj-6	109	5	an	an	DET
gsrj-6	109	6	evidence	evidence	NOUN
gsrj-6	109	7	score	score	NOUN
gsrj-6	109	8	of	of	ADP
gsrj-6	109	9	0.500	0.500	NUM
gsrj-6	109	10	,	,	PUNCT
gsrj-6	109	11	which	which	PRON
gsrj-6	109	12	was	be	AUX
gsrj-6	109	13	calculated	calculate	VERB
gsrj-6	109	14	from	from	ADP
gsrj-6	109	15	disgenet	disgenet	NOUN
gsrj-6	109	16	.	.	PUNCT
gsrj-6	110	1	pnpla3	pnpla3	NOUN
gsrj-6	110	2	gene	gene	NOUN
gsrj-6	110	3	represents	represent	VERB
gsrj-6	110	4	a	a	DET
gsrj-6	110	5	cytosine	cytosine	NOUN
gsrj-6	110	6	to	to	ADP
gsrj-6	110	7	guanine	guanine	NOUN
gsrj-6	110	8	substitution	substitution	NOUN
gsrj-6	110	9	,	,	PUNCT
gsrj-6	110	10	resulting	result	VERB
gsrj-6	110	11	in	in	ADP
gsrj-6	110	12	an	an	DET
gsrj-6	110	13	isoleucine	isoleucine	NOUN
gsrj-6	110	14	to	to	ADP
gsrj-6	110	15	methionine	methionine	NOUN
gsrj-6	110	16	switch	switch	NOUN
gsrj-6	110	17	at	at	ADP
gsrj-6	110	18	codon	codon	NOUN
gsrj-6	110	19	148	148	NUM
gsrj-6	110	20	and	and	CCONJ
gsrj-6	110	21	individuals	individual	NOUN
gsrj-6	110	22	with	with	ADP
gsrj-6	110	23	the	the	DET
gsrj-6	110	24	g	g	PROPN
gsrj-6	110	25	allele	allele	PROPN
gsrj-6	110	26	have	have	VERB
gsrj-6	110	27	a	a	DET
gsrj-6	110	28	higher	high	ADJ
gsrj-6	110	29	hepatic	hepatic	NOUN
gsrj-6	110	30	triglyceride	triglyceride	ADJ
gsrj-6	110	31	level	level	NOUN
gsrj-6	110	32	and	and	CCONJ
gsrj-6	110	33	elevated	elevated	ADJ
gsrj-6	110	34	serum	serum	NOUN
gsrj-6	110	35	of	of	ADP
gsrj-6	110	36	alt.21	alt.21	PROPN
gsrj-6	110	37	our	our	PRON
gsrj-6	110	38	study	study	NOUN
gsrj-6	110	39	found	find	VERB
gsrj-6	110	40	a	a	DET
gsrj-6	110	41	total	total	NOUN
gsrj-6	110	42	of	of	ADP
gsrj-6	110	43	13	13	NUM
gsrj-6	110	44	pathogenic	pathogenic	ADJ
gsrj-6	110	45	genes	gene	NOUN
gsrj-6	110	46	from	from	ADP
gsrj-6	110	47	disgenet	disgenet	ADJ
gsrj-6	110	48	platfrom	platfrom	NOUN
gsrj-6	110	49	with	with	ADP
gsrj-6	110	50	a	a	DET
gsrj-6	110	51	dsi	dsi	NOUN
gsrj-6	110	52	,	,	PUNCT
gsrj-6	110	53	dpi	dpi	PROPN
gsrj-6	110	54	and	and	CCONJ
gsrj-6	110	55	a	a	DET
gsrj-6	110	56	gda	gda	NOUN
gsrj-6	110	57	score	score	NOUN
gsrj-6	110	58	based	base	VERB
gsrj-6	110	59	on	on	ADP
gsrj-6	110	60	disgenet	disgenet	NOUN
gsrj-6	110	61	ranking	ranking	NOUN
gsrj-6	110	62	system	system	NOUN
gsrj-6	110	63	.	.	PUNCT
gsrj-6	111	1	our	our	PRON
gsrj-6	111	2	analysis	analysis	NOUN
gsrj-6	111	3	represents	represent	VERB
gsrj-6	111	4	high	high	ADJ
gsrj-6	111	5	frequency	frequency	NOUN
gsrj-6	111	6	of	of	ADP
gsrj-6	111	7	pnpla3	pnpla3	NOUN
gsrj-6	111	8	gene	gene	NOUN
gsrj-6	111	9	among	among	ADP
gsrj-6	111	10	hispanic	hispanic	ADJ
gsrj-6	111	11	groups	group	NOUN
gsrj-6	111	12	.	.	PUNCT
gsrj-6	112	1	furthermore	furthermore	ADV
gsrj-6	112	2	,	,	PUNCT
gsrj-6	112	3	genediet	genediet	ADJ
gsrj-6	112	4	interaction	interaction	NOUN
gsrj-6	112	5	plays	play	VERB
gsrj-6	112	6	a	a	DET
gsrj-6	112	7	vital	vital	ADJ
gsrj-6	112	8	role	role	NOUN
gsrj-6	112	9	in	in	ADP
gsrj-6	112	10	the	the	DET
gsrj-6	112	11	pathogenesis	pathogenesis	NOUN
gsrj-6	112	12	of	of	ADP
gsrj-6	112	13	liver	liver	NOUN
gsrj-6	112	14	cancer	cancer	NOUN
gsrj-6	112	15	in	in	ADP
gsrj-6	112	16	hispanics	hispanic	NOUN
gsrj-6	112	17	.	.	PUNCT
gsrj-6	113	1	figure	figure	NOUN
gsrj-6	113	2	2	2	NUM
gsrj-6	113	3	represents	represent	VERB
gsrj-6	113	4	the	the	DET
gsrj-6	113	5	13	13	NUM
gsrj-6	113	6	gene	gene	NOUN
gsrj-6	113	7	strongly	strongly	ADV
gsrj-6	113	8	associated	associate	VERB
gsrj-6	113	9	with	with	ADP
gsrj-6	113	10	hcc	hcc	PROPN
gsrj-6	113	11	.	.	PROPN
gsrj-6	114	1	based	base	VERB
gsrj-6	114	2	on	on	ADP
gsrj-6	114	3	the	the	DET
gsrj-6	114	4	gda	gda	PROPN
gsrj-6	114	5	score	score	NOUN
gsrj-6	114	6	from	from	ADP
gsrj-6	114	7	disgenet	disgenet	NOUN
gsrj-6	114	8	,	,	PUNCT
gsrj-6	114	9	pnpla3	pnpla3	NOUN
gsrj-6	114	10	(	(	PUNCT
gsrj-6	114	11	0.500	0.500	NUM
gsrj-6	114	12	)	)	PUNCT
gsrj-6	114	13	holds	hold	VERB
gsrj-6	114	14	a	a	DET
gsrj-6	114	15	strong	strong	ADJ
gsrj-6	114	16	association	association	NOUN
gsrj-6	114	17	with	with	ADP
gsrj-6	114	18	increased	increase	VERB
gsrj-6	114	19	risk	risk	NOUN
gsrj-6	114	20	of	of	ADP
gsrj-6	114	21	hcc	hcc	PROPN
gsrj-6	114	22	.	.	PUNCT
gsrj-6	115	1	the	the	DET
gsrj-6	115	2	gda	gda	PROPN
gsrj-6	115	3	score	score	NOUN
gsrj-6	115	4	of	of	ADP
gsrj-6	115	5	pnpla3	pnpla3	NOUN
gsrj-6	115	6	(	(	PUNCT
gsrj-6	115	7	0.500	0.500	NUM
gsrj-6	115	8	)	)	PUNCT
gsrj-6	115	9	is	be	AUX
gsrj-6	115	10	the	the	DET
gsrj-6	115	11	highest	high	ADJ
gsrj-6	115	12	as	as	ADP
gsrj-6	115	13	compared	compare	VERB
gsrj-6	115	14	to	to	ADP
gsrj-6	115	15	other	other	ADJ
gsrj-6	115	16	genes	gene	NOUN
gsrj-6	115	17	in	in	ADP
gsrj-6	115	18	list	list	NOUN
gsrj-6	115	19	.	.	PUNCT
gsrj-6	116	1	the	the	DET
gsrj-6	116	2	lowest	low	ADJ
gsrj-6	116	3	gda	gda	PROPN
gsrj-6	116	4	score	score	NOUN
gsrj-6	116	5	based	base	VERB
gsrj-6	116	6	on	on	ADP
gsrj-6	116	7	disgenet	disgenet	NOUN
gsrj-6	116	8	ranking	ranking	NOUN
gsrj-6	116	9	is	be	AUX
gsrj-6	116	10	ppard	ppard	ADJ
gsrj-6	116	11	.	.	PUNCT
gsrj-6	117	1	genes	gene	NOUN
gsrj-6	117	2	ldlr	ldlr	PROPN
gsrj-6	117	3	,	,	PUNCT
gsrj-6	117	4	fas	fas	ADJ
gsrj-6	117	5	,	,	PUNCT
gsrj-6	117	6	pemt	pemt	ADJ
gsrj-6	117	7	,	,	PUNCT
gsrj-6	117	8	nr1h4	nr1h4	PROPN
gsrj-6	117	9	,	,	PUNCT
gsrj-6	117	10	gnmt	gnmt	NOUN
gsrj-6	117	11	represents	represent	VERB
gsrj-6	117	12	the	the	DET
gsrj-6	117	13	same	same	ADJ
gsrj-6	117	14	gda	gda	NOUN
gsrj-6	117	15	score	score	NOUN
gsrj-6	117	16	of	of	ADP
gsrj-6	117	17	0.320	0.320	NUM
gsrj-6	117	18	which	which	PRON
gsrj-6	117	19	means	mean	VERB
gsrj-6	117	20	they	they	PRON
gsrj-6	117	21	all	all	PRON
gsrj-6	117	22	are	be	AUX
gsrj-6	117	23	equally	equally	ADV
gsrj-6	117	24	associated	associate	VERB
gsrj-6	117	25	in	in	ADP
gsrj-6	117	26	the	the	DET
gsrj-6	117	27	development	development	NOUN
gsrj-6	117	28	of	of	ADP
gsrj-6	117	29	hcc	hcc	PROPN
gsrj-6	117	30	.	.	PROPN
gsrj-6	118	1	1	1	NUM
gsrj-6	118	2	.	.	X
gsrj-6	118	3	discussion	discussion	NOUN
gsrj-6	118	4	this	this	DET
gsrj-6	118	5	study	study	NOUN
gsrj-6	118	6	attributed	attribute	VERB
gsrj-6	118	7	nearly	nearly	ADV
gsrj-6	118	8	80	80	NUM
gsrj-6	118	9	%	%	NOUN
gsrj-6	118	10	of	of	ADP
gsrj-6	118	11	hcc	hcc	PROPN
gsrj-6	118	12	cases	case	NOUN
gsrj-6	118	13	in	in	ADP
gsrj-6	118	14	1999	1999	NUM
gsrj-6	118	15	-	-	SYM
gsrj-6	118	16	2001	2001	NUM
gsrj-6	118	17	and	and	CCONJ
gsrj-6	118	18	2009	2009	NUM
gsrj-6	118	19	-	-	SYM
gsrj-6	118	20	2012	2012	NUM
gsrj-6	118	21	to	to	ADP
gsrj-6	118	22	eight	eight	NUM
gsrj-6	118	23	known	know	VERB
gsrj-6	118	24	risk	risk	NOUN
gsrj-6	118	25	factors	factor	NOUN
gsrj-6	118	26	in	in	ADP
gsrj-6	118	27	a	a	DET
gsrj-6	118	28	large	large	ADJ
gsrj-6	118	29	nationally	nationally	ADV
gsrj-6	118	30	representative	representative	ADJ
gsrj-6	118	31	sample	sample	NOUN
gsrj-6	118	32	of	of	ADP
gsrj-6	118	33	the	the	DET
gsrj-6	118	34	u.s	u.s	PROPN
gsrj-6	118	35	.	.	PROPN
gsrj-6	118	36	population	population	NOUN
gsrj-6	118	37	.	.	PUNCT
gsrj-6	119	1	metabolic	metabolic	ADJ
gsrj-6	119	2	risk	risk	NOUN
gsrj-6	119	3	factors	factor	NOUN
gsrj-6	119	4	are	be	AUX
gsrj-6	119	5	now	now	ADV
gsrj-6	119	6	contributing	contribute	VERB
gsrj-6	119	7	to	to	ADP
gsrj-6	119	8	nearly	nearly	ADV
gsrj-6	119	9	half	half	NOUN
gsrj-6	119	10	of	of	ADP
gsrj-6	119	11	hcc	hcc	PROPN
gsrj-6	119	12	cases	case	NOUN
gsrj-6	119	13	in	in	ADP
gsrj-6	119	14	the	the	DET
gsrj-6	119	15	us	us	PROPN
gsrj-6	119	16	.	.	PUNCT
gsrj-6	120	1	metabolic	metabolic	NOUN
gsrj-6	120	2	diseases	disease	NOUN
gsrj-6	120	3	(	(	PUNCT
gsrj-6	120	4	diabetes	diabetes	NOUN
gsrj-6	120	5	,	,	PUNCT
gsrj-6	120	6	obesity	obesity	NOUN
gsrj-6	120	7	,	,	PUNCT
gsrj-6	120	8	nash	nash	NOUN
gsrj-6	120	9	-	-	PUNCT
gsrj-6	120	10	cirrhosis	cirrhosis	NOUN
gsrj-6	120	11	,	,	PUNCT
gsrj-6	120	12	and	and	CCONJ
gsrj-6	120	13	nafld	nafld	ADV
gsrj-6	120	14	-	-	PUNCT
gsrj-6	120	15	advanced	advance	VERB
gsrj-6	120	16	fibrosis	fibrosis	NOUN
gsrj-6	120	17	)	)	PUNCT
gsrj-6	120	18	increased	increase	VERB
gsrj-6	120	19	from	from	ADP
gsrj-6	120	20	contributing	contribute	VERB
gsrj-6	120	21	an	an	DET
gsrj-6	120	22	estimated	estimate	VERB
gsrj-6	120	23	35	35	NUM
gsrj-6	120	24	%	%	NOUN
gsrj-6	120	25	of	of	ADP
gsrj-6	120	26	hcc	hcc	PROPN
gsrj-6	120	27	burden	burden	NOUN
gsrj-6	120	28	in	in	ADP
gsrj-6	120	29	1999	1999	NUM
gsrj-6	120	30	-	-	SYM
gsrj-6	120	31	2002	2002	NUM
gsrj-6	120	32	to	to	ADP
gsrj-6	120	33	42	42	NUM
gsrj-6	120	34	%	%	NOUN
gsrj-6	120	35	in	in	ADP
gsrj-6	120	36	2009	2009	NUM
gsrj-6	120	37	-	-	SYM
gsrj-6	120	38	2012	2012	NUM
gsrj-6	120	39	.	.	PUNCT
gsrj-6	121	1	concordantly	concordantly	ADV
gsrj-6	121	2	,	,	PUNCT
gsrj-6	121	3	non	non	ADJ
gsrj-6	121	4	-	-	ADJ
gsrj-6	121	5	metabolic	metabolic	ADJ
gsrj-6	121	6	risk	risk	NOUN
gsrj-6	121	7	factors	factor	NOUN
gsrj-6	121	8	decreased	decrease	VERB
gsrj-6	121	9	from	from	ADP
gsrj-6	121	10	66	66	NUM
gsrj-6	121	11	%	%	NOUN
gsrj-6	121	12	to	to	ADP
gsrj-6	121	13	59	59	NUM
gsrj-6	121	14	%	%	NOUN
gsrj-6	121	15	of	of	ADP
gsrj-6	121	16	total	total	ADJ
gsrj-6	121	17	hcc	hcc	PROPN
gsrj-6	121	18	burden	burden	NOUN
gsrj-6	121	19	over	over	ADP
gsrj-6	121	20	the	the	DET
gsrj-6	121	21	same	same	ADJ
gsrj-6	121	22	period	period	NOUN
gsrj-6	121	23	.	.	PUNCT
gsrj-6	122	1	stratification	stratification	NOUN
gsrj-6	122	2	by	by	ADP
gsrj-6	122	3	race	race	NOUN
gsrj-6	122	4	/	/	SYM
gsrj-6	122	5	ethnicity	ethnicity	NOUN
gsrj-6	122	6	showed	show	VERB
gsrj-6	122	7	a	a	DET
gsrj-6	122	8	similar	similar	ADJ
gsrj-6	122	9	shift	shift	NOUN
gsrj-6	122	10	across	across	ADP
gsrj-6	122	11	all	all	DET
gsrj-6	122	12	groups	group	NOUN
gsrj-6	122	13	.	.	PUNCT
gsrj-6	123	1	the	the	DET
gsrj-6	123	2	hcc	hcc	PROPN
gsrj-6	123	3	risk	risk	NOUN
gsrj-6	123	4	factor	factor	NOUN
gsrj-6	123	5	prevalence	prevalence	NOUN
gsrj-6	123	6	rates	rate	NOUN
gsrj-6	123	7	of	of	ADP
gsrj-6	123	8	obesity	obesity	NOUN
gsrj-6	123	9	and	and	CCONJ
gsrj-6	123	10	nafld	nafld	ADV
gsrj-6	123	11	-	-	PUNCT
gsrj-6	123	12	fib	fib	NOUN
gsrj-6	123	13	increased	increase	VERB
gsrj-6	123	14	for	for	ADP
gsrj-6	123	15	all	all	DET
gsrj-6	123	16	groups	group	NOUN
gsrj-6	123	17	and	and	CCONJ
gsrj-6	123	18	were	be	AUX
gsrj-6	123	19	particularly	particularly	ADV
gsrj-6	123	20	high	high	ADJ
gsrj-6	123	21	among	among	ADP
gsrj-6	123	22	hispanics	hispanic	NOUN
gsrj-6	123	23	and	and	CCONJ
gsrj-6	123	24	non	non	ADJ
gsrj-6	123	25	-	-	ADJ
gsrj-6	123	26	hispanic	hispanic	ADJ
gsrj-6	123	27	blacks	black	NOUN
gsrj-6	123	28	.	.	PUNCT
gsrj-6	124	1	a	a	DET
gsrj-6	124	2	genetic	genetic	ADJ
gsrj-6	124	3	variant	variant	NOUN
gsrj-6	124	4	in	in	ADP
gsrj-6	124	5	pnpla3	pnpla3	NOUN
gsrj-6	124	6	was	be	AUX
gsrj-6	124	7	identified	identify	VERB
gsrj-6	124	8	as	as	ADP
gsrj-6	124	9	strongly	strongly	ADV
gsrj-6	124	10	associated	associate	VERB
gsrj-6	124	11	with	with	ADP
gsrj-6	124	12	hcc	hcc	PROPN
gsrj-6	124	13	.	.	PROPN
gsrj-6	125	1	28	28	NUM
gsrj-6	125	2	georgetown	georgetown	PROPN
gsrj-6	125	3	scientific	scientific	PROPN
gsrj-6	125	4	research	research	PROPN
gsrj-6	125	5	journal	journal	PROPN
gsrj-6	125	6	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	125	7	these	these	DET
gsrj-6	125	8	findings	finding	NOUN
gsrj-6	125	9	highlight	highlight	VERB
gsrj-6	125	10	vulnerabilities	vulnerability	NOUN
gsrj-6	125	11	within	within	ADP
gsrj-6	125	12	certain	certain	ADJ
gsrj-6	125	13	racial	racial	ADJ
gsrj-6	125	14	and	and	CCONJ
gsrj-6	125	15	ethnic	ethnic	ADJ
gsrj-6	125	16	groups	group	NOUN
gsrj-6	125	17	within	within	ADP
gsrj-6	125	18	one	one	NUM
gsrj-6	125	19	country	country	NOUN
gsrj-6	125	20	’s	’s	PART
gsrj-6	125	21	population	population	NOUN
gsrj-6	125	22	of	of	ADP
gsrj-6	125	23	hcc	hcc	PROPN
gsrj-6	125	24	,	,	PUNCT
gsrj-6	125	25	which	which	PRON
gsrj-6	125	26	is	be	AUX
gsrj-6	125	27	increasing	increase	VERB
gsrj-6	125	28	in	in	ADP
gsrj-6	125	29	the	the	DET
gsrj-6	125	30	us	us	PROPN
gsrj-6	125	31	as	as	ADV
gsrj-6	125	32	well	well	ADV
gsrj-6	125	33	as	as	ADP
gsrj-6	125	34	worldwide	worldwide	ADV
gsrj-6	125	35	.	.	PUNCT
gsrj-6	126	1	25	25	NUM
gsrj-6	126	2	-	-	SYM
gsrj-6	126	3	28	28	NUM
gsrj-6	126	4	as	as	SCONJ
gsrj-6	126	5	the	the	DET
gsrj-6	126	6	obesity	obesity	NOUN
gsrj-6	126	7	epidemic	epidemic	NOUN
gsrj-6	126	8	had	have	AUX
gsrj-6	126	9	increased	increase	VERB
gsrj-6	126	10	from	from	ADP
gsrj-6	126	11	1999	1999	NUM
gsrj-6	126	12	until	until	ADP
gsrj-6	126	13	2012	2012	NUM
gsrj-6	126	14	,	,	PUNCT
gsrj-6	126	15	metabolic	metabolic	NOUN
gsrj-6	126	16	risk	risk	NOUN
gsrj-6	126	17	factors	factor	NOUN
gsrj-6	126	18	(	(	PUNCT
gsrj-6	126	19	nafld	nafld	ADV
gsrj-6	126	20	-	-	PUNCT
gsrj-6	126	21	fib	fib	NOUN
gsrj-6	126	22	and	and	CCONJ
gsrj-6	126	23	nashcirrhosis	nashcirrhosis	NOUN
gsrj-6	126	24	)	)	PUNCT
gsrj-6	126	25	became	become	VERB
gsrj-6	126	26	contributers	contributer	NOUN
gsrj-6	126	27	to	to	ADP
gsrj-6	126	28	hcc	hcc	PROPN
gsrj-6	126	29	development	development	NOUN
gsrj-6	126	30	in	in	ADP
gsrj-6	126	31	the	the	DET
gsrj-6	126	32	us	us	PROPN
gsrj-6	126	33	more	more	ADV
gsrj-6	126	34	so	so	ADV
gsrj-6	126	35	than	than	ADP
gsrj-6	126	36	nonmetabolic	nonmetabolic	ADJ
gsrj-6	126	37	risk	risk	NOUN
gsrj-6	126	38	factors	factor	NOUN
gsrj-6	126	39	(	(	PUNCT
gsrj-6	126	40	hbv	hbv	NOUN
gsrj-6	126	41	,	,	PUNCT
gsrj-6	126	42	hcv	hcv	PROPN
gsrj-6	126	43	)	)	PUNCT
gsrj-6	126	44	,	,	PUNCT
gsrj-6	126	45	excessive	excessive	ADJ
gsrj-6	126	46	alcohol	alcohol	NOUN
gsrj-6	126	47	use	use	NOUN
gsrj-6	126	48	,	,	PUNCT
gsrj-6	126	49	and	and	CCONJ
gsrj-6	126	50	smoking	smoking	NOUN
gsrj-6	126	51	.	.	PUNCT
gsrj-6	127	1	22,23	22,23	NOUN
gsrj-6	127	2	it	it	PRON
gsrj-6	127	3	is	be	AUX
gsrj-6	127	4	likely	likely	ADJ
gsrj-6	127	5	that	that	SCONJ
gsrj-6	127	6	there	there	PRON
gsrj-6	127	7	is	be	VERB
gsrj-6	127	8	an	an	DET
gsrj-6	127	9	interplay	interplay	NOUN
gsrj-6	127	10	between	between	ADP
gsrj-6	127	11	lack	lack	NOUN
gsrj-6	127	12	of	of	ADP
gsrj-6	127	13	access	access	NOUN
gsrj-6	127	14	to	to	ADP
gsrj-6	127	15	health	health	NOUN
gsrj-6	127	16	care	care	NOUN
gsrj-6	127	17	,	,	PUNCT
gsrj-6	127	18	racial	racial	ADJ
gsrj-6	127	19	disparities	disparity	NOUN
gsrj-6	127	20	,	,	PUNCT
gsrj-6	127	21	and	and	CCONJ
gsrj-6	127	22	genetics	genetic	NOUN
gsrj-6	127	23	leading	lead	VERB
gsrj-6	127	24	the	the	DET
gsrj-6	127	25	whole	whole	ADJ
gsrj-6	127	26	pathogenesis	pathogenesis	NOUN
gsrj-6	127	27	and	and	CCONJ
gsrj-6	127	28	playing	play	VERB
gsrj-6	127	29	a	a	DET
gsrj-6	127	30	major	major	ADJ
gsrj-6	127	31	role	role	NOUN
gsrj-6	127	32	in	in	ADP
gsrj-6	127	33	the	the	DET
gsrj-6	127	34	development	development	NOUN
gsrj-6	127	35	of	of	ADP
gsrj-6	127	36	liver	liver	NOUN
gsrj-6	127	37	disease	disease	NOUN
gsrj-6	127	38	that	that	PRON
gsrj-6	127	39	eventually	eventually	ADV
gsrj-6	127	40	forms	form	VERB
gsrj-6	127	41	into	into	ADP
gsrj-6	127	42	hcc	hcc	PROPN
gsrj-6	127	43	.	.	PUNCT
gsrj-6	128	1	specific	specific	ADJ
gsrj-6	128	2	genetic	genetic	ADJ
gsrj-6	128	3	contributions	contribution	NOUN
gsrj-6	128	4	may	may	AUX
gsrj-6	128	5	help	help	VERB
gsrj-6	128	6	explain	explain	VERB
gsrj-6	128	7	differences	difference	NOUN
gsrj-6	128	8	observed	observe	VERB
gsrj-6	128	9	in	in	ADP
gsrj-6	128	10	pafs	pafs	NOUN
gsrj-6	128	11	for	for	ADP
gsrj-6	128	12	hcc	hcc	PROPN
gsrj-6	128	13	between	between	ADP
gsrj-6	128	14	race	race	NOUN
gsrj-6	128	15	/	/	SYM
gsrj-6	128	16	ethnic	ethnic	ADJ
gsrj-6	128	17	groups.29	groups.29	NOUN
gsrj-6	128	18	while	while	SCONJ
gsrj-6	128	19	insulin	insulin	NOUN
gsrj-6	128	20	resistance	resistance	NOUN
gsrj-6	128	21	likely	likely	ADV
gsrj-6	128	22	plays	play	VERB
gsrj-6	128	23	a	a	DET
gsrj-6	128	24	role	role	NOUN
gsrj-6	128	25	in	in	ADP
gsrj-6	128	26	its	its	PRON
gsrj-6	128	27	pathogenesis	pathogenesis	NOUN
gsrj-6	128	28	,	,	PUNCT
gsrj-6	128	29	oxidative	oxidative	ADJ
gsrj-6	128	30	injury	injury	NOUN
gsrj-6	128	31	and	and	CCONJ
gsrj-6	128	32	inflammatory	inflammatory	ADJ
gsrj-6	128	33	reactions	reaction	NOUN
gsrj-6	128	34	could	could	AUX
gsrj-6	128	35	be	be	AUX
gsrj-6	128	36	influenced	influence	VERB
gsrj-6	128	37	by	by	ADP
gsrj-6	128	38	genetics	genetic	NOUN
gsrj-6	128	39	.	.	PUNCT
gsrj-6	129	1	a	a	DET
gsrj-6	129	2	study	study	NOUN
gsrj-6	129	3	performed	perform	VERB
gsrj-6	129	4	in	in	ADP
gsrj-6	129	5	the	the	DET
gsrj-6	129	6	us	us	PROPN
gsrj-6	129	7	among	among	ADP
gsrj-6	129	8	hispanic	hispanic	ADJ
gsrj-6	129	9	,	,	PUNCT
gsrj-6	129	10	nh	nh	PROPN
gsrj-6	129	11	black	black	ADJ
gsrj-6	129	12	and	and	CCONJ
gsrj-6	129	13	nh	nh	PROPN
gsrj-6	129	14	white	white	ADJ
gsrj-6	129	15	individuals	individual	NOUN
gsrj-6	129	16	identified	identify	VERB
gsrj-6	129	17	the	the	DET
gsrj-6	129	18	variant	variant	NOUN
gsrj-6	129	19	,	,	PUNCT
gsrj-6	129	20	rs73809	rs73809	PROPN
gsrj-6	129	21	,	,	PUNCT
gsrj-6	129	22	(	(	PUNCT
gsrj-6	129	23	148	148	NUM
gsrj-6	129	24	m	m	NOUN
gsrj-6	129	25	)	)	PUNCT
gsrj-6	129	26	in	in	ADP
gsrj-6	129	27	patatinlike	patatinlike	ADJ
gsrj-6	129	28	phospholipase	phospholipase	NOUN
gsrj-6	129	29	domain	domain	NOUN
gsrj-6	129	30	-	-	PUNCT
gsrj-6	129	31	containing	contain	VERB
gsrj-6	129	32	protein	protein	NOUN
gsrj-6	129	33	3	3	NUM
gsrj-6	129	34	(	(	PUNCT
gsrj-6	129	35	pnpla3	pnpla3	NOUN
gsrj-6	129	36	)	)	PUNCT
gsrj-6	129	37	as	as	ADP
gsrj-6	129	38	a	a	DET
gsrj-6	129	39	predictor	predictor	NOUN
gsrj-6	129	40	for	for	ADP
gsrj-6	129	41	hepatic	hepatic	ADJ
gsrj-6	129	42	fat	fat	NOUN
gsrj-6	129	43	content.30	content.30	NOUN
gsrj-6	129	44	the	the	DET
gsrj-6	129	45	study	study	NOUN
gsrj-6	129	46	confirmed	confirm	VERB
gsrj-6	129	47	that	that	SCONJ
gsrj-6	129	48	patients	patient	NOUN
gsrj-6	129	49	with	with	ADP
gsrj-6	129	50	nafldfib	nafldfib	PROPN
gsrj-6	129	51	who	who	PRON
gsrj-6	129	52	carry	carry	VERB
gsrj-6	129	53	an	an	DET
gsrj-6	129	54	allele	allele	NOUN
gsrj-6	129	55	of	of	ADP
gsrj-6	129	56	the	the	DET
gsrj-6	129	57	gene	gene	NOUN
gsrj-6	129	58	(	(	PUNCT
gsrj-6	129	59	rs73809	rs73809	NOUN
gsrj-6	129	60	)	)	PUNCT
gsrj-6	129	61	pnpla3	pnpla3	NOUN
gsrj-6	129	62	have	have	VERB
gsrj-6	129	63	an	an	DET
gsrj-6	129	64	increased	increase	VERB
gsrj-6	129	65	risk	risk	NOUN
gsrj-6	129	66	of	of	ADP
gsrj-6	129	67	developing	develop	VERB
gsrj-6	129	68	advanced	advanced	ADJ
gsrj-6	129	69	diseases	disease	NOUN
gsrj-6	129	70	,	,	PUNCT
gsrj-6	129	71	including	include	VERB
gsrj-6	129	72	nash	nash	NOUN
gsrj-6	129	73	-	-	PUNCT
gsrj-6	129	74	cirrhosis	cirrhosis	NOUN
gsrj-6	129	75	.	.	PUNCT
gsrj-6	130	1	risk	risk	NOUN
gsrj-6	130	2	allele	allele	NOUN
gsrj-6	130	3	(	(	PUNCT
gsrj-6	130	4	rs73809	rs73809	PROPN
gsrj-6	130	5	)	)	PUNCT
gsrj-6	130	6	was	be	AUX
gsrj-6	130	7	the	the	DET
gsrj-6	130	8	main	main	ADJ
gsrj-6	130	9	common	common	ADJ
gsrj-6	130	10	genetic	genetic	ADJ
gsrj-6	130	11	determinant	determinant	NOUN
gsrj-6	130	12	of	of	ADP
gsrj-6	130	13	hepatic	hepatic	ADJ
gsrj-6	130	14	fat	fat	ADJ
gsrj-6	130	15	content	content	NOUN
gsrj-6	130	16	and	and	CCONJ
gsrj-6	130	17	of	of	ADP
gsrj-6	130	18	progressive	progressive	ADJ
gsrj-6	130	19	nafld	nafld	ADV
gsrj-6	130	20	-	-	PUNCT
gsrj-6	130	21	fib	fib	NOUN
gsrj-6	130	22	,	,	PUNCT
gsrj-6	130	23	and	and	CCONJ
gsrj-6	130	24	this	this	DET
gsrj-6	130	25	allele	allele	NOUN
gsrj-6	130	26	was	be	AUX
gsrj-6	130	27	mostly	mostly	ADV
gsrj-6	130	28	observed	observe	VERB
gsrj-6	130	29	among	among	ADP
gsrj-6	130	30	hispanic	hispanic	ADJ
gsrj-6	130	31	groups	group	NOUN
gsrj-6	130	32	.	.	PUNCT
gsrj-6	131	1	it	it	PRON
gsrj-6	131	2	is	be	AUX
gsrj-6	131	3	not	not	PART
gsrj-6	131	4	clear	clear	ADJ
gsrj-6	131	5	as	as	ADP
gsrj-6	131	6	to	to	ADP
gsrj-6	131	7	why	why	SCONJ
gsrj-6	131	8	this	this	DET
gsrj-6	131	9	allele	allele	NOUN
gsrj-6	131	10	is	be	AUX
gsrj-6	131	11	increased	increase	VERB
gsrj-6	131	12	among	among	ADP
gsrj-6	131	13	hispanics	hispanic	NOUN
gsrj-6	131	14	.	.	PUNCT
gsrj-6	132	1	the	the	DET
gsrj-6	132	2	variant	variant	NOUN
gsrj-6	132	3	has	have	AUX
gsrj-6	132	4	been	be	AUX
gsrj-6	132	5	reported	report	VERB
gsrj-6	132	6	to	to	PART
gsrj-6	132	7	manifest	manifest	VERB
gsrj-6	132	8	in	in	ADP
gsrj-6	132	9	early	early	ADJ
gsrj-6	132	10	life	life	NOUN
gsrj-6	132	11	among	among	ADP
gsrj-6	132	12	hispanic	hispanic	ADJ
gsrj-6	132	13	adolescents	adolescent	NOUN
gsrj-6	132	14	,	,	PUNCT
gsrj-6	132	15	31	31	NUM
gsrj-6	132	16	as	as	ADV
gsrj-6	132	17	well	well	ADV
gsrj-6	132	18	was	be	AUX
gsrj-6	132	19	having	have	VERB
gsrj-6	132	20	a	a	DET
gsrj-6	132	21	prevalence	prevalence	NOUN
gsrj-6	132	22	of	of	ADP
gsrj-6	132	23	80	80	NUM
gsrj-6	132	24	%	%	NOUN
gsrj-6	132	25	in	in	ADP
gsrj-6	132	26	a	a	DET
gsrj-6	132	27	single	single	ADJ
gsrj-6	132	28	center	center	NOUN
gsrj-6	132	29	study	study	NOUN
gsrj-6	132	30	in	in	ADP
gsrj-6	132	31	mexico.32	mexico.32	PROPN
gsrj-6	132	32	this	this	PRON
gsrj-6	132	33	is	be	AUX
gsrj-6	132	34	consistent	consistent	ADJ
gsrj-6	132	35	with	with	ADP
gsrj-6	132	36	the	the	DET
gsrj-6	132	37	current	current	ADJ
gsrj-6	132	38	study	study	NOUN
gsrj-6	132	39	’s	’s	PART
gsrj-6	132	40	findings	finding	NOUN
gsrj-6	132	41	showing	show	VERB
gsrj-6	132	42	higher	high	ADJ
gsrj-6	132	43	burdens	burden	NOUN
gsrj-6	132	44	of	of	ADP
gsrj-6	132	45	nafld	nafld	ADV
gsrj-6	132	46	-	-	PUNCT
gsrj-6	132	47	fib	fib	NOUN
gsrj-6	132	48	among	among	ADP
gsrj-6	132	49	hispanics	hispanic	NOUN
gsrj-6	132	50	.	.	PUNCT
gsrj-6	133	1	overall	overall	ADJ
gsrj-6	133	2	,	,	PUNCT
gsrj-6	133	3	evolving	evolve	VERB
gsrj-6	133	4	knowledge	knowledge	NOUN
gsrj-6	133	5	in	in	ADP
gsrj-6	133	6	genetics	genetic	NOUN
gsrj-6	133	7	along	along	ADP
gsrj-6	133	8	with	with	ADP
gsrj-6	133	9	epidemiological	epidemiological	ADJ
gsrj-6	133	10	studies	study	NOUN
gsrj-6	133	11	focused	focus	VERB
gsrj-6	133	12	on	on	ADP
gsrj-6	133	13	race	race	NOUN
gsrj-6	133	14	/	/	SYM
gsrj-6	133	15	ethnic	ethnic	ADJ
gsrj-6	133	16	backgrounds	background	NOUN
gsrj-6	133	17	may	may	AUX
gsrj-6	133	18	help	help	AUX
gsrj-6	133	19	identify	identify	VERB
gsrj-6	133	20	patients	patient	NOUN
gsrj-6	133	21	at	at	ADP
gsrj-6	133	22	higher	high	ADJ
gsrj-6	133	23	risks	risk	NOUN
gsrj-6	133	24	for	for	ADP
gsrj-6	133	25	hcc.33	hcc.33	ADJ
gsrj-6	133	26	this	this	DET
gsrj-6	133	27	study	study	NOUN
gsrj-6	133	28	demonstrates	demonstrate	VERB
gsrj-6	133	29	that	that	SCONJ
gsrj-6	133	30	pnpla3	pnpla3	NOUN
gsrj-6	133	31	influences	influence	VERB
gsrj-6	133	32	liver	liver	NOUN
gsrj-6	133	33	fat	fat	ADJ
gsrj-6	133	34	accumulation	accumulation	NOUN
gsrj-6	133	35	early	early	ADV
gsrj-6	133	36	in	in	ADP
gsrj-6	133	37	life	life	NOUN
gsrj-6	133	38	in	in	ADP
gsrj-6	133	39	hispanic	hispanic	ADJ
gsrj-6	133	40	children	child	NOUN
gsrj-6	133	41	and	and	CCONJ
gsrj-6	133	42	adults	adult	NOUN
gsrj-6	133	43	.	.	PUNCT
gsrj-6	134	1	34	34	NUM
gsrj-6	134	2	this	this	DET
gsrj-6	134	3	analysis	analysis	NOUN
gsrj-6	134	4	also	also	ADV
gsrj-6	134	5	represents	represent	VERB
gsrj-6	134	6	,	,	PUNCT
gsrj-6	134	7	individuals	individual	NOUN
gsrj-6	134	8	carrying	carry	VERB
gsrj-6	134	9	the	the	DET
gsrj-6	134	10	gg	gg	NOUN
gsrj-6	134	11	genotype	genotype	NOUN
gsrj-6	134	12	of	of	ADP
gsrj-6	134	13	the	the	DET
gsrj-6	134	14	pnpla3	pnpla3	NOUN
gsrj-6	134	15	gene	gene	NOUN
gsrj-6	134	16	are	be	AUX
gsrj-6	134	17	susceptible	susceptible	ADJ
gsrj-6	134	18	to	to	ADP
gsrj-6	134	19	increased	increase	VERB
gsrj-6	134	20	hepatic	hepatic	ADJ
gsrj-6	134	21	fat	fat	NOUN
gsrj-6	134	22	when	when	SCONJ
gsrj-6	134	23	dietary	dietary	ADJ
gsrj-6	134	24	sugar	sugar	NOUN
gsrj-6	134	25	intake	intake	NOUN
gsrj-6	134	26	is	be	AUX
gsrj-6	134	27	high	high	ADJ
gsrj-6	134	28	.	.	PUNCT
gsrj-6	135	1	the	the	DET
gsrj-6	135	2	role	role	NOUN
gsrj-6	135	3	of	of	ADP
gsrj-6	135	4	pnpla	pnpla	ADJ
gsrj-6	135	5	gene	gene	NOUN
gsrj-6	135	6	may	may	AUX
gsrj-6	135	7	have	have	VERB
gsrj-6	135	8	an	an	DET
gsrj-6	135	9	association	association	NOUN
gsrj-6	135	10	in	in	ADP
gsrj-6	135	11	the	the	DET
gsrj-6	135	12	development	development	NOUN
gsrj-6	135	13	of	of	ADP
gsrj-6	135	14	nafld	nafld	ADV
gsrj-6	135	15	-	-	PUNCT
gsrj-6	135	16	fib	fib	NOUN
gsrj-6	135	17	and	and	CCONJ
gsrj-6	135	18	nash	nash	NOUN
gsrj-6	135	19	-	-	PUNCT
gsrj-6	135	20	cirrhosis	cirrhosis	NOUN
gsrj-6	135	21	in	in	ADP
gsrj-6	135	22	the	the	DET
gsrj-6	135	23	hispanics	hispanic	NOUN
gsrj-6	135	24	.	.	PUNCT
gsrj-6	136	1	other	other	ADJ
gsrj-6	136	2	studies	study	NOUN
gsrj-6	136	3	have	have	AUX
gsrj-6	136	4	also	also	ADV
gsrj-6	136	5	confirmed	confirm	VERB
gsrj-6	136	6	that	that	SCONJ
gsrj-6	136	7	this	this	DET
gsrj-6	136	8	gene	gene	NOUN
gsrj-6	136	9	predispose	predispose	VERB
gsrj-6	136	10	obese	obese	ADJ
gsrj-6	136	11	children	child	NOUN
gsrj-6	136	12	and	and	CCONJ
gsrj-6	136	13	adolescents	adolescent	NOUN
gsrj-6	136	14	to	to	PART
gsrj-6	136	15	exhibit	exhibit	VERB
gsrj-6	136	16	hepatic	hepatic	ADJ
gsrj-6	136	17	damage.35	damage.35	NOUN
gsrj-6	136	18	among	among	ADP
gsrj-6	136	19	non	non	ADJ
gsrj-6	136	20	-	-	ADJ
gsrj-6	136	21	metabolic	metabolic	ADJ
gsrj-6	136	22	risk	risk	NOUN
gsrj-6	136	23	factors	factor	NOUN
gsrj-6	136	24	,	,	PUNCT
gsrj-6	136	25	hcv	hcv	PROPN
gsrj-6	136	26	has	have	AUX
gsrj-6	136	27	long	long	ADV
gsrj-6	136	28	been	be	AUX
gsrj-6	136	29	recognized	recognize	VERB
gsrj-6	136	30	as	as	ADP
gsrj-6	136	31	a	a	DET
gsrj-6	136	32	major	major	ADJ
gsrj-6	136	33	predictor	predictor	NOUN
gsrj-6	136	34	of	of	ADP
gsrj-6	136	35	hcc	hcc	PROPN
gsrj-6	136	36	risk.36	risk.36	NOUN
gsrj-6	136	37	this	this	DET
gsrj-6	136	38	study	study	NOUN
gsrj-6	136	39	is	be	AUX
gsrj-6	136	40	also	also	ADV
gsrj-6	136	41	consistent	consistent	ADJ
gsrj-6	136	42	with	with	ADP
gsrj-6	136	43	previous	previous	ADJ
gsrj-6	136	44	studies	study	NOUN
gsrj-6	136	45	indicating	indicate	VERB
gsrj-6	136	46	a	a	DET
gsrj-6	136	47	largest	large	ADJ
gsrj-6	136	48	risk	risk	NOUN
gsrj-6	136	49	of	of	ADP
gsrj-6	136	50	hcv	hcv	NOUN
gsrj-6	136	51	in	in	ADP
gsrj-6	136	52	the	the	DET
gsrj-6	136	53	non	non	ADJ
gsrj-6	136	54	-	-	ADJ
gsrj-6	136	55	hispanic	hispanic	ADJ
gsrj-6	136	56	black	black	ADJ
gsrj-6	136	57	population	population	NOUN
gsrj-6	136	58	.	.	PUNCT
gsrj-6	137	1	36	36	NUM
gsrj-6	137	2	-	-	SYM
gsrj-6	137	3	37	37	NUM
gsrj-6	137	4	a	a	DET
gsrj-6	137	5	crosssectional	crosssectional	ADJ
gsrj-6	137	6	study	study	NOUN
gsrj-6	137	7	utilizing	utilize	VERB
gsrj-6	137	8	medicare	medicare	PROPN
gsrj-6	137	9	databases	database	NOUN
gsrj-6	137	10	have	have	AUX
gsrj-6	137	11	shown	show	VERB
gsrj-6	137	12	that	that	SCONJ
gsrj-6	137	13	the	the	DET
gsrj-6	137	14	proportion	proportion	NOUN
gsrj-6	137	15	of	of	ADP
gsrj-6	137	16	hcc	hcc	PROPN
gsrj-6	137	17	cases	case	NOUN
gsrj-6	137	18	attributable	attributable	ADJ
gsrj-6	137	19	to	to	ADP
gsrj-6	137	20	hcv	hcv	VERB
gsrj-6	137	21	and	and	CCONJ
gsrj-6	137	22	hbv	hbv	NOUN
gsrj-6	137	23	have	have	AUX
gsrj-6	137	24	doubled	double	VERB
gsrj-6	137	25	over	over	ADP
gsrj-6	137	26	approximately	approximately	ADV
gsrj-6	137	27	the	the	DET
gsrj-6	137	28	same	same	ADJ
gsrj-6	137	29	study	study	NOUN
gsrj-6	137	30	period.37,38	period.37,38	NOUN
gsrj-6	137	31	the	the	DET
gsrj-6	137	32	differing	differ	VERB
gsrj-6	137	33	estimations	estimation	NOUN
gsrj-6	137	34	in	in	ADP
gsrj-6	137	35	previous	previous	ADJ
gsrj-6	137	36	studies	study	NOUN
gsrj-6	137	37	compared	compare	VERB
gsrj-6	137	38	to	to	ADP
gsrj-6	137	39	the	the	DET
gsrj-6	137	40	current	current	NOUN
gsrj-6	137	41	is	be	AUX
gsrj-6	137	42	likely	likely	ADJ
gsrj-6	137	43	due	due	ADP
gsrj-6	137	44	to	to	ADP
gsrj-6	137	45	the	the	DET
gsrj-6	137	46	broader	broad	ADJ
gsrj-6	137	47	age	age	NOUN
gsrj-6	137	48	of	of	ADP
gsrj-6	137	49	subjects	subject	NOUN
gsrj-6	137	50	surveyed	survey	VERB
gsrj-6	137	51	presently	presently	ADV
gsrj-6	137	52	in	in	ADP
gsrj-6	137	53	nhanes	nhane	NOUN
gsrj-6	137	54	compared	compare	VERB
gsrj-6	137	55	to	to	ADP
gsrj-6	137	56	seer	seer	NOUN
gsrj-6	137	57	-	-	PUNCT
gsrj-6	137	58	medicare	medicare	PROPN
gsrj-6	137	59	databases	database	NOUN
gsrj-6	137	60	.	.	PUNCT
gsrj-6	138	1	the	the	DET
gsrj-6	138	2	known	know	VERB
gsrj-6	138	3	birth	birth	NOUN
gsrj-6	138	4	cohort	cohort	NOUN
gsrj-6	138	5	effect	effect	NOUN
gsrj-6	138	6	of	of	ADP
gsrj-6	138	7	those	those	PRON
gsrj-6	138	8	born	bear	VERB
gsrj-6	138	9	between	between	ADP
gsrj-6	138	10	1945	1945	NUM
gsrj-6	138	11	-	-	SYM
gsrj-6	138	12	1965	1965	NUM
gsrj-6	138	13	reaching	reach	VERB
gsrj-6	138	14	the	the	DET
gsrj-6	138	15	age	age	NOUN
gsrj-6	138	16	of	of	ADP
gsrj-6	138	17	peak	peak	NOUN
gsrj-6	138	18	hcc	hcc	PROPN
gsrj-6	138	19	risk	risk	NOUN
gsrj-6	138	20	had	have	AUX
gsrj-6	138	21	been	be	AUX
gsrj-6	138	22	previously	previously	ADV
gsrj-6	138	23	reported	report	VERB
gsrj-6	138	24	,	,	PUNCT
gsrj-6	138	25	37,39	37,39	NUM
gsrj-6	138	26	and	and	CCONJ
gsrj-6	138	27	the	the	DET
gsrj-6	138	28	greater	great	ADJ
gsrj-6	138	29	proportion	proportion	NOUN
gsrj-6	138	30	of	of	ADP
gsrj-6	138	31	hcv	hcv	NOUN
gsrj-6	138	32	contribution	contribution	NOUN
gsrj-6	138	33	was	be	AUX
gsrj-6	138	34	towards	towards	ADP
gsrj-6	138	35	hcc	hcc	PROPN
gsrj-6	138	36	among	among	ADP
gsrj-6	138	37	the	the	DET
gsrj-6	138	38	older	old	ADJ
gsrj-6	138	39	us	us	PROPN
gsrj-6	138	40	generation	generation	NOUN
gsrj-6	138	41	.	.	PUNCT
gsrj-6	139	1	the	the	DET
gsrj-6	139	2	current	current	ADJ
gsrj-6	139	3	study	study	NOUN
gsrj-6	139	4	does	do	AUX
gsrj-6	139	5	have	have	VERB
gsrj-6	139	6	certain	certain	ADJ
gsrj-6	139	7	limitations	limitation	NOUN
gsrj-6	139	8	.	.	PUNCT
gsrj-6	140	1	while	while	SCONJ
gsrj-6	140	2	this	this	DET
gsrj-6	140	3	study	study	NOUN
gsrj-6	140	4	has	have	AUX
gsrj-6	140	5	assumed	assume	VERB
gsrj-6	140	6	independent	independent	ADJ
gsrj-6	140	7	causation	causation	NOUN
gsrj-6	140	8	of	of	ADP
gsrj-6	140	9	hcc	hcc	PROPN
gsrj-6	140	10	for	for	ADP
gsrj-6	140	11	each	each	DET
gsrj-6	140	12	risk	risk	NOUN
gsrj-6	140	13	factor	factor	NOUN
gsrj-6	140	14	,	,	PUNCT
gsrj-6	140	15	the	the	DET
gsrj-6	140	16	course	course	NOUN
gsrj-6	140	17	of	of	ADP
gsrj-6	140	18	disease	disease	NOUN
gsrj-6	140	19	from	from	ADP
gsrj-6	140	20	obesity	obesity	NOUN
gsrj-6	140	21	,	,	PUNCT
gsrj-6	140	22	diabetes	diabetes	NOUN
gsrj-6	140	23	,	,	PUNCT
gsrj-6	140	24	nafld	nafld	ADV
gsrj-6	140	25	-	-	PUNCT
gsrj-6	140	26	fib	fib	ADJ
gsrj-6	140	27	,	,	PUNCT
gsrj-6	140	28	and	and	CCONJ
gsrj-6	140	29	nash	nash	NOUN
gsrj-6	140	30	-	-	PUNCT
gsrj-6	140	31	cirrhosis	cirrhosis	NOUN
gsrj-6	140	32	is	be	AUX
gsrj-6	140	33	not	not	PART
gsrj-6	140	34	a	a	DET
gsrj-6	140	35	mutually	mutually	ADV
gsrj-6	140	36	exclusive	exclusive	ADJ
gsrj-6	140	37	path	path	NOUN
gsrj-6	140	38	toward	toward	ADP
gsrj-6	140	39	malignancy	malignancy	NOUN
gsrj-6	140	40	.	.	PUNCT
gsrj-6	141	1	25,26,4043	25,26,4043	NOUN
gsrj-6	141	2	patients	patient	NOUN
gsrj-6	141	3	can	can	AUX
gsrj-6	141	4	often	often	ADV
gsrj-6	141	5	present	present	VERB
gsrj-6	141	6	with	with	ADP
gsrj-6	141	7	multiple	multiple	ADJ
gsrj-6	141	8	risk	risk	NOUN
gsrj-6	141	9	factors	factor	NOUN
gsrj-6	141	10	,	,	PUNCT
gsrj-6	141	11	raising	raise	VERB
gsrj-6	141	12	the	the	DET
gsrj-6	141	13	question	question	NOUN
gsrj-6	141	14	of	of	ADP
gsrj-6	141	15	how	how	SCONJ
gsrj-6	141	16	to	to	PART
gsrj-6	141	17	accurately	accurately	ADV
gsrj-6	141	18	weigh	weigh	VERB
gsrj-6	141	19	the	the	DET
gsrj-6	141	20	contribution	contribution	NOUN
gsrj-6	141	21	of	of	ADP
gsrj-6	141	22	each	each	DET
gsrj-6	141	23	risk	risk	NOUN
gsrj-6	141	24	and	and	CCONJ
gsrj-6	141	25	handle	handle	VERB
gsrj-6	141	26	overlapping	overlap	VERB
gsrj-6	141	27	interactions	interaction	NOUN
gsrj-6	141	28	with	with	ADP
gsrj-6	141	29	other	other	ADJ
gsrj-6	141	30	,	,	PUNCT
gsrj-6	141	31	possibly	possibly	ADV
gsrj-6	141	32	concurrent	concurrent	ADJ
gsrj-6	141	33	,	,	PUNCT
gsrj-6	141	34	risk	risk	NOUN
gsrj-6	141	35	factors	factor	NOUN
gsrj-6	141	36	.	.	PUNCT
gsrj-6	142	1	while	while	SCONJ
gsrj-6	142	2	this	this	DET
gsrj-6	142	3	study	study	NOUN
gsrj-6	142	4	served	serve	VERB
gsrj-6	142	5	to	to	PART
gsrj-6	142	6	focus	focus	VERB
gsrj-6	142	7	on	on	ADP
gsrj-6	142	8	contributions	contribution	NOUN
gsrj-6	142	9	of	of	ADP
gsrj-6	142	10	each	each	DET
gsrj-6	142	11	specific	specific	ADJ
gsrj-6	142	12	risk	risk	NOUN
gsrj-6	142	13	factor	factor	NOUN
gsrj-6	142	14	,	,	PUNCT
gsrj-6	142	15	29	29	NUM
gsrj-6	142	16	georgetown	georgetown	PROPN
gsrj-6	142	17	scientific	scientific	PROPN
gsrj-6	142	18	research	research	PROPN
gsrj-6	142	19	journal	journal	PROPN
gsrj-6	142	20	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	142	21	future	future	ADJ
gsrj-6	142	22	studies	study	NOUN
gsrj-6	142	23	are	be	AUX
gsrj-6	142	24	needed	need	VERB
gsrj-6	142	25	to	to	PART
gsrj-6	142	26	disentangle	disentangle	VERB
gsrj-6	142	27	these	these	DET
gsrj-6	142	28	interactions	interaction	NOUN
gsrj-6	142	29	using	use	VERB
gsrj-6	142	30	real	real	ADJ
gsrj-6	142	31	-	-	PUNCT
gsrj-6	142	32	world	world	NOUN
gsrj-6	142	33	data	datum	NOUN
gsrj-6	142	34	.44	.44	NUM
gsrj-6	142	35	importantly	importantly	ADV
gsrj-6	142	36	,	,	PUNCT
gsrj-6	142	37	the	the	DET
gsrj-6	142	38	average	average	ADJ
gsrj-6	142	39	age	age	NOUN
gsrj-6	142	40	of	of	ADP
gsrj-6	142	41	hcc	hcc	PROPN
gsrj-6	142	42	onset	onset	NOUN
gsrj-6	142	43	is	be	AUX
gsrj-6	142	44	65	65	NUM
gsrj-6	142	45	while	while	SCONJ
gsrj-6	142	46	the	the	DET
gsrj-6	142	47	study	study	NOUN
gsrj-6	142	48	’s	’s	PART
gsrj-6	142	49	cohort	cohort	NOUN
gsrj-6	142	50	had	have	VERB
gsrj-6	142	51	an	an	DET
gsrj-6	142	52	average	average	ADJ
gsrj-6	142	53	age	age	NOUN
gsrj-6	142	54	of	of	ADP
gsrj-6	142	55	46	46	NUM
gsrj-6	142	56	.	.	PUNCT
gsrj-6	143	1	while	while	SCONJ
gsrj-6	143	2	this	this	DET
gsrj-6	143	3	study	study	NOUN
gsrj-6	143	4	did	do	AUX
gsrj-6	143	5	adjust	adjust	VERB
gsrj-6	143	6	for	for	ADP
gsrj-6	143	7	age	age	NOUN
gsrj-6	143	8	,	,	PUNCT
gsrj-6	143	9	the	the	DET
gsrj-6	143	10	burden	burden	NOUN
gsrj-6	143	11	of	of	ADP
gsrj-6	143	12	each	each	DET
gsrj-6	143	13	metabolic	metabolic	NOUN
gsrj-6	143	14	risk	risk	NOUN
gsrj-6	143	15	factor	factor	NOUN
gsrj-6	143	16	may	may	AUX
gsrj-6	143	17	have	have	AUX
gsrj-6	143	18	been	be	AUX
gsrj-6	143	19	an	an	DET
gsrj-6	143	20	underestimation.16	underestimation.16	PROPN
gsrj-6	143	21	this	this	DET
gsrj-6	143	22	study	study	NOUN
gsrj-6	143	23	also	also	ADV
gsrj-6	143	24	assumes	assume	VERB
gsrj-6	143	25	that	that	SCONJ
gsrj-6	143	26	people	people	NOUN
gsrj-6	143	27	do	do	AUX
gsrj-6	143	28	not	not	PART
gsrj-6	143	29	change	change	VERB
gsrj-6	143	30	their	their	PRON
gsrj-6	143	31	lifestyle	lifestyle	NOUN
gsrj-6	143	32	habits	habit	NOUN
gsrj-6	143	33	as	as	SCONJ
gsrj-6	143	34	they	they	PRON
gsrj-6	143	35	grow	grow	VERB
gsrj-6	143	36	older	old	ADJ
gsrj-6	143	37	,	,	PUNCT
gsrj-6	143	38	thereby	thereby	ADV
gsrj-6	143	39	potentially	potentially	ADV
gsrj-6	143	40	decreasing	decrease	VERB
gsrj-6	143	41	their	their	PRON
gsrj-6	143	42	hcc	hcc	NOUN
gsrj-6	143	43	risk	risk	NOUN
gsrj-6	143	44	.	.	PUNCT
gsrj-6	144	1	29	29	NUM
gsrj-6	145	1	thus	thus	ADV
gsrj-6	145	2	,	,	PUNCT
gsrj-6	145	3	these	these	DET
gsrj-6	145	4	results	result	NOUN
gsrj-6	145	5	should	should	AUX
gsrj-6	145	6	be	be	AUX
gsrj-6	145	7	interpreted	interpret	VERB
gsrj-6	145	8	as	as	ADP
gsrj-6	145	9	epidemiological	epidemiological	ADJ
gsrj-6	145	10	evidence	evidence	NOUN
gsrj-6	145	11	for	for	ADP
gsrj-6	145	12	prevention	prevention	NOUN
gsrj-6	145	13	strategies	strategy	NOUN
gsrj-6	145	14	and	and	CCONJ
gsrj-6	145	15	public	public	ADJ
gsrj-6	145	16	health	health	NOUN
gsrj-6	145	17	education	education	NOUN
gsrj-6	145	18	on	on	ADP
gsrj-6	145	19	risk	risk	NOUN
gsrj-6	145	20	factors	factor	NOUN
gsrj-6	145	21	.	.	PUNCT
gsrj-6	146	1	in	in	ADP
gsrj-6	146	2	conclusion	conclusion	NOUN
gsrj-6	146	3	,	,	PUNCT
gsrj-6	146	4	these	these	DET
gsrj-6	146	5	results	result	NOUN
gsrj-6	146	6	display	display	VERB
gsrj-6	146	7	the	the	DET
gsrj-6	146	8	changing	change	VERB
gsrj-6	146	9	contributions	contribution	NOUN
gsrj-6	146	10	as	as	ADV
gsrj-6	146	11	well	well	ADV
gsrj-6	146	12	as	as	ADP
gsrj-6	146	13	the	the	DET
gsrj-6	146	14	proportions	proportion	NOUN
gsrj-6	146	15	of	of	ADP
gsrj-6	146	16	known	know	VERB
gsrj-6	146	17	hcc	hcc	NOUN
gsrj-6	146	18	risk	risk	NOUN
gsrj-6	146	19	factors	factor	NOUN
gsrj-6	146	20	among	among	ADP
gsrj-6	146	21	specific	specific	ADJ
gsrj-6	146	22	racial	racial	ADJ
gsrj-6	146	23	and	and	CCONJ
gsrj-6	146	24	ethnic	ethnic	ADJ
gsrj-6	146	25	groups	group	NOUN
gsrj-6	146	26	in	in	ADP
gsrj-6	146	27	a	a	DET
gsrj-6	146	28	representative	representative	ADJ
gsrj-6	146	29	sample	sample	NOUN
gsrj-6	146	30	of	of	ADP
gsrj-6	146	31	the	the	DET
gsrj-6	146	32	us	us	PROPN
gsrj-6	146	33	population	population	NOUN
gsrj-6	146	34	.	.	PUNCT
gsrj-6	147	1	the	the	DET
gsrj-6	147	2	results	result	NOUN
gsrj-6	147	3	of	of	ADP
gsrj-6	147	4	this	this	DET
gsrj-6	147	5	study	study	NOUN
gsrj-6	147	6	show	show	VERB
gsrj-6	147	7	that	that	SCONJ
gsrj-6	147	8	the	the	DET
gsrj-6	147	9	increasing	increase	VERB
gsrj-6	147	10	hcc	hcc	PROPN
gsrj-6	147	11	rates	rate	NOUN
gsrj-6	147	12	are	be	AUX
gsrj-6	147	13	due	due	ADJ
gsrj-6	147	14	to	to	ADP
gsrj-6	147	15	modifiable	modifiable	ADJ
gsrj-6	147	16	causes	cause	NOUN
gsrj-6	147	17	;	;	PUNCT
gsrj-6	147	18	this	this	PRON
gsrj-6	147	19	can	can	AUX
gsrj-6	147	20	be	be	AUX
gsrj-6	147	21	used	use	VERB
gsrj-6	147	22	to	to	PART
gsrj-6	147	23	inform	inform	VERB
gsrj-6	147	24	prevention	prevention	NOUN
gsrj-6	147	25	and	and	CCONJ
gsrj-6	147	26	education	education	NOUN
gsrj-6	147	27	programs	program	NOUN
gsrj-6	147	28	with	with	ADP
gsrj-6	147	29	awareness	awareness	NOUN
gsrj-6	147	30	as	as	ADP
gsrj-6	147	31	to	to	ADP
gsrj-6	147	32	racial	racial	ADJ
gsrj-6	147	33	and	and	CCONJ
gsrj-6	147	34	ethnic	ethnic	ADJ
gsrj-6	147	35	genetic	genetic	ADJ
gsrj-6	147	36	and	and	CCONJ
gsrj-6	147	37	lifestyle	lifestyle	NOUN
gsrj-6	147	38	differences	difference	NOUN
gsrj-6	147	39	.	.	PUNCT
gsrj-6	148	1	references	reference	NOUN
gsrj-6	148	2	1	1	NUM
gsrj-6	148	3	.	.	PUNCT
gsrj-6	149	1	shariff	shariff	PROPN
gsrj-6	149	2	,	,	PUNCT
gsrj-6	149	3	m.	m.	PROPN
gsrj-6	149	4	i.	i.	PROPN
gsrj-6	149	5	f.	f.	PROPN
gsrj-6	149	6	,	,	PUNCT
gsrj-6	149	7	cox	cox	PROPN
gsrj-6	149	8	,	,	PUNCT
gsrj-6	149	9	i.	i.	PROPN
gsrj-6	149	10	j.	j.	PROPN
gsrj-6	149	11	,	,	PUNCT
gsrj-6	149	12	gomaa	gomaa	PROPN
gsrj-6	149	13	,	,	PUNCT
gsrj-6	149	14	a.	a.	NOUN
gsrj-6	149	15	i.	i.	PROPN
gsrj-6	149	16	,	,	PUNCT
gsrj-6	149	17	khan	khan	PROPN
gsrj-6	149	18	,	,	PUNCT
gsrj-6	149	19	s.	s.	PROPN
gsrj-6	149	20	a.	a.	PROPN
gsrj-6	149	21	,	,	PUNCT
gsrj-6	149	22	gedroyc	gedroyc	PROPN
gsrj-6	149	23	,	,	PUNCT
gsrj-6	149	24	w.	w.	PROPN
gsrj-6	149	25	,	,	PUNCT
gsrj-6	149	26	&	&	CCONJ
gsrj-6	149	27	taylorrobinson	taylorrobinson	PROPN
gsrj-6	149	28	,	,	PUNCT
gsrj-6	149	29	s.	s.	PROPN
gsrj-6	149	30	d.	d.	PROPN
gsrj-6	149	31	(	(	PUNCT
gsrj-6	149	32	2009	2009	NUM
gsrj-6	149	33	)	)	PUNCT
gsrj-6	149	34	.	.	PUNCT
gsrj-6	150	1	hepatocellular	hepatocellular	ADJ
gsrj-6	150	2	carcinoma	carcinoma	NOUN
gsrj-6	150	3	:	:	PUNCT
gsrj-6	150	4	current	current	ADJ
gsrj-6	150	5	trends	trend	NOUN
gsrj-6	150	6	in	in	ADP
gsrj-6	150	7	worldwide	worldwide	ADJ
gsrj-6	150	8	epidemiology	epidemiology	NOUN
gsrj-6	150	9	,	,	PUNCT
gsrj-6	150	10	risk	risk	NOUN
gsrj-6	150	11	factors	factor	NOUN
gsrj-6	150	12	,	,	PUNCT
gsrj-6	150	13	diagnosis	diagnosis	NOUN
gsrj-6	150	14	and	and	CCONJ
gsrj-6	150	15	therapeutics	therapeutic	NOUN
gsrj-6	150	16	.	.	PUNCT
gsrj-6	151	1	expert	expert	NOUN
gsrj-6	151	2	review	review	NOUN
gsrj-6	151	3	of	of	ADP
gsrj-6	151	4	gastroenterology	gastroenterology	NOUN
gsrj-6	151	5	and	and	CCONJ
gsrj-6	151	6	hepatology	hepatology	NOUN
gsrj-6	151	7	.	.	PUNCT
gsrj-6	151	8	https://doi.org/10.1586/egh.09.35	https://doi.org/10.1586/egh.09.35	PROPN
gsrj-6	152	1	2	2	NUM
gsrj-6	152	2	.	.	PUNCT
gsrj-6	153	1	parkin	parkin	PROPN
gsrj-6	153	2	,	,	PUNCT
gsrj-6	153	3	d.	d.	PROPN
gsrj-6	153	4	m.	m.	PROPN
gsrj-6	153	5	(	(	PUNCT
gsrj-6	153	6	2001	2001	NUM
gsrj-6	153	7	)	)	PUNCT
gsrj-6	153	8	.	.	PUNCT
gsrj-6	154	1	global	global	ADJ
gsrj-6	154	2	cancer	cancer	NOUN
gsrj-6	154	3	statistics	statistic	NOUN
gsrj-6	154	4	in	in	ADP
gsrj-6	154	5	the	the	DET
gsrj-6	154	6	year	year	NOUN
gsrj-6	154	7	2000	2000	NUM
gsrj-6	154	8	.	.	PUNCT
gsrj-6	155	1	lancet	lancet	PROPN
gsrj-6	155	2	oncology	oncology	PROPN
gsrj-6	155	3	.	.	PUNCT
gsrj-6	156	1	https://doi.org/10.1016/s14702045(01)00486-7	https://doi.org/10.1016/s14702045(01)00486-7	PROPN
gsrj-6	156	2	3	3	X
gsrj-6	156	3	.	.	X
gsrj-6	156	4	rinella	rinella	PROPN
gsrj-6	156	5	,	,	PUNCT
gsrj-6	156	6	m.	m.	PROPN
gsrj-6	156	7	e.	e.	PROPN
gsrj-6	156	8	(	(	PUNCT
gsrj-6	156	9	2015	2015	NUM
gsrj-6	156	10	)	)	PUNCT
gsrj-6	156	11	.	.	PUNCT
gsrj-6	157	1	nonalcoholic	nonalcoholic	ADJ
gsrj-6	157	2	fatty	fatty	NOUN
gsrj-6	157	3	liver	liver	NOUN
gsrj-6	157	4	disease	disease	NOUN
gsrj-6	157	5	a	a	DET
gsrj-6	157	6	systematic	systematic	ADJ
gsrj-6	157	7	review	review	NOUN
gsrj-6	157	8	.	.	PUNCT
gsrj-6	158	1	jama	jama	PROPN
gsrj-6	158	2	journal	journal	PROPN
gsrj-6	158	3	of	of	ADP
gsrj-6	158	4	the	the	DET
gsrj-6	158	5	american	american	PROPN
gsrj-6	158	6	medical	medical	PROPN
gsrj-6	158	7	association	association	PROPN
gsrj-6	158	8	.	.	PUNCT
gsrj-6	159	1	https://doi.org/10.1001/jama.2015.5370	https://doi.org/10.1001/jama.2015.5370	PROPN
gsrj-6	159	2	4	4	NUM
gsrj-6	159	3	.	.	PUNCT
gsrj-6	159	4	paschos	paschos	ADJ
gsrj-6	159	5	,	,	PUNCT
gsrj-6	159	6	p.	p.	NOUN
gsrj-6	159	7	,	,	PUNCT
gsrj-6	159	8	&	&	CCONJ
gsrj-6	159	9	paletas	paleta	NOUN
gsrj-6	159	10	,	,	PUNCT
gsrj-6	159	11	k.	k.	PROPN
gsrj-6	159	12	(	(	PUNCT
gsrj-6	159	13	2009	2009	NUM
gsrj-6	159	14	)	)	PUNCT
gsrj-6	159	15	.	.	PUNCT
gsrj-6	160	1	non	non	PROPN
gsrj-6	160	2	alcoholic	alcoholic	ADJ
gsrj-6	160	3	fatty	fatty	NOUN
gsrj-6	160	4	liver	liver	NOUN
gsrj-6	160	5	disease	disease	NOUN
gsrj-6	160	6	and	and	CCONJ
gsrj-6	160	7	metabolic	metabolic	NOUN
gsrj-6	160	8	syndrome	syndrome	NOUN
gsrj-6	160	9	.	.	PUNCT
gsrj-6	161	1	hippokratia	hippokratia	NOUN
gsrj-6	161	2	.	.	PUNCT
gsrj-6	162	1	5	5	X
gsrj-6	162	2	.	.	X
gsrj-6	162	3	carrion	carrion	NOUN
gsrj-6	162	4	,	,	PUNCT
gsrj-6	162	5	a.	a.	PROPN
gsrj-6	162	6	f.	f.	PROPN
gsrj-6	162	7	,	,	PUNCT
gsrj-6	162	8	ghanta	ghanta	PROPN
gsrj-6	162	9	,	,	PUNCT
gsrj-6	162	10	r.	r.	PROPN
gsrj-6	162	11	,	,	PUNCT
gsrj-6	162	12	carrasquillo	carrasquillo	PROPN
gsrj-6	162	13	,	,	PUNCT
gsrj-6	162	14	o.	o.	PROPN
gsrj-6	162	15	,	,	PUNCT
gsrj-6	162	16	&	&	CCONJ
gsrj-6	162	17	martin	martin	PROPN
gsrj-6	162	18	,	,	PUNCT
gsrj-6	162	19	p.	p.	NOUN
gsrj-6	162	20	(	(	PUNCT
gsrj-6	162	21	2011	2011	NUM
gsrj-6	162	22	)	)	PUNCT
gsrj-6	162	23	.	.	PUNCT
gsrj-6	163	1	chronic	chronic	ADJ
gsrj-6	163	2	liver	liver	NOUN
gsrj-6	163	3	disease	disease	NOUN
gsrj-6	163	4	in	in	ADP
gsrj-6	163	5	the	the	DET
gsrj-6	163	6	hispanic	hispanic	ADJ
gsrj-6	163	7	population	population	NOUN
gsrj-6	163	8	of	of	ADP
gsrj-6	163	9	the	the	DET
gsrj-6	163	10	united	united	PROPN
gsrj-6	163	11	states	states	PROPN
gsrj-6	163	12	.	.	PUNCT
gsrj-6	164	1	clinical	clinical	ADJ
gsrj-6	164	2	gastroenterology	gastroenterology	NOUN
gsrj-6	164	3	and	and	CCONJ
gsrj-6	164	4	hepatology	hepatology	NOUN
gsrj-6	164	5	.	.	PUNCT
gsrj-6	165	1	https://doi.org/10.1016/j.cgh.2011.04.027	https://doi.org/10.1016/j.cgh.2011.04.027	PROPN
gsrj-6	165	2	6	6	NUM
gsrj-6	165	3	.	.	PUNCT
gsrj-6	166	1	caetano	caetano	PROPN
gsrj-6	166	2	,	,	PUNCT
gsrj-6	166	3	r.	r.	PROPN
gsrj-6	166	4	,	,	PUNCT
gsrj-6	166	5	&	&	CCONJ
gsrj-6	166	6	kaskutas	kaskuta	NOUN
gsrj-6	166	7	,	,	PUNCT
gsrj-6	166	8	l.	l.	PROPN
gsrj-6	166	9	a.	a.	PROPN
gsrj-6	166	10	(	(	PUNCT
gsrj-6	166	11	1995	1995	NUM
gsrj-6	166	12	)	)	PUNCT
gsrj-6	166	13	.	.	PUNCT
gsrj-6	167	1	changes	change	NOUN
gsrj-6	167	2	in	in	ADP
gsrj-6	167	3	drinking	drinking	NOUN
gsrj-6	167	4	patterns	pattern	NOUN
gsrj-6	167	5	among	among	ADP
gsrj-6	167	6	whites	white	NOUN
gsrj-6	167	7	,	,	PUNCT
gsrj-6	167	8	blacks	black	NOUN
gsrj-6	167	9	and	and	CCONJ
gsrj-6	167	10	hispanics	hispanic	NOUN
gsrj-6	167	11	,	,	PUNCT
gsrj-6	167	12	19841992	19841992	NUM
gsrj-6	167	13	.	.	PUNCT
gsrj-6	168	1	journal	journal	NOUN
gsrj-6	168	2	of	of	ADP
gsrj-6	168	3	studies	study	NOUN
gsrj-6	168	4	on	on	ADP
gsrj-6	168	5	alcohol	alcohol	NOUN
gsrj-6	168	6	.	.	PUNCT
gsrj-6	169	1	https://doi.org/10.15288/jsa.1995.56.558	https://doi.org/10.15288/jsa.1995.56.558	PROPN
gsrj-6	170	1	7	7	X
gsrj-6	170	2	.	.	X
gsrj-6	170	3	nguyen	nguyen	NOUN
gsrj-6	170	4	,	,	PUNCT
gsrj-6	170	5	g.	g.	PROPN
gsrj-6	170	6	c.	c.	PROPN
gsrj-6	170	7	,	,	PUNCT
gsrj-6	170	8	&	&	CCONJ
gsrj-6	170	9	thuluvath	thuluvath	NOUN
gsrj-6	170	10	,	,	PUNCT
gsrj-6	170	11	p.	p.	PROPN
gsrj-6	170	12	j.	j.	PROPN
gsrj-6	171	1	(	(	PUNCT
gsrj-6	171	2	2008	2008	NUM
gsrj-6	171	3	)	)	PUNCT
gsrj-6	171	4	.	.	PUNCT
gsrj-6	172	1	racial	racial	ADJ
gsrj-6	172	2	disparity	disparity	NOUN
gsrj-6	172	3	in	in	ADP
gsrj-6	172	4	liver	liver	NOUN
gsrj-6	172	5	disease	disease	NOUN
gsrj-6	172	6	:	:	PUNCT
gsrj-6	172	7	biological	biological	ADJ
gsrj-6	172	8	,	,	PUNCT
gsrj-6	172	9	cultural	cultural	ADJ
gsrj-6	172	10	,	,	PUNCT
gsrj-6	172	11	or	or	CCONJ
gsrj-6	172	12	socioeconomic	socioeconomic	ADJ
gsrj-6	172	13	factors	factor	NOUN
gsrj-6	172	14	.	.	PUNCT
gsrj-6	173	1	hepatology	hepatology	NOUN
gsrj-6	173	2	.	.	PUNCT
gsrj-6	174	1	https://doi.org/10.1002/hep.22223	https://doi.org/10.1002/hep.22223	PROPN
gsrj-6	174	2	8	8	NUM
gsrj-6	174	3	.	.	PUNCT
gsrj-6	175	1	kulik	kulik	PROPN
gsrj-6	175	2	,	,	PUNCT
gsrj-6	175	3	l.	l.	PROPN
gsrj-6	175	4	,	,	PUNCT
gsrj-6	175	5	&	&	CCONJ
gsrj-6	175	6	el	el	PROPN
gsrj-6	175	7	-	-	PUNCT
gsrj-6	175	8	serag	serag	PROPN
gsrj-6	175	9	,	,	PUNCT
gsrj-6	175	10	h.	h.	PROPN
gsrj-6	175	11	b.	b.	PROPN
gsrj-6	175	12	(	(	PUNCT
gsrj-6	175	13	2019	2019	NUM
gsrj-6	175	14	)	)	PUNCT
gsrj-6	175	15	.	.	PUNCT
gsrj-6	176	1	epidemiology	epidemiology	NOUN
gsrj-6	176	2	and	and	CCONJ
gsrj-6	176	3	management	management	NOUN
gsrj-6	176	4	of	of	ADP
gsrj-6	176	5	hepatocellular	hepatocellular	ADJ
gsrj-6	176	6	carcinoma	carcinoma	NOUN
gsrj-6	176	7	.	.	PUNCT
gsrj-6	177	1	gastroenterology	gastroenterology	NOUN
gsrj-6	177	2	.	.	PUNCT
gsrj-6	178	1	https://doi.org/10.1053/j.gastro.2018.08.065	https://doi.org/10.1053/j.gastro.2018.08.065	NOUN
gsrj-6	178	2	9	9	NUM
gsrj-6	178	3	.	.	X
gsrj-6	178	4	islami	islami	PROPN
gsrj-6	178	5	,	,	PUNCT
gsrj-6	178	6	f.	f.	PROPN
gsrj-6	178	7	,	,	PUNCT
gsrj-6	178	8	miller	miller	PROPN
gsrj-6	178	9	,	,	PUNCT
gsrj-6	178	10	k.	k.	PROPN
gsrj-6	178	11	d.	d.	PROPN
gsrj-6	178	12	,	,	PUNCT
gsrj-6	178	13	siegel	siegel	PROPN
gsrj-6	178	14	,	,	PUNCT
gsrj-6	178	15	r.	r.	PROPN
gsrj-6	178	16	l.	l.	PROPN
gsrj-6	178	17	,	,	PUNCT
gsrj-6	178	18	fedewa	fedewa	PROPN
gsrj-6	178	19	,	,	PUNCT
gsrj-6	178	20	s.	s.	PROPN
gsrj-6	178	21	a.	a.	PROPN
gsrj-6	178	22	,	,	PUNCT
gsrj-6	178	23	ward	ward	PROPN
gsrj-6	178	24	,	,	PUNCT
gsrj-6	178	25	e.	e.	PROPN
gsrj-6	178	26	m.	m.	PROPN
gsrj-6	178	27	,	,	PUNCT
gsrj-6	178	28	&	&	CCONJ
gsrj-6	178	29	jemal	jemal	ADJ
gsrj-6	178	30	,	,	PUNCT
gsrj-6	178	31	a.	a.	NOUN
gsrj-6	178	32	(	(	PUNCT
gsrj-6	178	33	2017	2017	NUM
gsrj-6	178	34	)	)	PUNCT
gsrj-6	178	35	.	.	PUNCT
gsrj-6	179	1	disparities	disparity	NOUN
gsrj-6	179	2	in	in	ADP
gsrj-6	179	3	liver	liver	NOUN
gsrj-6	179	4	cancer	cancer	NOUN
gsrj-6	179	5	occurrence	occurrence	NOUN
gsrj-6	179	6	in	in	ADP
gsrj-6	179	7	the	the	DET
gsrj-6	179	8	united	united	PROPN
gsrj-6	179	9	states	states	PROPN
gsrj-6	179	10	by	by	ADP
gsrj-6	179	11	race	race	NOUN
gsrj-6	179	12	/	/	SYM
gsrj-6	179	13	ethnicity	ethnicity	NOUN
gsrj-6	179	14	and	and	CCONJ
gsrj-6	179	15	state	state	NOUN
gsrj-6	179	16	.	.	PUNCT
gsrj-6	180	1	ca	can	AUX
gsrj-6	180	2	:	:	PUNCT
gsrj-6	180	3	a	a	DET
gsrj-6	180	4	cancer	cancer	NOUN
gsrj-6	180	5	journal	journal	NOUN
gsrj-6	180	6	for	for	ADP
gsrj-6	180	7	clinicians	clinician	NOUN
gsrj-6	180	8	.	.	PUNCT
gsrj-6	181	1	https://doi.org/10.3322/caac.21402	https://doi.org/10.3322/caac.21402	PROPN
gsrj-6	181	2	10	10	NUM
gsrj-6	181	3	.	.	PUNCT
gsrj-6	182	1	rich	rich	ADJ
gsrj-6	182	2	,	,	PUNCT
gsrj-6	182	3	n.	n.	PROPN
gsrj-6	182	4	e.	e.	PROPN
gsrj-6	182	5	,	,	PUNCT
gsrj-6	182	6	hester	hester	PROPN
gsrj-6	182	7	,	,	PUNCT
gsrj-6	182	8	c.	c.	NOUN
gsrj-6	182	9	,	,	PUNCT
gsrj-6	182	10	odewole	odewole	NOUN
gsrj-6	182	11	,	,	PUNCT
gsrj-6	182	12	m.	m.	NOUN
gsrj-6	182	13	,	,	PUNCT
gsrj-6	182	14	murphy	murphy	PROPN
gsrj-6	182	15	,	,	PUNCT
gsrj-6	182	16	c.	c.	PROPN
gsrj-6	182	17	c.	c.	PROPN
gsrj-6	182	18	,	,	PUNCT
gsrj-6	182	19	parikh	parikh	PROPN
gsrj-6	182	20	,	,	PUNCT
gsrj-6	182	21	n.	n.	PROPN
gsrj-6	182	22	d.	d.	PROPN
gsrj-6	182	23	,	,	PUNCT
gsrj-6	182	24	marrero	marrero	PROPN
gsrj-6	182	25	,	,	PUNCT
gsrj-6	182	26	j.	j.	PROPN
gsrj-6	182	27	a.	a.	PROPN
gsrj-6	182	28	,	,	PUNCT
gsrj-6	182	29	yopp	yopp	NOUN
gsrj-6	182	30	,	,	PUNCT
gsrj-6	182	31	a.	a.	PROPN
gsrj-6	182	32	c.	c.	PROPN
gsrj-6	182	33	,	,	PUNCT
gsrj-6	182	34	&	&	CCONJ
gsrj-6	182	35	singal	singal	PROPN
gsrj-6	182	36	,	,	PUNCT
gsrj-6	182	37	a.	a.	NOUN
gsrj-6	182	38	g.	g.	PROPN
gsrj-6	182	39	(	(	PUNCT
gsrj-6	182	40	2019	2019	NUM
gsrj-6	182	41	)	)	PUNCT
gsrj-6	182	42	.	.	PUNCT
gsrj-6	183	1	racial	racial	ADJ
gsrj-6	183	2	and	and	CCONJ
gsrj-6	183	3	ethnic	ethnic	ADJ
gsrj-6	183	4	differences	difference	NOUN
gsrj-6	183	5	in	in	ADP
gsrj-6	183	6	presentation	presentation	NOUN
gsrj-6	183	7	and	and	CCONJ
gsrj-6	183	8	outcomes	outcome	NOUN
gsrj-6	183	9	of	of	ADP
gsrj-6	183	10	hepatocellular	hepatocellular	ADJ
gsrj-6	183	11	carcinoma	carcinoma	NOUN
gsrj-6	183	12	.	.	PUNCT
gsrj-6	184	1	clinical	clinical	ADJ
gsrj-6	184	2	gastroenterology	gastroenterology	NOUN
gsrj-6	184	3	and	and	CCONJ
gsrj-6	184	4	hepatology	hepatology	NOUN
gsrj-6	184	5	.	.	PUNCT
gsrj-6	185	1	https://doi.org/10.1016/j.cgh.2018.05.039	https://doi.org/10.1016/j.cgh.2018.05.039	NOUN
gsrj-6	185	2	11	11	NUM
gsrj-6	185	3	.	.	PUNCT
gsrj-6	186	1	prevention	prevention	NOUN
gsrj-6	186	2	cfdca	cfdca	PROPN
gsrj-6	186	3	.	.	PUNCT
gsrj-6	187	1	national	national	ADJ
gsrj-6	187	2	health	health	PROPN
gsrj-6	187	3	and	and	CCONJ
gsrj-6	187	4	nutrition	nutrition	NOUN
gsrj-6	187	5	examination	examination	NOUN
gsrj-6	187	6	survey	survey	NOUN
gsrj-6	187	7	data	datum	NOUN
gsrj-6	187	8	.	.	PUNCT
gsrj-6	188	1	us	us	PROPN
gsrj-6	188	2	department	department	PROPN
gsrj-6	188	3	of	of	ADP
gsrj-6	188	4	health	health	PROPN
gsrj-6	188	5	and	and	CCONJ
gsrj-6	188	6	human	human	ADJ
gsrj-6	188	7	services	service	NOUN
gsrj-6	188	8	.	.	PUNCT
gsrj-6	189	1	2019	2019	NUM
gsrj-6	189	2	.	.	PUNCT
gsrj-6	190	1	12	12	NUM
gsrj-6	190	2	.	.	PUNCT
gsrj-6	191	1	(	(	PUNCT
gsrj-6	191	2	nchs	nch	NOUN
gsrj-6	191	3	)	)	PUNCT
gsrj-6	191	4	.	.	PUNCT
gsrj-6	192	1	national	national	ADJ
gsrj-6	192	2	health	health	PROPN
gsrj-6	192	3	and	and	CCONJ
gsrj-6	192	4	nutrition	nutrition	NOUN
gsrj-6	192	5	examination	examination	NOUN
gsrj-6	192	6	survey	survey	NOUN
gsrj-6	192	7	analytic	analytic	ADJ
gsrj-6	192	8	and	and	CCONJ
gsrj-6	192	9	reporting	report	VERB
gsrj-6	192	10	guidelines	guideline	NOUN
gsrj-6	192	11	.	.	PUNCT
gsrj-6	192	12	:	:	PUNCT
gsrj-6	193	1	us	us	PROPN
gsrj-6	193	2	department	department	PROPN
gsrj-6	193	3	of	of	ADP
gsrj-6	193	4	health	health	PROPN
gsrj-6	193	5	and	and	CCONJ
gsrj-6	193	6	30	30	NUM
gsrj-6	193	7	georgetown	georgetown	PROPN
gsrj-6	193	8	scientific	scientific	PROPN
gsrj-6	193	9	research	research	PROPN
gsrj-6	193	10	journal	journal	PROPN
gsrj-6	193	11	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	193	12	human	human	PROPN
gsrj-6	193	13	services	service	NOUN
gsrj-6	193	14	,	,	PUNCT
gsrj-6	193	15	centers	center	NOUN
gsrj-6	193	16	for	for	ADP
gsrj-6	193	17	disease	disease	NOUN
gsrj-6	193	18	control	control	NOUN
gsrj-6	193	19	and	and	CCONJ
gsrj-6	193	20	prevention	prevention	NOUN
gsrj-6	193	21	:	:	PUNCT
gsrj-6	193	22	hyattsville	hyattsville	PROPN
gsrj-6	193	23	,	,	PUNCT
gsrj-6	193	24	md	md	PROPN
gsrj-6	193	25	.	.	PROPN
gsrj-6	193	26	13	13	NUM
gsrj-6	193	27	.	.	PUNCT
gsrj-6	194	1	what	what	PRON
gsrj-6	194	2	's	be	AUX
gsrj-6	194	3	at	at	ADP
gsrj-6	194	4	-	-	PUNCT
gsrj-6	194	5	risk	risk	NOUN
gsrj-6	194	6	or	or	CCONJ
gsrj-6	194	7	heavy	heavy	ADJ
gsrj-6	194	8	drinking	drinking	NOUN
gsrj-6	194	9	?	?	PUNCT
gsrj-6	195	1	rethinking	rethink	VERB
gsrj-6	195	2	drinking	drinking	NOUN
gsrj-6	195	3	niaaa	niaaa	ADP
gsrj-6	195	4	:	:	PUNCT
gsrj-6	195	5	national	national	PROPN
gsrj-6	195	6	institute	institute	PROPN
gsrj-6	195	7	on	on	ADP
gsrj-6	195	8	alcohol	alcohol	NOUN
gsrj-6	195	9	abuse	abuse	NOUN
gsrj-6	195	10	and	and	CCONJ
gsrj-6	195	11	alcoholism	alcoholism	NOUN
gsrj-6	195	12	;	;	PUNCT
gsrj-6	195	13	[	[	X
gsrj-6	195	14	available	available	ADJ
gsrj-6	195	15	from	from	ADP
gsrj-6	195	16	:	:	PUNCT
gsrj-6	195	17	https://www.rethinkingdrinking.niaaa.nih.gov/	https://www.rethinkingdrinking.niaaa.nih.gov/	PROPN
gsrj-6	195	18	how	how	SCONJ
gsrj-6	195	19	-	-	PUNCT
gsrj-6	195	20	much	much	ADJ
gsrj-6	195	21	-	-	PUNCT
gsrj-6	195	22	is	be	AUX
gsrj-6	195	23	-	-	PUNCT
gsrj-6	195	24	too	too	ADV
gsrj-6	195	25	-	-	PUNCT
gsrj-6	195	26	much	much	ADJ
gsrj-6	195	27	/	/	SYM
gsrj-6	195	28	is	be	AUX
gsrj-6	195	29	-	-	PUNCT
gsrj-6	195	30	your	your	PRON
gsrj-6	195	31	-	-	PUNCT
gsrj-6	195	32	drinkingpattern	drinkingpattern	ADJ
gsrj-6	195	33	-	-	PUNCT
gsrj-6	195	34	risky	risky	ADJ
gsrj-6	195	35	/	/	SYM
gsrj-6	195	36	whats	what	NOUN
gsrj-6	195	37	-	-	PUNCT
gsrj-6	195	38	at	at	ADP
gsrj-6	195	39	-	-	PUNCT
gsrj-6	195	40	risk	risk	NOUN
gsrj-6	195	41	-	-	PUNCT
gsrj-6	195	42	or	or	CCONJ
gsrj-6	195	43	-	-	PUNCT
gsrj-6	195	44	heavydrinking.aspx	heavydrinking.aspx	NOUN
gsrj-6	195	45	.	.	PUNCT
gsrj-6	196	1	14	14	NUM
gsrj-6	196	2	.	.	PUNCT
gsrj-6	197	1	alberti	alberti	PROPN
gsrj-6	197	2	kg	kg	PROPN
gsrj-6	197	3	,	,	PUNCT
gsrj-6	197	4	eckel	eckel	PROPN
gsrj-6	197	5	rh	rh	PROPN
gsrj-6	197	6	,	,	PUNCT
gsrj-6	197	7	grundy	grundy	PROPN
gsrj-6	197	8	sm	sm	PROPN
gsrj-6	197	9	,	,	PUNCT
gsrj-6	197	10	zimmet	zimmet	NOUN
gsrj-6	197	11	pz	pz	PROPN
gsrj-6	197	12	,	,	PUNCT
gsrj-6	197	13	cleeman	cleeman	PROPN
gsrj-6	197	14	ji	ji	PROPN
gsrj-6	197	15	,	,	PUNCT
gsrj-6	197	16	donato	donato	PROPN
gsrj-6	197	17	ka	ka	PROPN
gsrj-6	197	18	,	,	PUNCT
gsrj-6	197	19	et	et	PROPN
gsrj-6	197	20	al	al	PROPN
gsrj-6	197	21	.	.	PUNCT
gsrj-6	197	22	(	(	PUNCT
gsrj-6	197	23	2009	2009	NUM
gsrj-6	197	24	)	)	PUNCT
gsrj-6	197	25	.	.	PUNCT
gsrj-6	198	1	harmonizing	harmonize	VERB
gsrj-6	198	2	the	the	DET
gsrj-6	198	3	metabolic	metabolic	NOUN
gsrj-6	198	4	syndrome	syndrome	NOUN
gsrj-6	198	5	:	:	PUNCT
gsrj-6	198	6	a	a	DET
gsrj-6	198	7	joint	joint	ADJ
gsrj-6	198	8	interim	interim	ADJ
gsrj-6	198	9	statement	statement	NOUN
gsrj-6	198	10	of	of	ADP
gsrj-6	198	11	the	the	DET
gsrj-6	198	12	international	international	ADJ
gsrj-6	198	13	diabetes	diabetes	PROPN
gsrj-6	198	14	federation	federation	PROPN
gsrj-6	198	15	task	task	PROPN
gsrj-6	198	16	force	force	NOUN
gsrj-6	198	17	on	on	ADP
gsrj-6	198	18	epidemiology	epidemiology	NOUN
gsrj-6	198	19	and	and	CCONJ
gsrj-6	198	20	prevention	prevention	NOUN
gsrj-6	198	21	;	;	PUNCT
gsrj-6	198	22	national	national	ADJ
gsrj-6	198	23	heart	heart	NOUN
gsrj-6	198	24	,	,	PUNCT
gsrj-6	198	25	lung	lung	NOUN
gsrj-6	198	26	,	,	PUNCT
gsrj-6	198	27	and	and	CCONJ
gsrj-6	198	28	blood	blood	NOUN
gsrj-6	198	29	institute	institute	NOUN
gsrj-6	198	30	;	;	PUNCT
gsrj-6	198	31	american	american	PROPN
gsrj-6	198	32	heart	heart	PROPN
gsrj-6	198	33	association	association	PROPN
gsrj-6	198	34	;	;	PUNCT
gsrj-6	198	35	world	world	NOUN
gsrj-6	198	36	heart	heart	PROPN
gsrj-6	198	37	federation	federation	PROPN
gsrj-6	198	38	;	;	PUNCT
gsrj-6	198	39	international	international	ADJ
gsrj-6	198	40	atherosclerosis	atherosclerosis	NOUN
gsrj-6	198	41	society	society	NOUN
gsrj-6	198	42	;	;	PUNCT
gsrj-6	198	43	and	and	CCONJ
gsrj-6	198	44	international	international	ADJ
gsrj-6	198	45	association	association	NOUN
gsrj-6	198	46	for	for	ADP
gsrj-6	198	47	the	the	DET
gsrj-6	198	48	study	study	NOUN
gsrj-6	198	49	of	of	ADP
gsrj-6	198	50	obesity	obesity	NOUN
gsrj-6	198	51	.	.	PUNCT
gsrj-6	199	1	circulation	circulation	NOUN
gsrj-6	199	2	.	.	PUNCT
gsrj-6	200	1	120(16):1640	120(16):1640	NUM
gsrj-6	200	2	-	-	SYM
gsrj-6	200	3	5	5	NUM
gsrj-6	200	4	.	.	NOUN
gsrj-6	200	5	15	15	NUM
gsrj-6	200	6	.	.	PUNCT
gsrj-6	201	1	lee	lee	PROPN
gsrj-6	201	2	jh	jh	PROPN
gsrj-6	201	3	,	,	PUNCT
gsrj-6	201	4	kim	kim	PROPN
gsrj-6	201	5	d	d	PROPN
gsrj-6	201	6	,	,	PUNCT
gsrj-6	201	7	kim	kim	PROPN
gsrj-6	201	8	hj	hj	PROPN
gsrj-6	201	9	,	,	PUNCT
gsrj-6	201	10	lee	lee	PROPN
gsrj-6	201	11	ch	ch	PROPN
gsrj-6	201	12	,	,	PUNCT
gsrj-6	201	13	yang	yang	PROPN
gsrj-6	201	14	ji	ji	PROPN
gsrj-6	201	15	,	,	PUNCT
gsrj-6	201	16	kim	kim	PROPN
gsrj-6	201	17	w	w	PROPN
gsrj-6	201	18	,	,	PUNCT
gsrj-6	201	19	et	et	PROPN
gsrj-6	201	20	al	al	PROPN
gsrj-6	201	21	.	.	PUNCT
gsrj-6	201	22	(	(	PUNCT
gsrj-6	201	23	2010	2010	NUM
gsrj-6	201	24	)	)	PUNCT
gsrj-6	201	25	.	.	PUNCT
gsrj-6	202	1	hepatic	hepatic	ADJ
gsrj-6	202	2	steatosis	steatosis	NOUN
gsrj-6	202	3	index	index	NOUN
gsrj-6	202	4	:	:	PUNCT
gsrj-6	202	5	a	a	DET
gsrj-6	202	6	simple	simple	ADJ
gsrj-6	202	7	screening	screening	NOUN
gsrj-6	202	8	tool	tool	NOUN
gsrj-6	202	9	reflecting	reflect	VERB
gsrj-6	202	10	nonalcoholic	nonalcoholic	NOUN
gsrj-6	202	11	fatty	fatty	NOUN
gsrj-6	202	12	liver	liver	NOUN
gsrj-6	202	13	disease	disease	NOUN
gsrj-6	202	14	.	.	PUNCT
gsrj-6	203	1	dig	dig	VERB
gsrj-6	203	2	liver	liver	NOUN
gsrj-6	203	3	dis	dis	PROPN
gsrj-6	203	4	.	.	PUNCT
gsrj-6	203	5	;	;	PUNCT
gsrj-6	204	1	42(7):503	42(7):503	PROPN
gsrj-6	204	2	-	-	PUNCT
gsrj-6	204	3	8	8	NUM
gsrj-6	204	4	.	.	PUNCT
gsrj-6	204	5	16	16	NUM
gsrj-6	204	6	.	.	PUNCT
gsrj-6	205	1	mcpherson	mcpherson	PROPN
gsrj-6	205	2	s	s	PROPN
gsrj-6	205	3	,	,	PUNCT
gsrj-6	205	4	stewart	stewart	PROPN
gsrj-6	205	5	sf	sf	PROPN
gsrj-6	205	6	,	,	PUNCT
gsrj-6	205	7	henderson	henderson	PROPN
gsrj-6	205	8	e	e	PROPN
gsrj-6	205	9	,	,	PUNCT
gsrj-6	205	10	burt	burt	NOUN
gsrj-6	205	11	ad	ad	NOUN
gsrj-6	205	12	,	,	PUNCT
gsrj-6	205	13	day	day	NOUN
gsrj-6	205	14	cp	cp	X
gsrj-6	205	15	.	.	PROPN
gsrj-6	205	16	(	(	PUNCT
gsrj-6	205	17	2010	2010	NUM
gsrj-6	205	18	)	)	PUNCT
gsrj-6	205	19	.	.	PUNCT
gsrj-6	206	1	simple	simple	ADJ
gsrj-6	206	2	non	non	ADJ
gsrj-6	206	3	-	-	ADJ
gsrj-6	206	4	invasive	invasive	ADJ
gsrj-6	206	5	fibrosis	fibrosis	NOUN
gsrj-6	206	6	scoring	scoring	NOUN
gsrj-6	206	7	systems	system	NOUN
gsrj-6	206	8	can	can	AUX
gsrj-6	206	9	reliably	reliably	ADV
gsrj-6	206	10	exclude	exclude	VERB
gsrj-6	206	11	advanced	advanced	ADJ
gsrj-6	206	12	fibrosis	fibrosis	NOUN
gsrj-6	206	13	in	in	ADP
gsrj-6	206	14	patients	patient	NOUN
gsrj-6	206	15	with	with	ADP
gsrj-6	206	16	nonalcoholic	nonalcoholic	NOUN
gsrj-6	206	17	fatty	fatty	NOUN
gsrj-6	206	18	liver	liver	NOUN
gsrj-6	206	19	disease	disease	NOUN
gsrj-6	206	20	.	.	PUNCT
gsrj-6	207	1	gut	gut	VERB
gsrj-6	207	2	.	.	PUNCT
gsrj-6	207	3	;	;	PUNCT
gsrj-6	208	1	59(9):1265	59(9):1265	NUM
gsrj-6	208	2	-	-	SYM
gsrj-6	208	3	9	9	NUM
gsrj-6	208	4	17	17	NUM
gsrj-6	208	5	.	.	PUNCT
gsrj-6	209	1	klein	klein	PROPN
gsrj-6	209	2	rj	rj	PROPN
gsrj-6	209	3	sc	sc	PROPN
gsrj-6	209	4	.	.	PUNCT
gsrj-6	209	5	(	(	PUNCT
gsrj-6	209	6	2001	2001	NUM
gsrj-6	209	7	)	)	PUNCT
gsrj-6	209	8	.	.	PUNCT
gsrj-6	210	1	age	age	NOUN
gsrj-6	210	2	adjustment	adjustment	NOUN
gsrj-6	210	3	using	use	VERB
gsrj-6	210	4	the	the	DET
gsrj-6	210	5	2000	2000	NUM
gsrj-6	210	6	projected	project	VERB
gsrj-6	210	7	u.s	u.s	PROPN
gsrj-6	210	8	.	.	PROPN
gsrj-6	210	9	population	population	NOUN
gsrj-6	210	10	.	.	PUNCT
gsrj-6	211	1	healthy	healthy	ADJ
gsrj-6	211	2	people	people	NOUN
gsrj-6	211	3	statistics	statistic	NOUN
gsrj-6	211	4	notes	note	NOUN
gsrj-6	211	5	;	;	PUNCT
gsrj-6	211	6	20	20	NUM
gsrj-6	211	7	.	.	NOUN
gsrj-6	211	8	18	18	NUM
gsrj-6	211	9	.	.	PUNCT
gsrj-6	212	1	levin	levin	PROPN
gsrj-6	212	2	ml	ml	PROPN
gsrj-6	212	3	.	.	PUNCT
gsrj-6	213	1	(	(	PUNCT
gsrj-6	213	2	1953	1953	NUM
gsrj-6	213	3	)	)	PUNCT
gsrj-6	213	4	.	.	PUNCT
gsrj-6	214	1	the	the	DET
gsrj-6	214	2	occurrence	occurrence	NOUN
gsrj-6	214	3	of	of	ADP
gsrj-6	214	4	lung	lung	NOUN
gsrj-6	214	5	cancer	cancer	NOUN
gsrj-6	214	6	in	in	ADP
gsrj-6	214	7	man	man	NOUN
gsrj-6	214	8	.	.	PUNCT
gsrj-6	215	1	acta	acta	PROPN
gsrj-6	215	2	unio	unio	PROPN
gsrj-6	215	3	int	int	PROPN
gsrj-6	215	4	contra	contra	PROPN
gsrj-6	215	5	cancrum	cancrum	PROPN
gsrj-6	215	6	.	.	PUNCT
gsrj-6	215	7	;	;	PUNCT
gsrj-6	215	8	9(3):531	9(3):531	NUM
gsrj-6	215	9	-	-	SYM
gsrj-6	215	10	12	12	NUM
gsrj-6	215	11	.	.	PUNCT
gsrj-6	216	1	19	19	NUM
gsrj-6	216	2	.	.	PUNCT
gsrj-6	216	3	ong	ong	PROPN
gsrj-6	216	4	jp	jp	PROPN
gsrj-6	216	5	,	,	PUNCT
gsrj-6	216	6	elariny	elariny	PROPN
gsrj-6	216	7	h	h	NOUN
gsrj-6	216	8	,	,	PUNCT
gsrj-6	216	9	collantes	collante	VERB
gsrj-6	216	10	r	r	NOUN
gsrj-6	216	11	,	,	PUNCT
gsrj-6	216	12	younoszai	younoszai	NOUN
gsrj-6	216	13	a	a	PRON
gsrj-6	216	14	,	,	PUNCT
gsrj-6	216	15	chandhoke	chandhoke	NOUN
gsrj-6	216	16	v	v	ADP
gsrj-6	216	17	,	,	PUNCT
gsrj-6	216	18	reines	reines	PROPN
gsrj-6	216	19	hd	hd	PROPN
gsrj-6	216	20	,	,	PUNCT
gsrj-6	216	21	et	et	PROPN
gsrj-6	216	22	al	al	PROPN
gsrj-6	216	23	.	.	PUNCT
gsrj-6	217	1	(	(	PUNCT
gsrj-6	217	2	2005	2005	NUM
gsrj-6	217	3	)	)	PUNCT
gsrj-6	217	4	.	.	PUNCT
gsrj-6	218	1	predictors	predictor	NOUN
gsrj-6	218	2	of	of	ADP
gsrj-6	218	3	nonalcoholic	nonalcoholic	NOUN
gsrj-6	218	4	steatohepatitis	steatohepatitis	NOUN
gsrj-6	218	5	and	and	CCONJ
gsrj-6	218	6	advanced	advanced	ADJ
gsrj-6	218	7	fibrosis	fibrosis	NOUN
gsrj-6	218	8	in	in	ADP
gsrj-6	218	9	morbidly	morbidly	ADV
gsrj-6	218	10	obese	obese	ADJ
gsrj-6	218	11	patients	patient	NOUN
gsrj-6	218	12	.	.	PUNCT
gsrj-6	219	1	obes	obes	PROPN
gsrj-6	219	2	surg	surg	NOUN
gsrj-6	219	3	.	.	PUNCT
gsrj-6	220	1	;	;	PUNCT
gsrj-6	220	2	15(3):310	15(3):310	NUM
gsrj-6	220	3	-	-	SYM
gsrj-6	220	4	5	5	NUM
gsrj-6	220	5	.	.	NOUN
gsrj-6	220	6	20	20	NUM
gsrj-6	220	7	.	.	X
gsrj-6	221	1	piñero	piñero	PROPN
gsrj-6	221	2	,	,	PUNCT
gsrj-6	221	3	j.	j.	PROPN
gsrj-6	221	4	,	,	PUNCT
gsrj-6	221	5	queralt	queralt	NOUN
gsrj-6	221	6	-	-	PUNCT
gsrj-6	221	7	rosinach	rosinach	NOUN
gsrj-6	221	8	,	,	PUNCT
gsrj-6	221	9	n.	n.	NOUN
gsrj-6	221	10	,	,	PUNCT
gsrj-6	221	11	bravo	bravo	PROPN
gsrj-6	221	12	,	,	PUNCT
gsrj-6	221	13	à	à	X
gsrj-6	221	14	.	.	PROPN
gsrj-6	221	15	,	,	PUNCT
gsrj-6	221	16	deu	deu	NOUN
gsrj-6	221	17	-	-	PUNCT
gsrj-6	221	18	pons	pons	PROPN
gsrj-6	221	19	,	,	PUNCT
gsrj-6	221	20	j.	j.	PROPN
gsrj-6	221	21	,	,	PUNCT
gsrj-6	221	22	bauer	bauer	PROPN
gsrj-6	221	23	-	-	PUNCT
gsrj-6	221	24	mehren	mehren	PROPN
gsrj-6	221	25	,	,	PUNCT
gsrj-6	221	26	a.	a.	NOUN
gsrj-6	221	27	,	,	PUNCT
gsrj-6	221	28	baron	baron	NOUN
gsrj-6	221	29	,	,	PUNCT
gsrj-6	221	30	m.	m.	NOUN
gsrj-6	221	31	,	,	PUNCT
gsrj-6	221	32	sanz	sanz	PROPN
gsrj-6	221	33	,	,	PUNCT
gsrj-6	221	34	f.	f.	PROPN
gsrj-6	221	35	,	,	PUNCT
gsrj-6	221	36	&	&	CCONJ
gsrj-6	221	37	furlong	furlong	PROPN
gsrj-6	221	38	,	,	PUNCT
gsrj-6	221	39	l.	l.	PROPN
gsrj-6	221	40	i.	i.	PROPN
gsrj-6	221	41	(	(	PUNCT
gsrj-6	221	42	2015	2015	NUM
gsrj-6	221	43	)	)	PUNCT
gsrj-6	221	44	.	.	PUNCT
gsrj-6	222	1	disgenet	disgenet	NOUN
gsrj-6	222	2	:	:	PUNCT
gsrj-6	222	3	a	a	DET
gsrj-6	222	4	discovery	discovery	NOUN
gsrj-6	222	5	platform	platform	NOUN
gsrj-6	222	6	for	for	ADP
gsrj-6	222	7	the	the	DET
gsrj-6	222	8	dynamical	dynamical	ADJ
gsrj-6	222	9	exploration	exploration	NOUN
gsrj-6	222	10	of	of	ADP
gsrj-6	222	11	human	human	ADJ
gsrj-6	222	12	diseases	disease	NOUN
gsrj-6	222	13	and	and	CCONJ
gsrj-6	222	14	their	their	PRON
gsrj-6	222	15	genes	gene	NOUN
gsrj-6	222	16	.	.	PUNCT
gsrj-6	223	1	database	database	NOUN
gsrj-6	223	2	.	.	PUNCT
gsrj-6	224	1	https://doi.org/10.1093/database/bav028	https://doi.org/10.1093/database/bav028	ADJ
gsrj-6	224	2	21	21	NUM
gsrj-6	224	3	.	.	PUNCT
gsrj-6	225	1	shannon	shannon	PROPN
gsrj-6	225	2	,	,	PUNCT
gsrj-6	225	3	p.	p.	NOUN
gsrj-6	225	4	,	,	PUNCT
gsrj-6	225	5	markiel	markiel	NOUN
gsrj-6	225	6	,	,	PUNCT
gsrj-6	225	7	a.	a.	NOUN
gsrj-6	225	8	,	,	PUNCT
gsrj-6	225	9	ozier	ozier	ADV
gsrj-6	225	10	,	,	PUNCT
gsrj-6	225	11	o.	o.	INTJ
gsrj-6	225	12	,	,	PUNCT
gsrj-6	225	13	baliga	baliga	ADJ
gsrj-6	225	14	,	,	PUNCT
gsrj-6	225	15	n.	n.	PROPN
gsrj-6	225	16	s.	s.	PROPN
gsrj-6	225	17	,	,	PUNCT
gsrj-6	225	18	wang	wang	PROPN
gsrj-6	225	19	,	,	PUNCT
gsrj-6	225	20	j.	j.	PROPN
gsrj-6	225	21	t.	t.	PROPN
gsrj-6	225	22	,	,	PUNCT
gsrj-6	225	23	ramage	ramage	NOUN
gsrj-6	225	24	,	,	PUNCT
gsrj-6	225	25	d.	d.	PROPN
gsrj-6	225	26	,	,	PUNCT
gsrj-6	225	27	amin	amin	PROPN
gsrj-6	225	28	,	,	PUNCT
gsrj-6	225	29	n.	n.	NOUN
gsrj-6	225	30	,	,	PUNCT
gsrj-6	225	31	schwikowski	schwikowski	PROPN
gsrj-6	225	32	,	,	PUNCT
gsrj-6	225	33	b.	b.	PROPN
gsrj-6	225	34	,	,	PUNCT
gsrj-6	225	35	&	&	CCONJ
gsrj-6	225	36	ideker	ideker	PROPN
gsrj-6	225	37	,	,	PUNCT
gsrj-6	225	38	t.	t.	PROPN
gsrj-6	225	39	(	(	PUNCT
gsrj-6	225	40	2003	2003	NUM
gsrj-6	225	41	)	)	PUNCT
gsrj-6	225	42	.	.	PUNCT
gsrj-6	226	1	cytoscape	cytoscape	NOUN
gsrj-6	226	2	:	:	PUNCT
gsrj-6	226	3	a	a	DET
gsrj-6	226	4	software	software	NOUN
gsrj-6	226	5	environment	environment	NOUN
gsrj-6	226	6	for	for	ADP
gsrj-6	226	7	integrated	integrated	ADJ
gsrj-6	226	8	models	model	NOUN
gsrj-6	226	9	of	of	ADP
gsrj-6	226	10	biomolecular	biomolecular	ADJ
gsrj-6	226	11	interaction	interaction	NOUN
gsrj-6	226	12	networks	network	NOUN
gsrj-6	226	13	.	.	PUNCT
gsrj-6	227	1	genome	genome	NOUN
gsrj-6	227	2	research	research	NOUN
gsrj-6	227	3	.	.	PUNCT
gsrj-6	228	1	https://doi.org/10.1101/gr.1239303	https://doi.org/10.1101/gr.1239303	PROPN
gsrj-6	229	1	22	22	NUM
gsrj-6	229	2	.	.	PUNCT
gsrj-6	230	1	hassan	hassan	PROPN
gsrj-6	230	2	,	,	PUNCT
gsrj-6	230	3	m.	m.	NOUN
gsrj-6	230	4	m.	m.	NOUN
gsrj-6	230	5	,	,	PUNCT
gsrj-6	230	6	kaseb	kaseb	NOUN
gsrj-6	230	7	,	,	PUNCT
gsrj-6	230	8	a.	a.	NOUN
gsrj-6	230	9	,	,	PUNCT
gsrj-6	230	10	etzel	etzel	ADJ
gsrj-6	230	11	,	,	PUNCT
gsrj-6	230	12	c.	c.	PROPN
gsrj-6	230	13	j.	j.	PROPN
gsrj-6	230	14	,	,	PUNCT
gsrj-6	230	15	elserag	elserag	PROPN
gsrj-6	230	16	,	,	PUNCT
gsrj-6	230	17	h.	h.	PROPN
gsrj-6	230	18	,	,	PUNCT
gsrj-6	230	19	spitz	spitz	PROPN
gsrj-6	230	20	,	,	PUNCT
gsrj-6	230	21	m.	m.	PROPN
gsrj-6	230	22	r.	r.	PROPN
gsrj-6	230	23	,	,	PUNCT
gsrj-6	230	24	chang	chang	PROPN
gsrj-6	230	25	,	,	PUNCT
gsrj-6	230	26	p.	p.	PROPN
gsrj-6	230	27	,	,	PUNCT
gsrj-6	230	28	hale	hale	PROPN
gsrj-6	230	29	,	,	PUNCT
gsrj-6	230	30	k.	k.	PROPN
gsrj-6	230	31	s.	s.	PROPN
gsrj-6	230	32	,	,	PUNCT
gsrj-6	230	33	liu	liu	PROPN
gsrj-6	230	34	,	,	PUNCT
gsrj-6	230	35	m.	m.	NOUN
gsrj-6	230	36	,	,	PUNCT
gsrj-6	230	37	rashid	rashid	PROPN
gsrj-6	230	38	,	,	PUNCT
gsrj-6	230	39	a.	a.	NOUN
gsrj-6	230	40	,	,	PUNCT
gsrj-6	230	41	shama	shama	NOUN
gsrj-6	230	42	,	,	PUNCT
gsrj-6	230	43	m.	m.	NOUN
gsrj-6	230	44	,	,	PUNCT
gsrj-6	230	45	abbruzzese	abbruzzese	PROPN
gsrj-6	230	46	,	,	PUNCT
gsrj-6	230	47	j.	j.	PROPN
gsrj-6	230	48	l.	l.	PROPN
gsrj-6	230	49	,	,	PUNCT
gsrj-6	230	50	loyer	loyer	PROPN
gsrj-6	230	51	,	,	PUNCT
gsrj-6	230	52	e.	e.	PROPN
gsrj-6	230	53	m.	m.	PROPN
gsrj-6	230	54	,	,	PUNCT
gsrj-6	230	55	kaur	kaur	PROPN
gsrj-6	230	56	,	,	PUNCT
gsrj-6	230	57	h.	h.	PROPN
gsrj-6	230	58	,	,	PUNCT
gsrj-6	230	59	hassabo	hassabo	PROPN
gsrj-6	230	60	,	,	PUNCT
gsrj-6	230	61	h.	h.	PROPN
gsrj-6	230	62	m.	m.	PROPN
gsrj-6	230	63	,	,	PUNCT
gsrj-6	230	64	vauthey	vauthey	INTJ
gsrj-6	230	65	,	,	PUNCT
gsrj-6	230	66	j.	j.	PROPN
gsrj-6	230	67	n.	n.	PROPN
gsrj-6	230	68	,	,	PUNCT
gsrj-6	230	69	wray	wray	PROPN
gsrj-6	230	70	,	,	PUNCT
gsrj-6	230	71	c.	c.	PROPN
gsrj-6	230	72	j.	j.	PROPN
gsrj-6	230	73	,	,	PUNCT
gsrj-6	230	74	hassan	hassan	PROPN
gsrj-6	230	75	,	,	PUNCT
gsrj-6	230	76	b.	b.	PROPN
gsrj-6	230	77	s.	s.	PROPN
gsrj-6	230	78	,	,	PUNCT
gsrj-6	230	79	patt	patt	PROPN
gsrj-6	230	80	,	,	PUNCT
gsrj-6	230	81	y.	y.	PROPN
gsrj-6	230	82	z.	z.	PROPN
gsrj-6	230	83	,	,	PUNCT
gsrj-6	230	84	hawk	hawk	PROPN
gsrj-6	230	85	,	,	PUNCT
gsrj-6	230	86	e.	e.	PROPN
gsrj-6	230	87	,	,	PUNCT
gsrj-6	230	88	…	…	PUNCT
gsrj-6	230	89	li	li	PROPN
gsrj-6	230	90	,	,	PUNCT
gsrj-6	230	91	d.	d.	PROPN
gsrj-6	230	92	(	(	PUNCT
gsrj-6	230	93	2013	2013	NUM
gsrj-6	230	94	)	)	PUNCT
gsrj-6	230	95	.	.	PUNCT
gsrj-6	231	1	genetic	genetic	ADJ
gsrj-6	231	2	variation	variation	NOUN
gsrj-6	231	3	in	in	ADP
gsrj-6	231	4	the	the	DET
gsrj-6	231	5	pnpla3	pnpla3	NOUN
gsrj-6	231	6	gene	gene	NOUN
gsrj-6	231	7	and	and	CCONJ
gsrj-6	231	8	hepatocellular	hepatocellular	ADJ
gsrj-6	231	9	carcinoma	carcinoma	NOUN
gsrj-6	231	10	in	in	ADP
gsrj-6	231	11	usa	usa	PROPN
gsrj-6	231	12	:	:	PUNCT
gsrj-6	231	13	risk	risk	NOUN
gsrj-6	231	14	and	and	CCONJ
gsrj-6	231	15	prognosis	prognosis	NOUN
gsrj-6	231	16	prediction	prediction	NOUN
gsrj-6	231	17	.	.	PUNCT
gsrj-6	232	1	molecular	molecular	ADJ
gsrj-6	232	2	carcinogenesis	carcinogenesis	NOUN
gsrj-6	232	3	.	.	PUNCT
gsrj-6	233	1	https://doi.org/10.1002/mc.22057	https://doi.org/10.1002/mc.22057	ADV
gsrj-6	233	2	23	23	NUM
gsrj-6	233	3	.	.	PUNCT
gsrj-6	234	1	ong	ong	PROPN
gsrj-6	234	2	jp	jp	PROPN
gsrj-6	234	3	,	,	PUNCT
gsrj-6	234	4	elariny	elariny	PROPN
gsrj-6	234	5	h	h	NOUN
gsrj-6	234	6	,	,	PUNCT
gsrj-6	234	7	collantes	collante	VERB
gsrj-6	234	8	r	r	NOUN
gsrj-6	234	9	,	,	PUNCT
gsrj-6	234	10	younoszai	younoszai	NOUN
gsrj-6	234	11	a	a	PRON
gsrj-6	234	12	,	,	PUNCT
gsrj-6	234	13	chandhoke	chandhoke	NOUN
gsrj-6	234	14	v	v	ADP
gsrj-6	234	15	,	,	PUNCT
gsrj-6	234	16	reines	reines	PROPN
gsrj-6	234	17	hd	hd	PROPN
gsrj-6	234	18	,	,	PUNCT
gsrj-6	234	19	et	et	PROPN
gsrj-6	234	20	al	al	PROPN
gsrj-6	234	21	.	.	PUNCT
gsrj-6	235	1	(	(	PUNCT
gsrj-6	235	2	2005	2005	NUM
gsrj-6	235	3	)	)	PUNCT
gsrj-6	235	4	.	.	PUNCT
gsrj-6	236	1	predictors	predictor	NOUN
gsrj-6	236	2	of	of	ADP
gsrj-6	236	3	nonalcoholic	nonalcoholic	NOUN
gsrj-6	236	4	steatohepatitis	steatohepatitis	NOUN
gsrj-6	236	5	and	and	CCONJ
gsrj-6	236	6	advanced	advanced	ADJ
gsrj-6	236	7	fibrosis	fibrosis	NOUN
gsrj-6	236	8	in	in	ADP
gsrj-6	236	9	morbidly	morbidly	ADV
gsrj-6	236	10	obese	obese	ADJ
gsrj-6	236	11	patients	patient	NOUN
gsrj-6	236	12	.	.	PUNCT
gsrj-6	237	1	obes	obes	PROPN
gsrj-6	237	2	surg	surg	NOUN
gsrj-6	237	3	.	.	PUNCT
gsrj-6	238	1	;	;	PUNCT
gsrj-6	238	2	15(3):310	15(3):310	NUM
gsrj-6	238	3	-	-	SYM
gsrj-6	238	4	5	5	NUM
gsrj-6	238	5	.	.	NOUN
gsrj-6	238	6	24	24	NUM
gsrj-6	238	7	.	.	PUNCT
gsrj-6	238	8	yasui	yasui	PROPN
gsrj-6	238	9	k	k	NOUN
gsrj-6	238	10	,	,	PUNCT
gsrj-6	238	11	hashimoto	hashimoto	NOUN
gsrj-6	238	12	e	e	NOUN
gsrj-6	238	13	,	,	PUNCT
gsrj-6	238	14	komorizono	komorizono	VERB
gsrj-6	238	15	y	y	PROPN
gsrj-6	238	16	,	,	PUNCT
gsrj-6	238	17	koike	koike	PROPN
gsrj-6	238	18	k	k	PROPN
gsrj-6	238	19	,	,	PUNCT
gsrj-6	238	20	arii	arii	PROPN
gsrj-6	238	21	s	s	PROPN
gsrj-6	238	22	,	,	PUNCT
gsrj-6	238	23	imai	imai	PROPN
gsrj-6	238	24	y	y	PROPN
gsrj-6	238	25	,	,	PUNCT
gsrj-6	238	26	et	et	PROPN
gsrj-6	238	27	al	al	PROPN
gsrj-6	238	28	.	.	PUNCT
gsrj-6	239	1	(	(	PUNCT
gsrj-6	239	2	2011	2011	NUM
gsrj-6	239	3	)	)	PUNCT
gsrj-6	239	4	.	.	PUNCT
gsrj-6	240	1	characteristics	characteristic	NOUN
gsrj-6	240	2	of	of	ADP
gsrj-6	240	3	patients	patient	NOUN
gsrj-6	240	4	with	with	ADP
gsrj-6	240	5	nonalcoholic	nonalcoholic	PROPN
gsrj-6	240	6	steatohepatitis	steatohepatitis	NOUN
gsrj-6	240	7	who	who	PRON
gsrj-6	240	8	develop	develop	VERB
gsrj-6	240	9	hepatocellular	hepatocellular	ADJ
gsrj-6	240	10	carcinoma	carcinoma	NOUN
gsrj-6	240	11	.	.	PUNCT
gsrj-6	241	1	clin	clin	PROPN
gsrj-6	241	2	gastroenterol	gastroenterol	PROPN
gsrj-6	241	3	hepatol	hepatol	ADJ
gsrj-6	241	4	.	.	PUNCT
gsrj-6	241	5	;	;	PUNCT
gsrj-6	241	6	9(5):428	9(5):428	NUM
gsrj-6	241	7	-	-	SYM
gsrj-6	241	8	33	33	NUM
gsrj-6	241	9	;	;	PUNCT
gsrj-6	241	10	quiz	quiz	PROPN
gsrj-6	241	11	e50	e50	PROPN
gsrj-6	241	12	.	.	PUNCT
gsrj-6	242	1	25	25	NUM
gsrj-6	242	2	.	.	PUNCT
gsrj-6	242	3	cholankeril	cholankeril	PROPN
gsrj-6	242	4	g	g	PROPN
gsrj-6	242	5	,	,	PUNCT
gsrj-6	242	6	patel	patel	PROPN
gsrj-6	242	7	r	r	NOUN
gsrj-6	242	8	,	,	PUNCT
gsrj-6	242	9	khurana	khurana	PROPN
gsrj-6	242	10	s	s	SYM
gsrj-6	242	11	,	,	PUNCT
gsrj-6	242	12	satapathy	satapathy	ADJ
gsrj-6	242	13	sk	sk	NOUN
gsrj-6	242	14	.	.	PUNCT
gsrj-6	243	1	(	(	PUNCT
gsrj-6	243	2	2017	2017	NUM
gsrj-6	243	3	)	)	PUNCT
gsrj-6	243	4	.	.	PUNCT
gsrj-6	244	1	hepatocellular	hepatocellular	ADJ
gsrj-6	244	2	carcinoma	carcinoma	NOUN
gsrj-6	244	3	in	in	ADP
gsrj-6	244	4	nonalcoholic	nonalcoholic	PROPN
gsrj-6	244	5	steatohepatitis	steatohepatitis	PROPN
gsrj-6	244	6	:	:	PUNCT
gsrj-6	244	7	current	current	ADJ
gsrj-6	244	8	knowledge	knowledge	NOUN
gsrj-6	244	9	and	and	CCONJ
gsrj-6	244	10	implications	implication	NOUN
gsrj-6	244	11	for	for	ADP
gsrj-6	244	12	management	management	NOUN
gsrj-6	244	13	.	.	PUNCT
gsrj-6	245	1	world	world	PROPN
gsrj-6	245	2	j	j	PROPN
gsrj-6	245	3	hepatol	hepatol	ADJ
gsrj-6	245	4	.	.	PUNCT
gsrj-6	246	1	;	;	PUNCT
gsrj-6	246	2	9(11):533	9(11):533	NUM
gsrj-6	246	3	31	31	NUM
gsrj-6	246	4	georgetown	georgetown	PROPN
gsrj-6	246	5	scientific	scientific	PROPN
gsrj-6	246	6	research	research	PROPN
gsrj-6	246	7	journal	journal	PROPN
gsrj-6	246	8	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	246	9	26	26	NUM
gsrj-6	246	10	.	.	PUNCT
gsrj-6	247	1	dongiovanni	dongiovanni	PROPN
gsrj-6	247	2	p	p	PROPN
gsrj-6	247	3	,	,	PUNCT
gsrj-6	247	4	romeo	romeo	PROPN
gsrj-6	247	5	s	s	PROPN
gsrj-6	247	6	,	,	PUNCT
gsrj-6	247	7	valenti	valenti	PROPN
gsrj-6	247	8	l.	l.	PROPN
gsrj-6	247	9	(	(	PUNCT
gsrj-6	247	10	2014	2014	NUM
gsrj-6	247	11	)	)	PUNCT
gsrj-6	247	12	.	.	PUNCT
gsrj-6	248	1	hepatocellular	hepatocellular	ADJ
gsrj-6	248	2	carcinoma	carcinoma	NOUN
gsrj-6	248	3	in	in	ADP
gsrj-6	248	4	nonalcoholic	nonalcoholic	ADJ
gsrj-6	248	5	fatty	fatty	NOUN
gsrj-6	248	6	liver	liver	NOUN
gsrj-6	248	7	:	:	PUNCT
gsrj-6	248	8	role	role	NOUN
gsrj-6	248	9	of	of	ADP
gsrj-6	248	10	environmental	environmental	ADJ
gsrj-6	248	11	and	and	CCONJ
gsrj-6	248	12	genetic	genetic	ADJ
gsrj-6	248	13	factors	factor	NOUN
gsrj-6	248	14	.	.	PUNCT
gsrj-6	249	1	world	world	PROPN
gsrj-6	249	2	j	j	PROPN
gsrj-6	249	3	gastroenterol	gastroenterol	PROPN
gsrj-6	249	4	.	.	PUNCT
gsrj-6	250	1	;	;	PUNCT
gsrj-6	250	2	20(36):12945	20(36):12945	NUM
gsrj-6	250	3	-	-	SYM
gsrj-6	250	4	55	55	NUM
gsrj-6	250	5	27	27	NUM
gsrj-6	250	6	.	.	PUNCT
gsrj-6	251	1	dhanasekaran	dhanasekaran	ADJ
gsrj-6	251	2	r	r	NOUN
gsrj-6	251	3	,	,	PUNCT
gsrj-6	251	4	limaye	limaye	VERB
gsrj-6	251	5	a	a	DET
gsrj-6	251	6	,	,	PUNCT
gsrj-6	251	7	cabrera	cabrera	PROPN
gsrj-6	251	8	r.	r.	PROPN
gsrj-6	251	9	(	(	PUNCT
gsrj-6	251	10	2012	2012	NUM
gsrj-6	251	11	)	)	PUNCT
gsrj-6	251	12	.	.	PUNCT
gsrj-6	252	1	hepatocellular	hepatocellular	ADJ
gsrj-6	252	2	carcinoma	carcinoma	NOUN
gsrj-6	252	3	:	:	PUNCT
gsrj-6	252	4	current	current	ADJ
gsrj-6	252	5	trends	trend	NOUN
gsrj-6	252	6	in	in	ADP
gsrj-6	252	7	worldwide	worldwide	ADJ
gsrj-6	252	8	epidemiology	epidemiology	NOUN
gsrj-6	252	9	,	,	PUNCT
gsrj-6	252	10	risk	risk	NOUN
gsrj-6	252	11	factors	factor	NOUN
gsrj-6	252	12	,	,	PUNCT
gsrj-6	252	13	diagnosis	diagnosis	NOUN
gsrj-6	252	14	,	,	PUNCT
gsrj-6	252	15	and	and	CCONJ
gsrj-6	252	16	therapeutics	therapeutic	NOUN
gsrj-6	252	17	.	.	PUNCT
gsrj-6	253	1	hepat	hepat	PROPN
gsrj-6	253	2	med	med	PROPN
gsrj-6	253	3	.	.	PUNCT
gsrj-6	254	1	4:1937	4:1937	X
gsrj-6	254	2	.	.	PROPN
gsrj-6	255	1	28	28	NUM
gsrj-6	255	2	.	.	PUNCT
gsrj-6	256	1	tampi	tampi	PROPN
gsrj-6	256	2	rp	rp	PROPN
gsrj-6	256	3	,	,	PUNCT
gsrj-6	256	4	wong	wong	PROPN
gsrj-6	256	5	vw	vw	PROPN
gsrj-6	256	6	,	,	PUNCT
gsrj-6	256	7	wong	wong	PROPN
gsrj-6	256	8	gl	gl	PROPN
gsrj-6	256	9	,	,	PUNCT
gsrj-6	256	10	shu	shu	PROPN
gsrj-6	256	11	ss	ss	PROPN
gsrj-6	256	12	,	,	PUNCT
gsrj-6	256	13	chan	chan	PROPN
gsrj-6	256	14	hl	hl	PROPN
gsrj-6	256	15	,	,	PUNCT
gsrj-6	256	16	fung	fung	PROPN
gsrj-6	256	17	j	j	PROPN
gsrj-6	256	18	,	,	PUNCT
gsrj-6	256	19	et	et	PROPN
gsrj-6	256	20	al	al	PROPN
gsrj-6	256	21	.	.	PROPN
gsrj-6	256	22	(	(	PUNCT
gsrj-6	256	23	2020	2020	NUM
gsrj-6	256	24	)	)	PUNCT
gsrj-6	256	25	.	.	PUNCT
gsrj-6	257	1	modelling	model	VERB
gsrj-6	257	2	the	the	DET
gsrj-6	257	3	economic	economic	ADJ
gsrj-6	257	4	and	and	CCONJ
gsrj-6	257	5	clinical	clinical	ADJ
gsrj-6	257	6	burden	burden	NOUN
gsrj-6	257	7	of	of	ADP
gsrj-6	257	8	nonalcoholic	nonalcoholic	NOUN
gsrj-6	257	9	steatohepatitis	steatohepatitis	PROPN
gsrj-6	257	10	in	in	ADP
gsrj-6	257	11	east	east	PROPN
gsrj-6	257	12	asia	asia	PROPN
gsrj-6	257	13	:	:	PUNCT
gsrj-6	257	14	data	datum	NOUN
gsrj-6	257	15	from	from	ADP
gsrj-6	257	16	hong	hong	PROPN
gsrj-6	257	17	kong	kong	PROPN
gsrj-6	257	18	.	.	PUNCT
gsrj-6	258	1	hepatol	hepatol	ADJ
gsrj-6	258	2	res	re	NOUN
gsrj-6	258	3	.	.	PUNCT
gsrj-6	259	1	29	29	NUM
gsrj-6	259	2	.	.	PUNCT
gsrj-6	260	1	tian	tian	PROPN
gsrj-6	260	2	y	y	PROPN
gsrj-6	260	3	,	,	PUNCT
gsrj-6	260	4	li	li	PROPN
gsrj-6	260	5	t	t	PROPN
gsrj-6	260	6	,	,	PUNCT
gsrj-6	260	7	qi	qi	PROPN
gsrj-6	260	8	s	s	PROPN
gsrj-6	260	9	,	,	PUNCT
gsrj-6	260	10	alhourani	alhourani	PROPN
gsrj-6	260	11	h	h	NOUN
gsrj-6	260	12	,	,	PUNCT
gsrj-6	260	13	luo	luo	PROPN
gsrj-6	260	14	b	b	PROPN
gsrj-6	260	15	,	,	PUNCT
gsrj-6	260	16	chenqin	chenqin	PROPN
gsrj-6	260	17	j	j	PROPN
gsrj-6	260	18	,	,	PUNCT
gsrj-6	260	19	et	et	PROPN
gsrj-6	260	20	al	al	PROPN
gsrj-6	260	21	.	.	PROPN
gsrj-6	260	22	(	(	PUNCT
gsrj-6	260	23	2020	2020	NUM
gsrj-6	260	24	)	)	PUNCT
gsrj-6	260	25	.	.	PUNCT
gsrj-6	261	1	the	the	DET
gsrj-6	261	2	impact	impact	NOUN
gsrj-6	261	3	of	of	ADP
gsrj-6	261	4	metabolic	metabolic	NOUN
gsrj-6	261	5	syndrome	syndrome	NOUN
gsrj-6	261	6	(	(	PUNCT
gsrj-6	261	7	mets	met	NOUN
gsrj-6	261	8	)	)	PUNCT
gsrj-6	261	9	on	on	ADP
gsrj-6	261	10	surgical	surgical	ADJ
gsrj-6	261	11	outcome	outcome	NOUN
gsrj-6	261	12	for	for	ADP
gsrj-6	261	13	patients	patient	NOUN
gsrj-6	261	14	with	with	ADP
gsrj-6	261	15	mostly	mostly	ADV
gsrj-6	261	16	hbv	hbv	NOUN
gsrj-6	261	17	-	-	PUNCT
gsrj-6	261	18	related	relate	VERB
gsrj-6	261	19	hepatocellular	hepatocellular	ADJ
gsrj-6	261	20	carcinoma	carcinoma	NOUN
gsrj-6	261	21	(	(	PUNCT
gsrj-6	261	22	hcc	hcc	NOUN
gsrj-6	261	23	)	)	PUNCT
gsrj-6	261	24	underwent	underwent	NOUN
gsrj-6	261	25	hepatectomy	hepatectomy	NOUN
gsrj-6	261	26	.	.	PUNCT
gsrj-6	262	1	j	j	PROPN
gsrj-6	262	2	surg	surg	PROPN
gsrj-6	262	3	oncol	oncol	PROPN
gsrj-6	262	4	.	.	PUNCT
gsrj-6	263	1	30	30	NUM
gsrj-6	263	2	.	.	PUNCT
gsrj-6	264	1	mclaren	mclaren	PROPN
gsrj-6	264	2	l.	l.	PROPN
gsrj-6	264	3	(	(	PUNCT
gsrj-6	264	4	2007	2007	NUM
gsrj-6	264	5	)	)	PUNCT
gsrj-6	264	6	.	.	PUNCT
gsrj-6	265	1	socioeconomic	socioeconomic	ADJ
gsrj-6	265	2	status	status	NOUN
gsrj-6	265	3	and	and	CCONJ
gsrj-6	265	4	obesity	obesity	NOUN
gsrj-6	265	5	.	.	PUNCT
gsrj-6	266	1	epidemiol	epidemiol	PROPN
gsrj-6	266	2	rev	rev	PROPN
gsrj-6	266	3	.	.	PROPN
gsrj-6	266	4	;	;	PUNCT
gsrj-6	266	5	29:29	29:29	NUM
gsrj-6	266	6	-	-	SYM
gsrj-6	266	7	48	48	NUM
gsrj-6	266	8	.	.	PUNCT
gsrj-6	267	1	31	31	NUM
gsrj-6	267	2	.	.	PUNCT
gsrj-6	268	1	santoro	santoro	PROPN
gsrj-6	268	2	,	,	PUNCT
gsrj-6	268	3	n.	n.	NOUN
gsrj-6	268	4	,	,	PUNCT
gsrj-6	268	5	kursawe	kursawe	PROPN
gsrj-6	268	6	,	,	PUNCT
gsrj-6	268	7	r.	r.	PROPN
gsrj-6	268	8	,	,	PUNCT
gsrj-6	268	9	d’adamo	d’adamo	PROPN
gsrj-6	268	10	,	,	PUNCT
gsrj-6	268	11	e.	e.	PROPN
gsrj-6	268	12	,	,	PUNCT
gsrj-6	268	13	dykas	dykas	PROPN
gsrj-6	268	14	,	,	PUNCT
gsrj-6	268	15	d.	d.	PROPN
gsrj-6	268	16	j.	j.	PROPN
gsrj-6	268	17	,	,	PUNCT
gsrj-6	268	18	zhang	zhang	PROPN
gsrj-6	268	19	,	,	PUNCT
gsrj-6	268	20	c.	c.	PROPN
gsrj-6	268	21	k.	k.	PROPN
gsrj-6	268	22	,	,	PUNCT
gsrj-6	268	23	bale	bale	NOUN
gsrj-6	268	24	,	,	PUNCT
gsrj-6	268	25	a.	a.	PROPN
gsrj-6	268	26	e.	e.	PROPN
gsrj-6	268	27	,	,	PUNCT
gsrj-6	268	28	calí	calí	NOUN
gsrj-6	268	29	,	,	PUNCT
gsrj-6	268	30	a.	a.	NOUN
gsrj-6	268	31	m.	m.	NOUN
gsrj-6	268	32	,	,	PUNCT
gsrj-6	268	33	narayan	narayan	PROPN
gsrj-6	268	34	,	,	PUNCT
gsrj-6	268	35	d.	d.	PROPN
gsrj-6	268	36	,	,	PUNCT
gsrj-6	268	37	shaw	shaw	PROPN
gsrj-6	268	38	,	,	PUNCT
gsrj-6	268	39	m.	m.	NOUN
gsrj-6	268	40	m.	m.	NOUN
gsrj-6	268	41	,	,	PUNCT
gsrj-6	268	42	pierpont	pierpont	PROPN
gsrj-6	268	43	,	,	PUNCT
gsrj-6	268	44	b.	b.	PROPN
gsrj-6	268	45	,	,	PUNCT
gsrj-6	268	46	savoye	savoye	NOUN
gsrj-6	268	47	,	,	PUNCT
gsrj-6	268	48	m.	m.	NOUN
gsrj-6	268	49	,	,	PUNCT
gsrj-6	268	50	lartaud	lartaud	PROPN
gsrj-6	268	51	,	,	PUNCT
gsrj-6	268	52	d.	d.	PROPN
gsrj-6	268	53	,	,	PUNCT
gsrj-6	268	54	eldrich	eldrich	PROPN
gsrj-6	268	55	,	,	PUNCT
gsrj-6	268	56	s.	s.	PROPN
gsrj-6	268	57	,	,	PUNCT
gsrj-6	268	58	cushman	cushman	PROPN
gsrj-6	268	59	,	,	PUNCT
gsrj-6	268	60	s.	s.	PROPN
gsrj-6	268	61	w.	w.	PROPN
gsrj-6	268	62	,	,	PUNCT
gsrj-6	268	63	zhao	zhao	PROPN
gsrj-6	268	64	,	,	PUNCT
gsrj-6	268	65	h.	h.	PROPN
gsrj-6	268	66	,	,	PUNCT
gsrj-6	268	67	shulman	shulman	PROPN
gsrj-6	268	68	,	,	PUNCT
gsrj-6	268	69	g.	g.	PROPN
gsrj-6	268	70	i.	i.	PROPN
gsrj-6	268	71	,	,	PUNCT
gsrj-6	268	72	&	&	CCONJ
gsrj-6	268	73	caprio	caprio	PROPN
gsrj-6	268	74	,	,	PUNCT
gsrj-6	268	75	s.	s.	PROPN
gsrj-6	268	76	(	(	PUNCT
gsrj-6	268	77	2010	2010	NUM
gsrj-6	268	78	)	)	PUNCT
gsrj-6	268	79	.	.	PUNCT
gsrj-6	269	1	a	a	DET
gsrj-6	269	2	common	common	ADJ
gsrj-6	269	3	variant	variant	NOUN
gsrj-6	269	4	in	in	ADP
gsrj-6	269	5	the	the	DET
gsrj-6	269	6	patatin	patatin	NOUN
gsrj-6	269	7	-	-	PUNCT
gsrj-6	269	8	like	like	ADJ
gsrj-6	269	9	phospholipase	phospholipase	NOUN
gsrj-6	269	10	3	3	NUM
gsrj-6	269	11	gene	gene	NOUN
gsrj-6	269	12	(	(	PUNCT
gsrj-6	269	13	pnpla3	pnpla3	NOUN
gsrj-6	269	14	)	)	PUNCT
gsrj-6	269	15	is	be	AUX
gsrj-6	269	16	associated	associate	VERB
gsrj-6	269	17	with	with	ADP
gsrj-6	269	18	fatty	fatty	NOUN
gsrj-6	269	19	liver	liver	NOUN
gsrj-6	269	20	disease	disease	NOUN
gsrj-6	269	21	in	in	ADP
gsrj-6	269	22	obese	obese	ADJ
gsrj-6	269	23	children	child	NOUN
gsrj-6	269	24	and	and	CCONJ
gsrj-6	269	25	adolescents	adolescent	NOUN
gsrj-6	269	26	.	.	PUNCT
gsrj-6	270	1	hepatology	hepatology	NOUN
gsrj-6	270	2	(	(	PUNCT
gsrj-6	270	3	baltimore	baltimore	PROPN
gsrj-6	270	4	,	,	PUNCT
gsrj-6	270	5	md	md	PROPN
gsrj-6	270	6	.	.	PUNCT
gsrj-6	270	7	)	)	PUNCT
gsrj-6	270	8	.	.	PUNCT
gsrj-6	271	1	https://doi.org/10.1002/hep.23832	https://doi.org/10.1002/hep.23832	PROPN
gsrj-6	271	2	32	32	NUM
gsrj-6	271	3	.	.	PUNCT
gsrj-6	272	1	romeo	romeo	PROPN
gsrj-6	272	2	s	s	PROPN
gsrj-6	272	3	,	,	PUNCT
gsrj-6	272	4	kozlitina	kozlitina	PROPN
gsrj-6	272	5	j	j	PROPN
gsrj-6	272	6	,	,	PUNCT
gsrj-6	272	7	xing	xing	PROPN
gsrj-6	272	8	c	c	PROPN
gsrj-6	272	9	,	,	PUNCT
gsrj-6	272	10	pertsemlidis	pertsemlidis	NOUN
gsrj-6	272	11	a	a	PRON
gsrj-6	272	12	,	,	PUNCT
gsrj-6	272	13	cox	cox	PROPN
gsrj-6	272	14	d	d	PROPN
gsrj-6	272	15	,	,	PUNCT
gsrj-6	272	16	pennacchio	pennacchio	PROPN
gsrj-6	272	17	la	la	PROPN
gsrj-6	272	18	,	,	PUNCT
gsrj-6	272	19	et	et	PROPN
gsrj-6	272	20	al	al	PROPN
gsrj-6	272	21	.	.	PUNCT
gsrj-6	273	1	(	(	PUNCT
gsrj-6	273	2	2008	2008	NUM
gsrj-6	273	3	)	)	PUNCT
gsrj-6	273	4	.	.	PUNCT
gsrj-6	274	1	genetic	genetic	ADJ
gsrj-6	274	2	variation	variation	NOUN
gsrj-6	274	3	in	in	ADP
gsrj-6	274	4	pnpla3	pnpla3	NOUN
gsrj-6	274	5	confers	confer	NOUN
gsrj-6	274	6	susceptibility	susceptibility	NOUN
gsrj-6	274	7	to	to	ADP
gsrj-6	274	8	nonalcoholic	nonalcoholic	NOUN
gsrj-6	274	9	fatty	fatty	NOUN
gsrj-6	274	10	liver	liver	NOUN
gsrj-6	274	11	disease	disease	NOUN
gsrj-6	274	12	.	.	PUNCT
gsrj-6	275	1	nat	nat	PROPN
gsrj-6	275	2	genet	genet	PROPN
gsrj-6	275	3	.	.	PUNCT
gsrj-6	276	1	40(12):1461	40(12):1461	X
gsrj-6	276	2	-	-	SYM
gsrj-6	276	3	5	5	NUM
gsrj-6	276	4	.	.	NOUN
gsrj-6	276	5	33	33	NUM
gsrj-6	276	6	.	.	PUNCT
gsrj-6	276	7	goran	goran	PROPN
gsrj-6	276	8	mi	mi	PROPN
gsrj-6	276	9	,	,	PUNCT
gsrj-6	276	10	walker	walker	PROPN
gsrj-6	276	11	r	r	PROPN
gsrj-6	276	12	,	,	PUNCT
gsrj-6	276	13	le	le	X
gsrj-6	276	14	ka	ka	PROPN
gsrj-6	276	15	,	,	PUNCT
gsrj-6	276	16	mahurkar	mahurkar	PROPN
gsrj-6	276	17	s	s	PROPN
gsrj-6	276	18	,	,	PUNCT
gsrj-6	276	19	vikman	vikman	NOUN
gsrj-6	276	20	s	s	PROPN
gsrj-6	276	21	,	,	PUNCT
gsrj-6	276	22	davis	davis	PROPN
gsrj-6	276	23	jn	jn	PROPN
gsrj-6	276	24	,	,	PUNCT
gsrj-6	276	25	et	et	PROPN
gsrj-6	276	26	al	al	PROPN
gsrj-6	276	27	.	.	PUNCT
gsrj-6	277	1	(	(	PUNCT
gsrj-6	277	2	2010	2010	NUM
gsrj-6	277	3	)	)	PUNCT
gsrj-6	277	4	.	.	PUNCT
gsrj-6	278	1	effects	effect	NOUN
gsrj-6	278	2	of	of	ADP
gsrj-6	278	3	pnpla3	pnpla3	NOUN
gsrj-6	278	4	on	on	ADP
gsrj-6	278	5	liver	liver	NOUN
gsrj-6	278	6	fat	fat	NOUN
gsrj-6	278	7	and	and	CCONJ
gsrj-6	278	8	metabolic	metabolic	NOUN
gsrj-6	278	9	profile	profile	NOUN
gsrj-6	278	10	in	in	ADP
gsrj-6	278	11	hispanic	hispanic	ADJ
gsrj-6	278	12	children	child	NOUN
gsrj-6	278	13	and	and	CCONJ
gsrj-6	278	14	adolescents	adolescent	NOUN
gsrj-6	278	15	.	.	PUNCT
gsrj-6	279	1	diabetes	diabetes	NOUN
gsrj-6	279	2	.	.	PUNCT
gsrj-6	280	1	;	;	PUNCT
gsrj-6	281	1	59(12):3127	59(12):3127	NUM
gsrj-6	281	2	-	-	SYM
gsrj-6	281	3	30	30	NUM
gsrj-6	281	4	.	.	PUNCT
gsrj-6	282	1	34	34	NUM
gsrj-6	282	2	.	.	PUNCT
gsrj-6	283	1	martinez	martinez	PROPN
gsrj-6	283	2	la	la	PROPN
gsrj-6	283	3	,	,	PUNCT
gsrj-6	283	4	larrieta	larrieta	PROPN
gsrj-6	283	5	e	e	NOUN
gsrj-6	283	6	,	,	PUNCT
gsrj-6	283	7	kershenobich	kershenobich	PROPN
gsrj-6	283	8	d	d	PROPN
gsrj-6	283	9	,	,	PUNCT
gsrj-6	283	10	torre	torre	PROPN
gsrj-6	283	11	a.	a.	NOUN
gsrj-6	283	12	(	(	PUNCT
gsrj-6	283	13	2017	2017	NUM
gsrj-6	283	14	)	)	PUNCT
gsrj-6	283	15	.	.	PUNCT
gsrj-6	284	1	the	the	DET
gsrj-6	284	2	expression	expression	NOUN
gsrj-6	284	3	of	of	ADP
gsrj-6	284	4	pnpla3	pnpla3	NOUN
gsrj-6	284	5	polymorphism	polymorphism	NOUN
gsrj-6	284	6	could	could	AUX
gsrj-6	284	7	be	be	AUX
gsrj-6	284	8	the	the	DET
gsrj-6	284	9	key	key	NOUN
gsrj-6	284	10	for	for	ADP
gsrj-6	284	11	severe	severe	ADJ
gsrj-6	284	12	liver	liver	NOUN
gsrj-6	284	13	disease	disease	NOUN
gsrj-6	284	14	in	in	ADP
gsrj-6	284	15	nafld	nafld	ADJ
gsrj-6	284	16	in	in	ADP
gsrj-6	284	17	hispanic	hispanic	ADJ
gsrj-6	284	18	population	population	NOUN
gsrj-6	284	19	.	.	PUNCT
gsrj-6	285	1	ann	ann	PROPN
gsrj-6	285	2	hepatol	hepatol	PROPN
gsrj-6	285	3	.	.	PUNCT
gsrj-6	286	1	;	;	PUNCT
gsrj-6	286	2	16(6):909	16(6):909	NUM
gsrj-6	286	3	-	-	SYM
gsrj-6	286	4	15	15	NUM
gsrj-6	286	5	.	.	NOUN
gsrj-6	286	6	35	35	NUM
gsrj-6	286	7	.	.	PUNCT
gsrj-6	286	8	altekruse	altekruse	VERB
gsrj-6	286	9	sf	sf	PROPN
gsrj-6	286	10	,	,	PUNCT
gsrj-6	286	11	mcglynn	mcglynn	PROPN
gsrj-6	286	12	ka	ka	PROPN
gsrj-6	286	13	,	,	PUNCT
gsrj-6	286	14	reichman	reichman	NOUN
gsrj-6	286	15	me	i	PRON
gsrj-6	286	16	.	.	PUNCT
gsrj-6	287	1	(	(	PUNCT
gsrj-6	287	2	2009	2009	NUM
gsrj-6	287	3	)	)	PUNCT
gsrj-6	287	4	.	.	PUNCT
gsrj-6	288	1	hepatocellular	hepatocellular	ADJ
gsrj-6	288	2	carcinoma	carcinoma	NOUN
gsrj-6	288	3	incidence	incidence	NOUN
gsrj-6	288	4	,	,	PUNCT
gsrj-6	288	5	mortality	mortality	NOUN
gsrj-6	288	6	,	,	PUNCT
gsrj-6	288	7	and	and	CCONJ
gsrj-6	288	8	survival	survival	NOUN
gsrj-6	288	9	trends	trend	NOUN
gsrj-6	288	10	in	in	ADP
gsrj-6	288	11	the	the	DET
gsrj-6	288	12	united	united	PROPN
gsrj-6	288	13	states	states	PROPN
gsrj-6	288	14	from	from	ADP
gsrj-6	288	15	1975	1975	NUM
gsrj-6	288	16	to	to	ADP
gsrj-6	288	17	2005	2005	NUM
gsrj-6	288	18	.	.	PUNCT
gsrj-6	289	1	j	j	PROPN
gsrj-6	289	2	clin	clin	PROPN
gsrj-6	289	3	oncol	oncol	PROPN
gsrj-6	289	4	.	.	PUNCT
gsrj-6	289	5	;	;	PUNCT
gsrj-6	290	1	27(9):1485	27(9):1485	NUM
gsrj-6	290	2	-	-	SYM
gsrj-6	290	3	91	91	NUM
gsrj-6	290	4	.	.	PUNCT
gsrj-6	291	1	36	36	NUM
gsrj-6	291	2	.	.	PUNCT
gsrj-6	292	1	ott	ott	PROPN
gsrj-6	292	2	jj	jj	PROPN
gsrj-6	292	3	,	,	PUNCT
gsrj-6	292	4	stevens	stevens	PROPN
gsrj-6	292	5	ga	ga	PROPN
gsrj-6	292	6	,	,	PUNCT
gsrj-6	292	7	groeger	groeger	PROPN
gsrj-6	292	8	j	j	PROPN
gsrj-6	292	9	,	,	PUNCT
gsrj-6	292	10	wiersma	wiersma	PROPN
gsrj-6	292	11	st	st	PROPN
gsrj-6	292	12	.	.	PROPN
gsrj-6	292	13	(	(	PUNCT
gsrj-6	292	14	2012	2012	NUM
gsrj-6	292	15	)	)	PUNCT
gsrj-6	292	16	.	.	PUNCT
gsrj-6	293	1	global	global	ADJ
gsrj-6	293	2	epidemiology	epidemiology	NOUN
gsrj-6	293	3	of	of	ADP
gsrj-6	293	4	hepatitis	hepatitis	PROPN
gsrj-6	293	5	b	b	PROPN
gsrj-6	293	6	virus	virus	NOUN
gsrj-6	293	7	infection	infection	NOUN
gsrj-6	293	8	:	:	PUNCT
gsrj-6	293	9	new	new	ADJ
gsrj-6	293	10	estimates	estimate	NOUN
gsrj-6	293	11	of	of	ADP
gsrj-6	293	12	age	age	NOUN
gsrj-6	293	13	-	-	PUNCT
gsrj-6	293	14	specific	specific	ADJ
gsrj-6	293	15	hbsag	hbsag	ADJ
gsrj-6	293	16	seroprevalence	seroprevalence	NOUN
gsrj-6	293	17	and	and	CCONJ
gsrj-6	293	18	endemicity	endemicity	NOUN
gsrj-6	293	19	.	.	PUNCT
gsrj-6	294	1	vaccine	vaccine	NOUN
gsrj-6	294	2	.	.	PUNCT
gsrj-6	295	1	;	;	PUNCT
gsrj-6	295	2	30(12):2212	30(12):2212	NUM
gsrj-6	295	3	-	-	SYM
gsrj-6	295	4	9	9	NUM
gsrj-6	295	5	.	.	NOUN
gsrj-6	295	6	37	37	NUM
gsrj-6	295	7	.	.	PUNCT
gsrj-6	296	1	degos	degos	PROPN
gsrj-6	296	2	f	f	PROPN
gsrj-6	296	3	,	,	PUNCT
gsrj-6	296	4	christidis	christidis	PROPN
gsrj-6	296	5	c	c	NOUN
gsrj-6	296	6	,	,	PUNCT
gsrj-6	296	7	ganne	ganne	NOUN
gsrj-6	296	8	-	-	PUNCT
gsrj-6	296	9	carrie	carrie	PROPN
gsrj-6	296	10	n	n	CCONJ
gsrj-6	296	11	,	,	PUNCT
gsrj-6	296	12	farmachidi	farmachidi	PROPN
gsrj-6	296	13	jp	jp	PROPN
gsrj-6	296	14	,	,	PUNCT
gsrj-6	296	15	degott	degott	NOUN
gsrj-6	296	16	c	c	NOUN
gsrj-6	296	17	,	,	PUNCT
gsrj-6	296	18	guettier	guettier	NOUN
gsrj-6	296	19	c	c	NOUN
gsrj-6	296	20	,	,	PUNCT
gsrj-6	296	21	et	et	PROPN
gsrj-6	296	22	al	al	PROPN
gsrj-6	296	23	.	.	PUNCT
gsrj-6	296	24	(	(	PUNCT
gsrj-6	296	25	2000	2000	NUM
gsrj-6	296	26	)	)	PUNCT
gsrj-6	296	27	.	.	PUNCT
gsrj-6	297	1	hepatitis	hepatitis	PROPN
gsrj-6	297	2	c	c	PROPN
gsrj-6	297	3	virus	virus	NOUN
gsrj-6	297	4	related	relate	VERB
gsrj-6	297	5	cirrhosis	cirrhosis	NOUN
gsrj-6	297	6	:	:	PUNCT
gsrj-6	297	7	time	time	NOUN
gsrj-6	297	8	to	to	ADP
gsrj-6	297	9	occurrence	occurrence	NOUN
gsrj-6	297	10	of	of	ADP
gsrj-6	297	11	hepatocellular	hepatocellular	ADJ
gsrj-6	297	12	carcinoma	carcinoma	NOUN
gsrj-6	297	13	and	and	CCONJ
gsrj-6	297	14	death	death	NOUN
gsrj-6	297	15	.	.	PUNCT
gsrj-6	298	1	gut	gut	VERB
gsrj-6	298	2	.	.	PUNCT
gsrj-6	298	3	;	;	PUNCT
gsrj-6	299	1	47(1):131	47(1):131	PROPN
gsrj-6	299	2	-	-	SYM
gsrj-6	299	3	6	6	NUM
gsrj-6	299	4	.	.	NOUN
gsrj-6	299	5	38	38	NUM
gsrj-6	299	6	.	.	PUNCT
gsrj-6	300	1	rosenberg	rosenberg	PROPN
gsrj-6	300	2	es	es	PROPN
gsrj-6	300	3	,	,	PUNCT
gsrj-6	300	4	rosenthal	rosenthal	PROPN
gsrj-6	300	5	em	em	PRON
gsrj-6	300	6	,	,	PUNCT
gsrj-6	300	7	hall	hall	PROPN
gsrj-6	300	8	ew	ew	PROPN
gsrj-6	300	9	,	,	PUNCT
gsrj-6	300	10	barker	barker	PROPN
gsrj-6	300	11	l	l	PROPN
gsrj-6	300	12	,	,	PUNCT
gsrj-6	300	13	hofmeister	hofmeister	PROPN
gsrj-6	300	14	mg	mg	PROPN
gsrj-6	300	15	,	,	PUNCT
gsrj-6	300	16	sullivan	sullivan	PROPN
gsrj-6	300	17	ps	ps	PROPN
gsrj-6	300	18	,	,	PUNCT
gsrj-6	300	19	et	et	PROPN
gsrj-6	300	20	al	al	PROPN
gsrj-6	300	21	.	.	PUNCT
gsrj-6	301	1	prevalence	prevalence	NOUN
gsrj-6	301	2	of	of	ADP
gsrj-6	301	3	hepatitis	hepatitis	PROPN
gsrj-6	301	4	c	c	PROPN
gsrj-6	301	5	virus	virus	NOUN
gsrj-6	301	6	infection	infection	NOUN
gsrj-6	301	7	in	in	ADP
gsrj-6	301	8	us	us	PROPN
gsrj-6	301	9	states	state	NOUN
gsrj-6	301	10	and	and	CCONJ
gsrj-6	301	11	the	the	DET
gsrj-6	301	12	district	district	NOUN
gsrj-6	301	13	of	of	ADP
gsrj-6	301	14	columbia	columbia	PROPN
gsrj-6	301	15	,	,	PUNCT
gsrj-6	301	16	2013	2013	NUM
gsrj-6	301	17	to	to	ADP
gsrj-6	301	18	2016	2016	NUM
gsrj-6	301	19	.	.	PUNCT
gsrj-6	302	1	(	(	PUNCT
gsrj-6	302	2	2018	2018	NUM
gsrj-6	302	3	)	)	PUNCT
gsrj-6	302	4	.	.	PUNCT
gsrj-6	303	1	jama	jama	PROPN
gsrj-6	303	2	netw	netw	PROPN
gsrj-6	303	3	open.;1(8):e186371	open.;1(8):e186371	PROPN
gsrj-6	303	4	.	.	PUNCT
gsrj-6	304	1	39	39	NUM
gsrj-6	304	2	.	.	PUNCT
gsrj-6	305	1	denniston	denniston	PROPN
gsrj-6	305	2	mm	mm	PROPN
gsrj-6	305	3	,	,	PUNCT
gsrj-6	305	4	jiles	jiles	PROPN
gsrj-6	305	5	rb	rb	PROPN
gsrj-6	305	6	,	,	PUNCT
gsrj-6	305	7	drobeniuc	drobeniuc	PROPN
gsrj-6	305	8	j	j	PROPN
gsrj-6	305	9	,	,	PUNCT
gsrj-6	305	10	klevens	klevens	PROPN
gsrj-6	305	11	rm	rm	PROPN
gsrj-6	305	12	,	,	PUNCT
gsrj-6	305	13	ward	ward	PROPN
gsrj-6	305	14	jw	jw	PROPN
gsrj-6	305	15	,	,	PUNCT
gsrj-6	305	16	mcquillan	mcquillan	PROPN
gsrj-6	305	17	gm	gm	PROPN
gsrj-6	305	18	,	,	PUNCT
gsrj-6	305	19	et	et	PROPN
gsrj-6	305	20	al	al	PROPN
gsrj-6	305	21	.	.	PUNCT
gsrj-6	306	1	(	(	PUNCT
gsrj-6	306	2	2014	2014	NUM
gsrj-6	306	3	)	)	PUNCT
gsrj-6	306	4	.	.	PUNCT
gsrj-6	307	1	chronic	chronic	ADJ
gsrj-6	307	2	hepatitis	hepatitis	PROPN
gsrj-6	307	3	c	c	PROPN
gsrj-6	307	4	virus	virus	NOUN
gsrj-6	307	5	infection	infection	NOUN
gsrj-6	307	6	in	in	ADP
gsrj-6	307	7	the	the	DET
gsrj-6	307	8	united	united	PROPN
gsrj-6	307	9	states	states	PROPN
gsrj-6	307	10	,	,	PUNCT
gsrj-6	307	11	national	national	ADJ
gsrj-6	307	12	health	health	NOUN
gsrj-6	307	13	and	and	CCONJ
gsrj-6	307	14	nutrition	nutrition	NOUN
gsrj-6	307	15	examination	examination	NOUN
gsrj-6	307	16	survey	survey	NOUN
gsrj-6	307	17	2003	2003	NUM
gsrj-6	307	18	to	to	ADP
gsrj-6	307	19	2010	2010	NUM
gsrj-6	307	20	.	.	PUNCT
gsrj-6	308	1	ann	ann	PROPN
gsrj-6	308	2	intern	intern	PROPN
gsrj-6	308	3	med	me	VERB
gsrj-6	308	4	.	.	PUNCT
gsrj-6	308	5	;	;	PUNCT
gsrj-6	309	1	160(5):293	160(5):293	NUM
gsrj-6	309	2	-	-	SYM
gsrj-6	309	3	300	300	NUM
gsrj-6	309	4	.	.	NUM
gsrj-6	309	5	40	40	NUM
gsrj-6	309	6	.	.	PUNCT
gsrj-6	310	1	harris	harris	PROPN
gsrj-6	310	2	am	be	AUX
gsrj-6	310	3	,	,	PUNCT
gsrj-6	310	4	iqbal	iqbal	PROPN
gsrj-6	310	5	k	k	PROPN
gsrj-6	310	6	,	,	PUNCT
gsrj-6	310	7	schillie	schillie	PROPN
gsrj-6	310	8	s	s	PROPN
gsrj-6	310	9	,	,	PUNCT
gsrj-6	310	10	britton	britton	PROPN
gsrj-6	310	11	j	j	PROPN
gsrj-6	310	12	,	,	PUNCT
gsrj-6	310	13	kainer	kainer	PROPN
gsrj-6	310	14	ma	ma	PROPN
gsrj-6	310	15	,	,	PUNCT
gsrj-6	310	16	tressler	tressler	NOUN
gsrj-6	310	17	s	s	PROPN
gsrj-6	310	18	,	,	PUNCT
gsrj-6	310	19	et	et	PROPN
gsrj-6	310	20	al	al	PROPN
gsrj-6	310	21	.	.	PROPN
gsrj-6	310	22	increases	increase	NOUN
gsrj-6	310	23	in	in	ADP
gsrj-6	310	24	acute	acute	ADJ
gsrj-6	310	25	hepatitis	hepatitis	PROPN
gsrj-6	310	26	b	b	PROPN
gsrj-6	310	27	virus	virus	NOUN
gsrj-6	310	28	infections	infection	NOUN
gsrj-6	310	29	kentucky	kentucky	PROPN
gsrj-6	310	30	,	,	PUNCT
gsrj-6	310	31	tennessee	tennessee	PROPN
gsrj-6	310	32	,	,	PUNCT
gsrj-6	310	33	and	and	CCONJ
gsrj-6	310	34	west	west	PROPN
gsrj-6	310	35	virginia	virginia	PROPN
gsrj-6	310	36	,	,	PUNCT
gsrj-6	310	37	2006	2006	NUM
gsrj-6	310	38	-	-	SYM
gsrj-6	310	39	2013	2013	NUM
gsrj-6	310	40	.	.	PUNCT
gsrj-6	311	1	(	(	PUNCT
gsrj-6	311	2	2016	2016	NUM
gsrj-6	311	3	)	)	PUNCT
gsrj-6	311	4	.	.	PUNCT
gsrj-6	312	1	mmwr	mmwr	ADJ
gsrj-6	312	2	morb	morb	NOUN
gsrj-6	312	3	mortal	mortal	ADJ
gsrj-6	312	4	wkly	wkly	PROPN
gsrj-6	312	5	rep	rep	PROPN
gsrj-6	312	6	.	.	PROPN
gsrj-6	312	7	;	;	PUNCT
gsrj-6	312	8	65(3):47	65(3):47	PROPN
gsrj-6	312	9	-	-	SYM
gsrj-6	312	10	50	50	NUM
gsrj-6	312	11	.	.	PUNCT
gsrj-6	312	12	41	41	NUM
gsrj-6	312	13	.	.	PUNCT
gsrj-6	313	1	pham	pham	PROPN
gsrj-6	313	2	c	c	PROPN
gsrj-6	313	3	,	,	PUNCT
gsrj-6	313	4	fong	fong	PROPN
gsrj-6	313	5	tl	tl	PROPN
gsrj-6	313	6	,	,	PUNCT
gsrj-6	313	7	zhang	zhang	PROPN
gsrj-6	313	8	j	j	PROPN
gsrj-6	313	9	,	,	PUNCT
gsrj-6	313	10	liu	liu	PROPN
gsrj-6	313	11	l.	l.	PROPN
gsrj-6	313	12	striking	strike	VERB
gsrj-6	313	13	racial	racial	ADJ
gsrj-6	313	14	/	/	SYM
gsrj-6	313	15	ethnic	ethnic	ADJ
gsrj-6	313	16	disparities	disparity	NOUN
gsrj-6	313	17	in	in	ADP
gsrj-6	313	18	liver	liver	NOUN
gsrj-6	313	19	cancer	cancer	NOUN
gsrj-6	313	20	32	32	NUM
gsrj-6	313	21	georgetown	georgetown	PROPN
gsrj-6	313	22	scientific	scientific	PROPN
gsrj-6	313	23	research	research	PROPN
gsrj-6	313	24	journal	journal	PROPN
gsrj-6	313	25	https://doi.org/10.48091/lkml8578	https://doi.org/10.48091/lkml8578	PROPN
gsrj-6	313	26	incidence	incidence	NOUN
gsrj-6	313	27	rates	rate	NOUN
gsrj-6	313	28	and	and	CCONJ
gsrj-6	313	29	temporal	temporal	ADJ
gsrj-6	313	30	trends	trend	NOUN
gsrj-6	313	31	in	in	ADP
gsrj-6	313	32	california	california	PROPN
gsrj-6	313	33	,	,	PUNCT
gsrj-6	313	34	1988	1988	NUM
gsrj-6	313	35	-	-	SYM
gsrj-6	313	36	2012	2012	NUM
gsrj-6	313	37	.	.	PUNCT
gsrj-6	314	1	(	(	PUNCT
gsrj-6	314	2	2018	2018	NUM
gsrj-6	314	3	)	)	PUNCT
gsrj-6	314	4	.	.	PUNCT
gsrj-6	315	1	j	j	PROPN
gsrj-6	315	2	natl	natl	PROPN
gsrj-6	315	3	cancer	cancer	PROPN
gsrj-6	315	4	inst	inst	PROPN
gsrj-6	315	5	.	.	PUNCT
gsrj-6	315	6	;	;	PUNCT
gsrj-6	316	1	110(11):1259	110(11):1259	X
gsrj-6	316	2	-	-	SYM
gsrj-6	316	3	69	69	NUM
gsrj-6	316	4	.	.	PUNCT
gsrj-6	317	1	42	42	NUM
gsrj-6	317	2	.	.	PUNCT
gsrj-6	317	3	le	le	PROPN
gsrj-6	317	4	mh	mh	PROPN
gsrj-6	317	5	,	,	PUNCT
gsrj-6	317	6	yeo	yeo	PROPN
gsrj-6	317	7	yh	yh	PROPN
gsrj-6	317	8	,	,	PUNCT
gsrj-6	317	9	cheung	cheung	PROPN
gsrj-6	317	10	r	r	PROPN
gsrj-6	317	11	,	,	PUNCT
gsrj-6	317	12	henry	henry	PROPN
gsrj-6	317	13	l	l	PROPN
gsrj-6	317	14	,	,	PUNCT
gsrj-6	317	15	lok	lok	PROPN
gsrj-6	317	16	as	as	ADP
gsrj-6	317	17	,	,	PUNCT
gsrj-6	317	18	nguyen	nguyen	PROPN
gsrj-6	317	19	mh	mh	PROPN
gsrj-6	317	20	.	.	PUNCT
gsrj-6	317	21	(	(	PUNCT
gsrj-6	317	22	2020	2020	NUM
gsrj-6	317	23	)	)	PUNCT
gsrj-6	317	24	.	.	PUNCT
gsrj-6	318	1	chronic	chronic	ADJ
gsrj-6	318	2	hepatitis	hepatitis	PROPN
gsrj-6	318	3	b	b	PROPN
gsrj-6	318	4	prevalence	prevalence	NOUN
gsrj-6	318	5	among	among	ADP
gsrj-6	318	6	foreign	foreign	NOUN
gsrj-6	318	7	-	-	PUNCT
gsrj-6	318	8	born	bear	VERB
gsrj-6	318	9	and	and	CCONJ
gsrj-6	318	10	u.s.born	u.s.born	ADJ
gsrj-6	318	11	adults	adult	NOUN
gsrj-6	318	12	in	in	ADP
gsrj-6	318	13	the	the	DET
gsrj-6	318	14	united	united	PROPN
gsrj-6	318	15	states	states	PROPN
gsrj-6	318	16	,	,	PUNCT
gsrj-6	318	17	1999	1999	NUM
gsrj-6	318	18	-	-	SYM
gsrj-6	318	19	2016	2016	NUM
gsrj-6	318	20	.	.	PUNCT
gsrj-6	319	1	hepatology	hepatology	NOUN
gsrj-6	319	2	.	.	PUNCT
gsrj-6	320	1	;	;	PUNCT
gsrj-6	321	1	71(2):431	71(2):431	NUM
gsrj-6	321	2	-	-	SYM
gsrj-6	321	3	43	43	NUM
gsrj-6	321	4	.	.	PUNCT
gsrj-6	322	1	43	43	NUM
gsrj-6	322	2	.	.	PUNCT
gsrj-6	323	1	bugianesi	bugianesi	PROPN
gsrj-6	323	2	e.	e.	PROPN
gsrj-6	323	3	(	(	PUNCT
gsrj-6	323	4	2005	2005	NUM
gsrj-6	323	5	)	)	PUNCT
gsrj-6	323	6	.	.	PUNCT
gsrj-6	324	1	review	review	NOUN
gsrj-6	324	2	article	article	NOUN
gsrj-6	324	3	:	:	PUNCT
gsrj-6	324	4	steatosis	steatosis	NOUN
gsrj-6	324	5	,	,	PUNCT
gsrj-6	324	6	the	the	DET
gsrj-6	324	7	metabolic	metabolic	NOUN
gsrj-6	324	8	syndrome	syndrome	NOUN
gsrj-6	324	9	and	and	CCONJ
gsrj-6	324	10	cancer	cancer	NOUN
gsrj-6	324	11	.	.	PUNCT
gsrj-6	325	1	aliment	aliment	NOUN
gsrj-6	325	2	pharmacol	pharmacol	VERB
gsrj-6	325	3	ther	ther	ADV
gsrj-6	325	4	.	.	PUNCT
gsrj-6	326	1	;	;	PUNCT
gsrj-6	327	1	22	22	NUM
gsrj-6	327	2	suppl	suppl	ADJ
gsrj-6	327	3	2:40	2:40	NUM
gsrj-6	327	4	-	-	SYM
gsrj-6	327	5	3	3	NUM
gsrj-6	327	6	.	.	NUM
gsrj-6	327	7	44	44	NUM
gsrj-6	327	8	.	.	PUNCT
gsrj-6	327	9	bugianesi	bugianesi	PROPN
gsrj-6	327	10	e	e	PROPN
gsrj-6	327	11	,	,	PUNCT
gsrj-6	327	12	leone	leone	PROPN
gsrj-6	327	13	n	n	CCONJ
gsrj-6	327	14	,	,	PUNCT
gsrj-6	327	15	vanni	vanni	PROPN
gsrj-6	327	16	e	e	PROPN
gsrj-6	327	17	,	,	PUNCT
gsrj-6	327	18	marchesini	marchesini	NOUN
gsrj-6	327	19	g	g	NOUN
gsrj-6	327	20	,	,	PUNCT
gsrj-6	327	21	brunello	brunello	PROPN
gsrj-6	327	22	f	f	PROPN
gsrj-6	327	23	,	,	PUNCT
gsrj-6	327	24	carucci	carucci	NOUN
gsrj-6	327	25	p	p	NOUN
gsrj-6	327	26	,	,	PUNCT
gsrj-6	327	27	et	et	PROPN
gsrj-6	327	28	al	al	PROPN
gsrj-6	327	29	.	.	PUNCT
gsrj-6	327	30	(	(	PUNCT
gsrj-6	327	31	2002	2002	NUM
gsrj-6	327	32	)	)	PUNCT
gsrj-6	327	33	.	.	PUNCT
gsrj-6	328	1	expanding	expand	VERB
gsrj-6	328	2	the	the	DET
gsrj-6	328	3	natural	natural	ADJ
gsrj-6	328	4	history	history	NOUN
gsrj-6	328	5	of	of	ADP
gsrj-6	328	6	nonalcoholic	nonalcoholic	PROPN
gsrj-6	328	7	steatohepatitis	steatohepatitis	PROPN
gsrj-6	328	8	:	:	PUNCT
gsrj-6	328	9	from	from	ADP
gsrj-6	328	10	cryptogenic	cryptogenic	ADJ
gsrj-6	328	11	cirrhosis	cirrhosis	NOUN
gsrj-6	328	12	to	to	ADP
gsrj-6	328	13	hepatocellular	hepatocellular	ADJ
gsrj-6	328	14	carcinoma	carcinoma	NOUN
gsrj-6	328	15	.	.	PUNCT
gsrj-6	329	1	gastroenterology.;123(1):134	gastroenterology.;123(1):134	PROPN
gsrj-6	329	2	-	-	SYM
gsrj-6	329	3	40	40	NUM
gsrj-6	329	4	.	.	PUNCT
gsrj-6	330	1	45	45	NUM
gsrj-6	330	2	.	.	PUNCT
gsrj-6	330	3	brumback	brumback	VERB
gsrj-6	330	4	b	b	PROPN
gsrj-6	330	5	,	,	PUNCT
gsrj-6	330	6	berg	berg	PROPN
gsrj-6	330	7	a.	a.	PROPN
gsrj-6	330	8	(	(	PUNCT
gsrj-6	330	9	2008	2008	NUM
gsrj-6	330	10	)	)	PUNCT
gsrj-6	330	11	.	.	PUNCT
gsrj-6	331	1	on	on	ADP
gsrj-6	331	2	effectmeasure	effectmeasure	PROPN
gsrj-6	331	3	modification	modification	NOUN
gsrj-6	331	4	:	:	PUNCT
gsrj-6	331	5	relationships	relationship	NOUN
gsrj-6	331	6	among	among	ADP
gsrj-6	331	7	changes	change	NOUN
gsrj-6	331	8	in	in	ADP
gsrj-6	331	9	the	the	DET
gsrj-6	331	10	relative	relative	ADJ
gsrj-6	331	11	risk	risk	NOUN
gsrj-6	331	12	,	,	PUNCT
gsrj-6	331	13	odds	odd	NOUN
gsrj-6	331	14	ratio	ratio	NOUN
gsrj-6	331	15	,	,	PUNCT
gsrj-6	331	16	and	and	CCONJ
gsrj-6	331	17	risk	risk	NOUN
gsrj-6	331	18	difference	difference	NOUN
gsrj-6	331	19	.	.	PUNCT
gsrj-6	332	1	stat	stat	PROPN
gsrj-6	332	2	med	med	PROPN
gsrj-6	332	3	.	.	PUNCT
gsrj-6	332	4	;	;	PUNCT
gsrj-6	333	1	27(18):3453	27(18):3453	NUM
gsrj-6	333	2	-	-	SYM
gsrj-6	333	3	65	65	NUM
gsrj-6	333	4	.	.	PUNCT
gsrj-6	334	1	33	33	NUM
gsrj-6	334	2	biological	biological	ADJ
gsrj-6	334	3	and	and	CCONJ
gsrj-6	334	4	physical	physical	ADJ
gsrj-6	334	5	interactions	interaction	NOUN
gsrj-6	334	6	at	at	ADP
gsrj-6	334	7	local	local	ADJ
gsrj-6	334	8	ocean	ocean	NOUN
gsrj-6	334	9	scales	scale	NOUN
gsrj-6	334	10	:	:	PUNCT
gsrj-6	334	11	coupled	couple	VERB
gsrj-6	334	12	systems	system	NOUN
gsrj-6	334	13	determinants	determinant	NOUN
gsrj-6	334	14	of	of	ADP
gsrj-6	334	15	hepatocellular	hepatocellular	ADJ
gsrj-6	334	16	carcinoma	carcinoma	NOUN
gsrj-6	334	17	in	in	ADP
gsrj-6	334	18	the	the	DET
gsrj-6	334	19	united	united	PROPN
gsrj-6	334	20	states	states	PROPN
gsrj-6	334	21	:	:	PUNCT
gsrj-6	334	22	differences	difference	NOUN
gsrj-6	334	23	in	in	ADP
gsrj-6	334	24	risk	risk	NOUN
gsrj-6	334	25	factor	factor	NOUN
gsrj-6	334	26	and	and	CCONJ
gsrj-6	334	27	geneti	geneti	VERB
gsrj-6	334	28	the	the	DET
gsrj-6	334	29	preventative	preventative	ADJ
gsrj-6	334	30	and	and	CCONJ
gsrj-6	334	31	healing	healing	NOUN
gsrj-6	334	32	properties	property	NOUN
gsrj-6	334	33	of	of	ADP
gsrj-6	334	34	performing	perform	VERB
gsrj-6	334	35	arts	art	NOUN
gsrj-6	334	36	in	in	ADP
gsrj-6	334	37	female	female	ADJ
gsrj-6	334	38	genital	genital	ADJ
gsrj-6	334	39	mutilation	mutilation	NOUN
gsrj-6	334	40	policy	policy	NOUN
gsrj-6	334	41	brief	brief	NOUN
gsrj-6	334	42	:	:	PUNCT
gsrj-6	334	43	comparison	comparison	NOUN
gsrj-6	334	44	and	and	CCONJ
gsrj-6	334	45	recommendations	recommendation	NOUN
gsrj-6	334	46	for	for	ADP
gsrj-6	334	47	state	state	NOUN
gsrj-6	334	48	covid-19	covid-19	PROPN
gsrj-6	334	49	responses	response	NOUN
gsrj-6	334	50	of	of	ADP
gsrj-6	334	51	new	new	PROPN
gsrj-6	334	52	mexico	mexico	PROPN
gsrj-6	334	53	and	and	CCONJ
gsrj-6	334	54	utah	utah	PROPN
gsrj-6	334	55	interplay	interplay	NOUN
gsrj-6	334	56	of	of	ADP
gsrj-6	334	57	nicotine	nicotine	NOUN
gsrj-6	334	58	and	and	CCONJ
gsrj-6	334	59	social	social	ADJ
gsrj-6	334	60	stress	stress	NOUN
gsrj-6	334	61	mediate	mediate	VERB
gsrj-6	334	62	dopaminergic	dopaminergic	ADJ
gsrj-6	334	63	neuron	neuron	NOUN
gsrj-6	334	64	firing	fire	VERB
gsrj-6	334	65	in	in	ADP
gsrj-6	334	66	the	the	DET
gsrj-6	334	67	ventral	ventral	ADJ
gsrj-6	334	68	tegmental	tegmental	NOUN
gsrj-6	334	69	evaluating	evaluate	VERB
gsrj-6	334	70	the	the	DET
gsrj-6	334	71	efficacy	efficacy	NOUN
gsrj-6	334	72	of	of	ADP
gsrj-6	334	73	targeted	target	VERB
gsrj-6	334	74	inhibitor	inhibitor	NOUN
gsrj-6	334	75	therapeutics	therapeutic	NOUN
gsrj-6	334	76	for	for	ADP
gsrj-6	334	77	sonic	sonic	ADJ
gsrj-6	334	78	hedgehog	hedgehog	ADJ
gsrj-6	334	79	medulloblastoma	medulloblastoma	NOUN
gsrj-6	334	80	:	:	PUNCT
gsrj-6	334	81	signi	signi	ADJ
gsrj-6	334	82	refractory	refractory	NOUN
gsrj-6	334	83	epilepsy	epilepsy	NOUN
gsrj-6	334	84	:	:	PUNCT
gsrj-6	334	85	mechanisms	mechanism	NOUN
gsrj-6	334	86	of	of	ADP
gsrj-6	334	87	pharmacoresistance	pharmacoresistance	ADJ
gsrj-6	334	88	table	table	NOUN
gsrj-6	334	89	of	of	ADP
gsrj-6	334	90	contents	content	NOUN